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The gastrointestinal tract is colonized by a distinct array of microbes that is specific to each 
individual (1). Whereas the human body consists of trillions somatic cells, it harbors a larger 
number of microorganisms in the intestines (2-4). In general, human commensals exhibit 
beneficial effects for the host; however, gut microorganisms may also be deleterious, as for 
instance in immunocompromised hosts where they invade the tissues, leading to mucosal 
and disseminated infection. Hence, the immune system plays a significant role in keeping the 
pathogens at bay. While some of the fungi are non-harmful commensals, others may cause 
mild to severe cutaneous infections or even life-threatening systemic infections. Whereas the 
total number of eukaryotic species on Earth has been estimated at roughly 9 million, with 
fungi representing approximately 7% of this number (5), only about 600 species of fungi are 
human pathogens (6). Candida spp are the fourth most common cause of hospital-acquired 
systemic infections in the United States with crude mortality rates of up to 50% (7, 8). 
During the course of fungal infection, one of the first steps in mounting effective immune 
responses is the recognition of the invaders by the host, with Pattern Recognition Receptors 
(PRRs) as key players in this phenomenon. Numerous studies revealed differential roles 
of receptors present on/within the immune cells, PRRs that are classified in four families: 
C-type lectin-like (CLR), Toll-like (TLR), NOD-like (NLR), and RIG-I-like (RLR) receptors. 
Most known PRRs that bind to Candida Pathogen Associated Molecular Patterns (PAMPs) 
are C-type lectins. Mannan present in the fungal cell wall is mainly recognised by Dectin-2 
(9), Mannose Receptor (10), Galectin-3 (11), DC-SIGN (12) and MBL (13), recognition that 
leads to the induction of protective proinflamamtory cytokines. Dectin-1 recognizes β-1,3 
and β-1,6-glucan on Candida conidia, resulting in the subsequent induction of cytokines and 
fungus internalisation (14, 15). The majority of CLRs signal via Syk/CARD9 (16, 17), while 
DC-SIGN activates NF-kB subunit p56 via Raf1 (18). TLR2 and TLR4, which signal through 
MyD88, bind to peptidoglycan and play a significant role in Candida recognition as shown 
by the experiments conducted with genetically modified mice (19-22). Chitin is a component 
of the inner cell wall of fungi and induces IL-10 and TNF-α through MR, TLR2 and Dectin-1 
mediated signalling pathways, with NOD2 and TLR9 required for its recognition (23, 24). 
NLRP3 is important in controlling mucosal and disseminated candidiasis by processing 
pro-IL-1β to IL-1β downstream of Dectin-1 and TLR2, and mice deficient in NLRP3 are more 
susceptible to Candida infection (25-27). Nevertheless, the specific impact of several other 
PRRs that possibly contribute to antifungal host defense remains unknown, and, especially 
differences in recognition of various Candida species are poorly investigated. 
In the first part of the thesis, I will investigate the specific roles of two of the most 
important C-type lectin receptors, Dectin-1 and Dectin-2, for the recognition of Candida 
and the induction of effective innate immune responses. In Chapter 2 the in vitro priming 
effects of Candida albicans in human Peripheral Blood Mononuclear Cells (PBMCs) will 
be explored. Moreover, cells deficient in Dectin-1 receptor and a number of Candida cell 
wall mutants will be evaluated in order to indentify which Candida component and which 
signaling pathway is responsible for the priming. In Chapter 3 the biological role of Dectin-2 
receptor in interaction with Candida albicans will be evaluated, whereas Chapter 4 will 
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Figure 1: Recognition of C. albicans. The pattern recognition receptors present on the immune cells recognize the 
fungal cell wall components and intracellular DNA and RNA. These signals activate canonical or non-canonical 
nuclear pathways, with the subsequent induction of the immune responses, such as secretion of cytokines, 
chemokines, initiation of phagocytosis and/or inflammasome activation. Adaptation from ‘Antifungal innate 
immunity: recognition and inflammatory networks’ in Seminars in Immunopathology by Becker & Ifrim, 2014.
Figure 2: Trained immunity 
◀
reveal the effects of systemic candidiasis caused by Candida glabrata in murine models, 
and, particularly the contribution of Dectin-2 to antifungal defense. 
One of the dogma of immunology is that innate immune responses are only temporarily 
activated during an infection, after which they return to normal: the innate immune response 
would thus react identically each time it encounters a pathogen. That would, therefore, by 
definition exclude the presence of adaptive characteristics, or immunological memory, within 
the innate immune system. Subsequently, this fact would lead to the conclusion that solely 
vertebrates have immunological memory, as all other organisms on Earth have only innate 
host defense. The hypothesis that the innate immune system is incapable of mounting adaptive 
responses (28) has been however contradicted by studies showing that organisms lacking 
adaptive immune system, such as plants and insects, have specific memory and are able to 
mount a response to a secondary infection (29). Furthermore, mice lacking T- and B-cells were 
13
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protected by microbial infections, protection offered by NK cells and monocytes, respectively 
(30, 31). Therefore, the immune cells such as NK cells and monocytes/macrophages are able to 
exhibit adaptive characteristics (32), with epigenetic reprogramming of monocytes at the level 
of histone H3 methylation as the molecular mechanism responsible for long-term memory of 
innate immunity: this process has been termed ‘trained immunity’ (31, 33, 34). 
Subsequently, the initiation of innate immune memory through trained immunity 
might be responsible on one hand for the nonspecific protective effects of certain vaccines, 
such as well-known Bacille Calmette-Guerin (BCG) (35), and on the other hand for 
excessive inflammatory responses in autoinflammatory/autoimmune diseases (36). 
Therefore, the effects of trained immunity phenomena can be explored at different levels, 
either by identifying potential therapeutic targets for excessive inflammatory diseases, or by 
assessing long-term responses of monocytes, macrophages and NK cells to a large spectrum 
of microbes that confer resistance or tolerance to subsequent infections (34, 37-41). 
In the second part of the thesis I will investigate the capacity of Candida to induce innate 
immune memory after a challenge (or infection). In Chapter 5 the training effect of different 
ligands, present either at the level of the cell wall or inside the cell of regular commensals of 
human flora, will be assessed. Their effects on primary monocytes and the impact on our 
knowledge regarding the complex interactions among the immune cells and different microbes 
will be described. The immune reactivity of S. cerevisiae at a strain level and its ability to 
modulate the cytokine responses of human primary cells to bacteria and fungi will be addressed 
in Chapter 6. In addition, in Chapter 7 we will study the capacity of Candida albicans to train 
primary cells from Chronic Mucocutaneous Candidiasis (CMC) and Hyperimmunoglobulin E 
Syndrome (HIES) patients, with an emphasizes on NK cells and IFN-γ.
In order to present an up-to-date overview of our knowledge regarding the pattern 
recognition receptors and inflammatory networks of two very common fungal pathogens, 
Candida albicans and Aspergillus fumigatus, a bibliographic review will be provided in 
Chapter 8. Finally, an overall summary of the findings presented in this thesis will be 
described in Chapter 9. In this chapter I will propose future directions for the increased 
understanding of the role of C-type lectin receptors in Candida infections and I will point 
out likely challenging prospects with regard to training the immunity.
14
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Abstract
The immune system is essential to maintain homeostasis with resident microbial populations, 
ensuring that the symbiotic host–microbial relationship is maintained. In parallel, commensal 
microbes significantly shape mammalian immunity at the host mucosal surface, as well as 
systemically. Candida albicans is an opportunistic pathogen that lives as a commensal on skin 
and mucosa of healthy individuals. Little is known about its capacity to modulate responses 
toward other microorganisms, such as colonizing bacteria (e.g., intestinal microorganisms). 
The aim of this study was to assess the cytokine production of PBMCs induced by commensal 
bacteria when these cells were primed by C. albicans. We show that C. albicans and β-1,3-
glucan induce priming of human primary mononuclear cells and this leads to enhanced 
cytokine production upon in vitro stimulation with TLR ligands and bacterial commensals. 
This priming requires the β-1,3-glucan receptor dectin-1 and the noncanonical Raf-1 pathway. 
In addition, although purified mannans cannot solely mediate the priming, the presence of 
mannosyl residues in the cell wall of C. albicans is nevertheless required. In conclusion, C. 
albicans is able to modify cytokine responses to TLR ligands and colonizing bacteria, which is 
likely to impact the inflammatory reaction during mucosal diseases. 
Keywords: Candida, priming, Dectin-1/Raf-1
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Introduction
Immediately after birth, the gastrointestinal tract is colonized by a diverse array of microbes, 
leading to a stable microbiota that is unique to each individual (1). The human body consists 
of trillions of somatic cells and harbors about 10 times more microorganisms in the intestines 
(2). The adult microbiota is composed of permanent members (up to 1000 species), as well as 
transient colonizers that are acquired from external sources. It consists of many prokaryotic 
and eukaryotic microbes, but bacterial species dominate. The most common anaerobic bacteria 
within the gastrointestinal tract are Bacteroides, Bifidobacterium, Eubacterium, Fusobacterium, 
Clostridium, and Lactobacillus species (3). These organisms are present in extremely high 
concentrations and have evolved to degrade a variety of dietary substances, simultaneously 
enhancing the host digestive efficiency, as well as their own nutrient supply (4). In addition 
to their beneficial effects, gut microorganisms may be deleterious: when host defense is 
compromised, they may invade host tissues, which leads to mucosal and sometimes subsequent 
disseminated infection. A role for the gut flora in the pathogenesis of autoinflammatory 
diseases, such as Crohn’s disease and ulcerative colitis, has also long been suggested (5). Hence, 
the immune system controls microbial composition; conversely, the gut microflora shapes 
immunity (6). Commensal microbes influence mucosal and systemic immunity, lymphoid 
structure development and epithelial function, T cell subsets, and innate lymph cells (6). Candida 
albicans is primarily a human commensal of the skin and mucous membranes; however, under 
circumstances of disturbed host defense, it may become a pathogen (7, 8). The dual consequences 
of C. albicans colonization and/or infection suggest that this fungus might modulate the host 
immune response against other colonizing microorganisms. It was demonstrated that C. albicans 
triggers differential immune signaling upon interaction with either inflammatory or tolerogenic 
dendritic cells (9). The role of C. albicans in experimental colitis is controversial: on one hand it 
may activate dendritic cells in Peyer’s patches (9), whereas on the other hand it may increase the 
severity of colitis (10, 11). Nevertheless, all of these studies were performed in mice, and it is not 
known whether Candida modulates inflammation in human primary cells. 
In this study, using human primary cells, we investigated whether C. albicans is able 
to modulate cytokine responses to secondary stimuli, such as TLR ligands and colonizing 
microorganisms, by inducing either inflammation or tolerance. We established that C. 
albicans and, more specifically, β-1,3-glucan (β-glucan) can efficiently prime human 
immune cell responses to TLRs and bacteria, leading to enhanced cytokine production 
in vitro. By deciphering the receptor-signaling pathway involved (dectin-1/Raf-1), we also 
provide a possible novel therapeutic target in autoinflammatory disorders.
Materials and Methods
Blood samples. Blood was collected from healthy volunteers at Sanquin Bloodbank in 
Nijmegen, The Netherlands, after obtaining informed consent. Human PBMCs were 
isolated from buffy coats.
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Reagents. Ficoll-Paque (GE Healthcare) was used to isolate PBMCs by differential 
centrifugation. RPMI 1640 Dutch Modification (RPMI) (Sigma-Aldrich), supplemented 
with 1% gentamicin, 1% L-glutamine, and 1% pyruvate (Life Technologies, Nieuwekerk, The 
Netherlands) was used as culture medium. Candida β-glucan and mannan were isolated and 
purified as described previously (12, 13). Three sources of C. albicans mannan were tested: 
mannan serotype A, mannan isolated from Candida yeast grown in yeast extract/peptone/
dextrose broth at 30°C (pronase treated), and mannan isolated from Candida hyphae 
grown in serum at 37°C (not treated with pronase). Pam3Cys4 (EMC microcollections) 
and LPS (Escherichia coli serotype 055:B5) were purchased from Sigma-Aldrich, with an 
additional purification step for LPS (14). Human dectin-1/CLEC7A mAb and isotype Ab 
were purchased from R&D Systems (Abingdon, U.K.).
Microorganisms. Candida albicans ATCC MYA-3573 (UC 820), och1∆, och1∆/och1∆/
OCH1, pmr∆, pmr1∆/pmr1∆/PMR1, mnn4∆, mnn4∆/mnn4∆/MNN4, and the parental 
strain C. albicans NGY152 were grown overnight to yeast cells in Sabouraud broth at 
37°C. Cells were harvested by centrifugation, washed twice with PBS, and resuspended 
in culture medium (RPMI; ICN Biomedicals, Aurora, OH). Candida yeast was heat-killed 
for 30 min at 95°C. To generate hyphae, yeast cells were grown at 37°C in culture medium 
adjusted to pH 6.4 using hydrochloric acid. Hyphae were killed by exposure to 95°C for 
30 min and resuspended in culture medium to a hyphal inoculum size that originated 
from 1x106/ml. The OCH1 gene was disrupted using the ura-blaster method (15), and 
the reintegrant strain was constructed as previously described (16). Creation of the mnn4 
null mutant and of its reintegrant mnn4∆/mnn4∆/MNN4 control strain was performed as 
described (17). The PMR1 gene was disrupted and reintroduced in pmr1∆/pmr1∆/PMR1 
as described (18). Three common colonizing bacteria of the intestines or the skin were 
chosen: Escherichia coli ATCC 35218 was grown overnight in culture medium, washed 
three times with PBS, and heat-killed for 60 min at 80°C; Staphylococcus aureus strain 
Seattle 1945 (ATCC 25923) was grown overnight in culture medium, washed twice with 
cold PBS, and heat-killed for 30 min at 100°C; and Bacteroides fragilis ATCC 25285 was 
grown as before but was heat-killed for 30 min at 95°C. 
In vitro cytokine production. The PBMC fraction was obtained by density centrifugation of 
diluted blood (1 part blood:1 part pyrogen-free saline) over Ficoll-Paque (GE Healthcare). 
PBMCs were washed twice in saline and resuspended in culture medium. Cells were counted 
with a Beckman Coulter Z1 Particle Counter and adjusted to 5x106 cells/ml. PBMCs (5x106) 
were added at a volume of 100 µl/well in round-bottom 96-well plates. Cells were incubated 
with one of the first stimuli for 24 h and reincubated for another 24 or 48 h with one of the 
second stimuli. As a priming stimulus, we used 50 µl either heat-killed C. albicans yeast 
or hyphae at two concentrations (1x103/ml or 1x104/ml), β-glucan (100 µg/ml), mannan 
(100 µg/ml), three C. albicans mutants and their corresponding reintegrants: heat-killed 
och1∆ null mutant, pmr1∆ null mutant, mnn4∆ null mutant, och1∆/och1∆/OCH1, pmr1∆/
pmr1∆/PMR1 and mnn4Δ/mnn4Δ/MNN4 revertant strains (1x104/ml), as well as their 
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parental strain NGY152 (1x104/ml). After 24 h, cells were subjected to a second stimulation 
with various stimuli, in a volume of 50 µl. The second stimulus was one of the following: 
LPS (10 ng/ml), Pam3Cys4 (10 µg/ml), heat killed E. coli (1x108/ml), heat-killed S. aureus 
(1x107/ml), or heat killed B. fragilis (1x107/ml) in a final volume of 200 µl. After 24 or 48 h, 
supernatants were collected and stored at -80°C until assayed. To determine whether our 
priming reagents were endotoxin free, we performed a series of experiments in the presence 
of polymyxin B. Prior to priming, the reagents were incubated for 3 h with polymyxin B (2 
µg/ml). To investigate whether priming could be blocked, we preincubated PBMCs for 1 h 
with dectin-1/CLEC7A Ab (dectin-1 antagonist; 10 µg/ml) or with the isotype control (10 
µg/ml), Syk inhibitor (50 nM) or Raf-1 inhibitor (50 nM), before priming with β-glucan. 
After this, cells were treated with either RPMI or β-glucan (100 µg/ml) and incubated for 24 
h, followed by a second stimulation with LPS (10 ng/ml) for an additional 24 h. Cytokines 
were measured after the second stimulation.
Cytokine assay. The concentrations of TNF-α and IL-1β (R&D Systems) and IL-6 and IL-10 
(Sanquin, Amsterdam, The Netherlands) were measured in cell culture supernatants using 
ELISA, according to the manufacturer’s instructions. Proinflammatory cytokines TNF-α, 
IL-1β, and IL-6 were measured at 24 h after the second stimulation, whereas the anti-
inflammatory cytokine IL-10 was measured at 48 h after the second stimulation.
Statistical analysis. Results from at least two sets of experiments with a minimum four 
volunteers were pooled and analyzed with SPSS. Data are given as mean ±SEM. The paired 
Wilcoxon test was used to compare differences between the effect of a particular stimulus 
and the RPMI medium control. The level of significance was set at p<0.05.
Results
C. albicans primes the cytokine responses of cells restimulated  
with TLR ligands and colonizing bacteria
To investigate the effect of Candida on the cytokine responses to colonizing bacteria, PBMCs 
from healthy donors were first exposed to low doses of Candida. After 24 h, cells were 
restimulated with common colonizing bacteria of the skin or gut or with pure components 
of the bacterial or fungal cell wall (Fig. 1A). Exposure to either Candida yeast or hyphae 
enhanced the production of TNF-α, IL-6, and IL-1β (Fig. 1B, 1C) of PBMCs incubated 
with a second bacterial stimulus, such as E. coli, S. aureus, or B. fragilis. This priming effect 
was also observed when bacterial cell wall components, such as LPS, found in the outer 
membrane of Gram-negative bacteria, and the lipopeptide analogs of the N-terminal part 
of bacterial lipoprotein, Pam3Cys4, were used as a second stimulus. Notably, the increased 
production of proinflammatory cytokines did not correlate with a decrease in the anti-
inflammatory cytokine IL-10 (Fig. 1B, 1C). A 10-fold lower concentration of Candida yeast 
or hyphae was also able to prime but to a lesser extent (~2-fold less). 
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Fig. 1: C. albicans primes the cytokine responses of cells restimulated with TLR ligands and colonizing bacteria. 
(A) In vitro priming scheme. PBMCs were incubated with Candida (priming stimulus) for 24 h at 37°C. Thereafter, 
bacteria found in the human microbiota, as well as their cell wall pure components, were added (second stimuli) 
for an additional 24 or 48 h. PBMCs were exposed to RPMI or heat-killed C. albicans yeast (B) or hyphae (C) 
(1x104 cells/ml). After 24 h, PBMCs were exposed to several pure ligands or heat-killed bacteria. Cytokines 
were measured in supernatants 24 h (TNF-α, IL-1β, and IL-6) and 48 h (IL-10) after the second stimulation 
(n=6; three independent experiments). Bars indicate mean ±SEM. *p , 0.05 versus RPMI-primed cells, Wilcoxon 
nonparametric test for two related samples. Bf, B. fragilis; Ec, E. coli; P3C, Pam3Cys4; Sa, S. aureus. 
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Priming is not due to endotoxin contamination
Prior to priming, all stimuli (RPMI, β-glucan, and mannan) were incubated with cell culture 
medium (control) or with polymyxin B for 3 h at 37°C. Thereafter, PBMCs were primed for 
24 h and then restimulated with LPS, Pam3Cys4 or cell culture medium only (RPMI) for an 
additional 24 h (Supplemental Fig. 1). Polymyxin B treatment of β-glucan did not affect its 
ability to prime PBMCs, excluding the effect of endotoxin contamination in the described 
effect. Mannan was still not able to prime, either with or without polymyxin B. In addition, 
β-glucan and polymyxin B priming was completely abrogated when PBMCs were restimulated 
with LPS; this was not the case for the same mix and restimulation with Pam3Cys4.
Mannans do not prime cytokine production by themselves  
but are essential for potentiation by Candida 
The outer layer of the cell wall of Candida is enriched with mannoproteins, whereas 
the inner layer is composed of chitin and β-glucan (19). Mannosylated proteins and 
phospholipomannan of Candida are known to induce proinflammatory cytokines (20, 21). 
Therefore, we assessed the priming effect of pure mannans using the in vitro experimental 
setting depicted in Fig. 1A. We tested three purified preparations of Candida mannan as 
priming stimuli; none produced a priming effect compared with the nonprimed control 
(Fig. 2). Because mannans may potentiate priming by other cell wall components, we used 
a genetic complementary approach to investigate the role of specific mannosyl residues. The 
Candida och1 null mutant has a defect in N-linked mannosylation (Fig. 3A), resulting in a 
77% reduction of cytokine production in direct stimulations (19). In contrast, the Candida 
mnn4 mutant, defective in tertiary branch mannosylphosphorylation (Fig. 3A) (17, 22), has 
no effect on the direct induction of cytokine production. Candida pmr1 null mutant has a 
defect in phosphomannosylation, as well as in O- and N-linked glycosylation (18) (Fig. 3A). 
In our preincubation model, both Candida och1 and pmr1 null mutants had a partial 
defect in priming properties and could not potentiate the production of proinflammatory 
cytokines to the same extent as the parental strain (Fig. 3B, 3C). Of note, the priming effect 
Fig. 2: By themselves, mannans do not prime cytokine production, but they are essential for potentiation by C. 
albicans. PBMCs were exposed to either RPMI or Candida mannan isolated from Candida hyphae grown in serum 
at 37°C at a concentration of 100 µg/ml. After 24 h, PBMCs were restimulated with several pure ligands or heat-
killed bacteria. Cytokines were measured in supernatants 24 h (TNF-α, IL-1β, and IL-6) and 48 h (IL-10) after 
the second incubation. Three types of Candida mannan were tested, but none of them induced priming compared 
with the nonprimed control (n=5; two independent experiments). No statistical differences were detected using 
the Wilcoxon nonparametric test for two related samples. Ec, E. coli; P3C, Pam3Cys4; Sa, S. aureus.
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was restored when cells were exposed to the reconstituted strains, och1∆/och1∆/OCH1 and 
pmr1∆/pmr1∆/PMR1 (Fig. 3B, 3C). The mnn4 null mutant was still able to prime cytokine 
production to the same extent as the parental strain Candida NGY152, and the same was 
valid for the reconstituted strain mnn4∆/mnn4∆/MNN4 (Fig. 3D). Altogether, these results 
show that, although pure mannans do not prime for the production of proinflammatory 
cytokines, O- and, especially, N-linked mannosyl proteins at the surface of Candida are 
nevertheless required for the proper priming. 
β-glucan primes the response to components of human microbiota 
through dectin-1 and Raf-1 
Although β-glucan is a component of the inner layer of the Candida cell wall, it is a potent 
inducer of cytokines through its interaction with dectin-1 (23). Therefore, we assessed the 
effect of β-glucan in the priming model. Incubation of PBMCs with purified β-glucan from 
Candida was able to exert a priming effect similar to that obtained with Candida whole 
organism (Fig. 4A). The effect was most prominent for TNF-α and IL-1β and less so for IL-6. 
The β-glucan priming led to a decreased amount of the anti-inflammatory cytokine IL-10 
induced by the secondary stimuli (Fig. 4A). When we blocked the dectin-1 receptor with an 
anti–dectin-1 Ab before priming with β-glucan, the priming effect was reduced considerably, 
whereas the isotype control had no effect (Fig. 4B). We completed the analysis using PBMCs 
from two sisters with congenital dectin-1 deficiency (24). In these experiments β-glucan 
priming was completely abolished, highlighting the importance of the dectin-1 receptor 
in mediating the β-glucan–dependent priming of cytokine production upon exposure to 
TLR ligands and colonizing bacteria (Fig. 4C). Dectin-1 signaling is primarily mediated by 
Syk/CARD9 (25). The inhibition of Syk kinase before β-glucan stimulation did not affect 
the priming and subsequent enhancement of TNF-α release upon LPS restimulation (Fig. 
4D). However, inhibiting the noncanonical serine-threonine Raf-1 kinase (26) significantly 
decreased the priming effect (Fig. 4E). Altogether, these results show that β-glucan, a major 
component of the cell wall of Candida, exerts a strong priming effect toward restimulation 
with TLR ligands and colonizing bacteria and that this effect is mediated through the 
β-glucan receptor dectin-1 and the noncanonical Raf-1 kinase pathway. 
Because live Candida cell walls consist of β-glucan masked by a layer of mannosylated 
proteins, it is possible that the simultaneous priming of PBMCs with β-glucan and mannan 
induces the production of proinflammatory cytokines to the same extent as does whole 
Candida. However, the priming effect of the two major Candida cell wall components, β-glucan 
and mannan, was not different from that of β-glucan alone (Fig. 5). These results underscore 
our observation that the priming of Candida is due to β-glucan and not to mannan.
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Fig. 3: Mannosylation of fungal cell wall proteins is involved in the potentiation of cytokine production. 
(A) Schematic diagram representing the activity of Och1, Pmr1, and Mnn4 enzymes on C. albicans cell wall 
glycosylation. For N-mannosylation, the Och1 mannosyltransferase mediates the addition of the first α-1,6-mannose 
to the core N-mannan structure. Two α-1,6-mannose residues form the backbone onto which α-1,2-mannose- and 
α-1,3-mannose-linked residues are subsequently attached by different enzymes to form the N-linked outer chain. 
Phosphomannan is attached to this outer chain via a phosphodiester bond, which requires Mnn4. Pmr1 is not a 
glycosyltransferase and does not add any mannans directly but exerts its effects on both N-mannosylation and 
O-mannosylation. The arrows represent where truncations in N-mannosylation and O-mannosylation occur. (B–D) 
PBMCs were exposed to NGY152, och1∆, pmr1∆, mnn4∆, och1∆/och1∆/OCH1, pmr1∆/pmr1∆/PMR1, or mnn4∆/
mnn4∆/MNN4 (104 cells/ml). After 24 h, PBMCs were restimulated with heat-killed bacteria. Cytokines (IL-1β and 
IL-6) were measured in supernatants 24 h after the second incubation (n=10; four independent experiments). Bars 
indicate mean ±SEM. All Candida strains induced a significant increase in proinflammatory cytokine production 
compared with nonprimed (RPMI) cells, whereas och1∆ and pmr1∆ null mutants resulted in significantly less 
priming of cytokine production compared with the parental strain or their corresponding reconstituted strains. *p , 
0.05, **p , 0.01, ***p , 0.001, Wilcoxon nonparametric test for two related samples. Ec, E. coli; Sa, S. aureus.
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Fig. 4: β-glucan primes the response to components of human microbiota. (A) PBMCs were incubated with 
RPMI or β-glucan (100 µg/ml). After 24 h, PBMCs were reincubated with pure ligands or heat-killed bacteria. 
Cytokines were measured in supernatants 24 h (TNF-α, IL-1β, and IL-6) and 48 h (IL-10) after the second 
stimulation (n=11; five independent experiments). (C) PBMCs from 16 healthy volunteers and 2 dectin-1–
deficient sisters (24) were incubated with RPMI and β-glucan (100 µg/ml) for 24 h, followed by a second 
stimulation with either TLR ligands or whole bacteria for an additional 24 h. PBMCs were incubated with 
RPMI, CLEC7A Ab, and the isotype control (10 µg/ml) (B), Syk inhibitor (1 mM) (D), or Raf-1 inhibitor (50 
nM) (E). After 1 h of incubation, cells were treated either with RPMI or β-glucan (100 µg/ml) and, after an 
additional 24 h, restimulated with LPS. For (B), n=7; three independent experiments; for (D) and (E), n=10; 
five independent experiments. Bars indicate mean ±SEM. *p , 0.05, **p , 0.01 versus RPMI–stimulated cells, 
Wilcoxon nonparametric test for two related samples. Bf, B. fragilis; Ec, E. coli; P3C, Pam3Cys4; Sa, S. aureus.
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Discussion
In the current study, we analyzed the capacity of the human commensal yeast C. albicans to 
modulate the cytokine response of human primary cells to bacteria that usually colonize the 
skin and mucosal surfaces. Candida, either yeast or hyphae, primes the cells for enhanced 
proinflammatory cytokine production when they are exposed to a secondary bacterial stimulus. 
This priming activity is dependent on carbohydrate components of the cell wall of Candida, with 
an important role for the recognition of β-glucan by the dectin-1/Raf-1 pathway. 
An important aspect is which molecular pattern of Candida is responsible for this 
increased immune activity. Combining purified cell wall components and genetic approaches, 
we established that fungal mannan itself does not prime PBMCs for the production of 
cytokines. Surprisingly, however, neither the och1 nor the pmr1 null Candida mutant was able 
to prime the production of proinflammatory cytokines at the same extent as was wild-type 
Candida or parental strain NGY152, whereas the use of a reconstituted strain entirely restored 
the priming effect. Thus, the presence of O- and N-linked mannosyl proteins at the Candida 
cell surface is required for proper priming, supposedly by aiding cell priming by an additional 
cell wall component. Of note, although, under aqueous conditions, long chains of purified 
β-glucan form a right-handed triple helical complex that is required for the proper binding 
to pattern recognition receptors (27–29), purified mannan might not have the required 
structure to be recognized by its receptor, offering an alternative explanation for the lack of 
priming induced by pure mannans. Different biological effects of mannans were reported, 
including induction of proinflammatory cytokines (19, 30) and of IL-10 (31). It was shown 
that when Candida mannoprotein was administered to mice before or during immunization 
with viable Candida, it downregulated mannan-specific delayed hypersensitivity (32), whereas 
mannoproteins confer protection to candidiasis and might contain epitopes involved in this 
protective response (32). In this study, we show that mannans incorporated in Candida cell 
wall have adjuvant activity for the priming effect exerted by this yeast. 
In search of the main component of the Candida cell wall that induces priming, 
we demonstrate that β-glucan can mimic the priming effect obtained upon Candida 
preincubation. This effect of β-glucan is in line with previous studies showing that β-glucan 
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Fig. 5: Priming with a combination of β-glucans and mannans. PBMCs were incubated simultaneously with β-glucan 
and mannan (100 µg/ml); after 24 h, cells were stimulated either with TLR ligands or with whole bacteria for an 
additional 24 h (n=7; three independent experiments). Bars indicate mean ±SEM. *p , 0.05, **p , 0.01 versus RPMI-
stimulated cells, Wilcoxon nonparametric test for two related samples. Ec, E. coli; P3C, Pam3Cys4; Sa, S. aureus.
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is an immunostimulant and, moreover, displays antitumor activity (33, 34). The receptor 
mediating the priming effects of β-glucans is dectin-1, as shown by experiments with cells 
genetically deficient for this receptor. Downstream signaling occurs via two pathways: the 
canonical Syk/CARD9 and the noncanonical serine-threonine kinase Raf-1 (25, 26, 35). 
We found that inhibition of Syk kinase, prior to exposure to β-glucan, did not influence the 
priming activity of β-glucan. In contrast, the incubation of PBMCs with a Raf-1 inhibitor 
prior to first stimulation significantly reduced the effect. This observation distinguishes the 
direct effect of dectin-1 stimulation (Syk dependent) from the priming effect mediated by 
dectin-1 (Raf-1 dependent). Indeed, a previous study showed a dual intracellular signaling 
upon dectin-1 activation, in which the Raf-1 pathway integrates with the Syk pathway 
at the level of NF-kB (35). Because priming is induced by purified TLR ligands, which 
are important components of bacteria, we tend to conclude that the priming induced by 
Candida and β-glucans acts on TLR-dependent-signaling pathways. 
Candida is a common commensal of the intestinal tract, and it was reported to increase 
the severity of intestinal inflammation in murine models of colitis (10, 11). The β-glucan 
receptor dectin-1 is involved in this effect, and polymorphisms in this receptor have been 
associated with the severity of ulcerative colitis (11) but not with the susceptibility to 
ulcerative colitis or Crohn’s disease (36). Little is known about the mechanisms through 
which Candida may influence autoinflammatory diseases, such as Crohn’s disease. Although 
simultaneous stimulation of cells with Candida derived polysaccharides and TLR ligands is 
known to be synergistic for cytokine induction, it is not known whether prestimulation of 
immune cells with Candida can prime or tolerize (as in the case of TLR stimulation with LPS 
or Pam3Cys4) the cells for subsequent stimulation with colonizing bacteria. In the current 
study, we demonstrate that preincubation of human primary cells with Candida primes 
them for the production of cytokines, and this amplification of inflammation may represent 
one mechanism for the increased severity of colitis induced by Candida. The priming effect 
found in this study may be relevant for these observations. Whether this effect of Candida is 
also relevant for inflammatory bowel disease in humans is not clear. However, because Abs 
toward C. albicans were shown to be associated specifically with Crohn’s disease, one may 
speculate that Candida plays a role in this disease (37). It is attractive to hypothesize that 
this has to do with the priming effect described in this article. 
Chronic stimulation of host immune cells by microorganisms may result in an enhanced 
functional state and, hence, increased resistance to infection or in immunosuppression 
(or tolerance). The latter may imply protection against tissue damage. Understanding the 
interplay between these two strategies may allow us to define how fungi adapt to the human 
immune system. It was proposed that Candida may either promote tolerance (9) or amplify 
inflammation and contribute to disease activity in Crohn’s disease (11). In the current 
study, Candida did not induce tolerance, but it promoted the proinflammatory response of 
human primary cells to colonizing bacteria. Such priming may be related to the epigenetic 
reprogramming of Candida described in monocytes (38). Thus, the fungal microbiota may 
actively contribute to the state of host defense at mucosal sites. When leukocytes at the mucosal 
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sites previously primed by Candida encounter potentially pathogenic colonizing bacteria, 
the enhanced state of the host response may potentiate the defense (e.g., by recruitment and 
activation of effective immune cells and by induction of diffusion in mucosal sites). 
In conclusion, we demonstrate that chronic exposure of primary human immune cells 
to C. albicans primes them for subsequent stimulation with TLR ligands and colonizing 
microorganisms, a mechanism that could explain the effects of this fungus on inflammatory 
bowel diseases. By identifying dectin-1/Raf-1 as one of the pathways responsible for these 
effects, we provide a potential therapeutic target in autoinflammatory diseases, such as 
Crohn’s disease. Further studies are warranted to assess this hypothesis.
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Abstract
Despite the fact that Candida albicans is an important human fungal pathogen and Dectin-2 
is a major pattern recognition receptor for fungi, our knowledge regarding the role of 
Dectin-2 for the host defense against disseminated candidiasis is limited. Dectin-2 deficient 
(Dectin-2-/-) mice were more susceptible to systemic candidiasis, and the susceptibility was 
mirrored by an elevated fungal load in the kidneys that correlated with the presence of 
large inflammatory foci. Phagocytosis of Candida by peritoneal macrophages lacking the 
Dectin-2 receptor was moderately decreased, while production of most of the macrophage-
derived cytokines from Dectin-2-/- mice with systemic candidiasis was decreased. No 
striking differences among several Candida mutants defective in mannans could be detected 
between naïve wild-type and Dectin-2-/- mice, apart from the β-mannan-deficient bmt1∆/
bmt2∆/bmt5∆ triple mutant, suggesting that β-mannan may partially mask α-mannan 
detection, which is the major fungal structure recognized by Dectin-2. Deciphering 
the mechanisms responsible for host defense against the majority of C.  albicans strains 
represents an important step in understanding the pathophysiology of systemic candidiasis, 
which might lead to the development of novel immunotherapeutic strategies.
Key words: Dectin-2, Candida albicans, systemic infection
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Introduction 
Although Candida albicans is a regular commensal of the skin, mucosal and gut flora, 
in susceptible individuals it represents the main cause of vaginal, mucocutaneous and 
systemic candidiasis (1). Moreover, disseminated candidiasis has a very high mortality rate 
in immunocompromised patients with transplantation, chemotherapy, or extensive ICU 
stay (2). To maintain C. albicans in its commensal state, the human host defense system 
should be able to recognize the yeast and activate the immune responses to suppress the 
uncontrolled outgrowth of the microorganism. This recognition is mediated by pattern 
recognition receptors (PRRs), which recognize pathogen associated molecular patterns 
(PAMPs) of the pathogens with subsequent induction of the activation of host defense. 
Among the four PRR classes, C-type lectin receptors (CLRs) are the most important family 
of receptors for the recognition of Candida spp, mainly because the fungal cell wall structure 
is composed predominantly of polysaccharides such as α- and β-mannans (components of 
mannoproteins), β-glucans and chitin (3).
Dectin-2 is a C-type lectin receptor present mostly on dendritic cells, macrophages and 
neutrophils that recognizes α-mannan (4, 5), affording protection against systemic infection 
with C. albicans by inducing Th-17 immune responses (5). It signals through CARD9, resulting 
in subsequent NF-kB activation (6). Dectin-2 forms heterodimers with Dectin-3, leading 
to proinflammatory responses during C. albicans infection (7). In addition to C. albicans, 
Dectin-2 also recognizes C. glabrata, and mice lacking Dectin-2 were less able to secrete Th1 
and Th17 cytokines, to produce ROS and to activate pathways involved in phagocytosis during 
activation with this pathogen (8). Furthermore, Dectin-2 present on alveolar macrophages is 
involved in triggering airway inflammation mediated by the house dust mite (9), while on 
dendritic cells it primes the Th2 responses to this microorganism (10).
Despite these reports on the role of Dectin-2 for the recognition of fungal pathogens, 
only limited information is available regarding the role of Dectin-2 for triggering the innate 
immune responses (such as inflammation, neutrophil/macrophages phagocytosis and killing, 
etc) during disseminated candidiasis. In this study, we investigate the role of Dectin-2 as a 
pattern recognition receptor and an essential trigger of host defense in a murine model of 
systemic candidiasis. Additionally, we assessed whether mannans are the main fungal PAMP 
recognized by Dectin-2, by testing a broad panel of Candida cell wall mutants. 
Materials and Methods
Generation of Dectin-2-/- mice. Dectin-2-/- mice were generated by Ozgene Pty Ltd, as 
described previously (11). Eight- to twelve-week-old female Dectin-2-/- (Clec4n-/-) mice 
on a C57BL/6J background were obtained from a breeding colony at the Central Animal 
Laboratory, Radboud University Medical Centre and used for the experiments when they 
were 20-25g. Age-matched C57BL/6J female mice were obtained from Charles River Wiga 
(Sulzfeld, Germany). The animals were fed standard Laboratory Chow (Hope Farms, 
Woerden, The Netherlands) and water ad libitum. The experiments were repeated at least 
41
The role of Dectin-2 for host defense against disseminated candidiasis
3
twice with a minimum of four animals per time point. All experiments were approved by 
the Ethics Committee on Animal Experiments of Radboud University, Nijmegen. 
Candida strains, culture media, and growth conditions. C. albicans ATCC MYA-3573 (UC 820), 
a strain described in detail elsewhere (12), was used in all experiments. Candida was grown and 
maintained on Sabouraud dextrose (SD) plates. For inoculum preparation, a single colony was 
grown in SD broth at 29°C for 24 h, with shaking. Cells were washed twice in sterile phosphate-
buffered saline (PBS) and counted using a hemocytometer. Cell density was adjusted with PBS to 
the desired inoculum level. Candida yeast was heat-killed for 30 min at 95°C. To generate hyphae, 
yeast cells were inoculated and grown overnight at 37°C in culture medium adjusted to pH 6.4 
with hydrochloric acid. Hyphae were killed by exposure to 95°C for 30 minutes and resuspended 
in culture medium to a hyphal inoculum size that originated from 1x108 CFU/ml.
The OCH1 and PMR1 genes were disrupted to generate strains with severe truncations in 
N- and O-linked mannan that were compared to controls strains in och1∆/och1∆/OCH1 
and pmr1∆/pmr1∆/PMR1 in which a wild type copy of the disrupted gene was reintroduced 
as described (13-15). The phosphomannan-deficient mnn4∆ serotype B null mutant, the 
parental and its revertant were constructed as described (16). The bmt1∆ (17), bmt2∆, 
bmt5∆ (18) and bmt1∆/bmt2∆/bmt5∆ (Courjol et al., unpublished data, (19)), β-mannosyl 
transferase mutants were constructed as previously described.
C. albicans infection model and fungal burden. Wild-type and Dectin-2-/- mice were injected 
via the lateral tail vein with Candida (2.5×105 CFU per mouse) in a 100 μL volume of sterile 
pyrogen-free PBS. Mice were monitored daily. For survival studies, groups of 10 mice were 
followed-up for a period of 28 days. For immunological and histological studies, a non-lethal 
experimental model of disseminated candidiasis was used, in which animals were injected with 
1x105 CFU per mouse via the lateral tail vein. This lower dose of Candida was used in order to 
avoid a bias induced by differential mortality at various time points (20). Subgroups of 4 animals 
were sacrificed on day 3, 7, 14 or 28 days after infection. Tissues were collected and processed 
for fungal burden and cytokine analysis. To assess the tissue outgrowth of Candida, the liver and 
kidneys were removed aseptically, weighed, and homogenized in sterile PBS in a tissue grinder. 
The number of viable Candida cells in the tissues was determined by plating serial dilutions on 
SD agar plates, as described elsewhere (21). The colony-forming units were counted after 24 h of 
incubation at 29°C and expressed as log colony-forming units per gram of tissue.
Histopathology. Kidney samples from wild-type and infected mice were kept in formaldehyde 
until processed. Sections were dehydrated with xylene, rehydrated through a graded series 
of ethanol solutions, and stained with hematoxylin and eosin (H&E) or periodic acid-Schiff 
(PAS) using conventional staining methods. All individual segments were evaluated for the 
presence and intensity of inflammation, as well as for the presence of fungi. Tissue sections 
were analyzed with a VisionTekTM digital microscope (Sakura), using VisionTek Live software.
In-vitro cytokine production. Peritoneal macrophages were isolated from mice by injecting 
5 ml of ice-cold sterile PBS (pH 7.4) into the peritoneal cavity. After centrifugation and 
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washing, cells were resuspended in RPMI-1640 culture medium containing 1 mM pyruvate, 
2 mM L-glutamine and 50 mg/L gentamicin. Cells were counted using a Z1 Coulter Particle 
Counter (Beckman Coulter, Woerden, The Netherlands), adjusted to 1×106 cells/ml and 
cultured in 96-well round-bottom microtiter plates (Costar, Corning, The Netherlands) at 
1×105 cells/well, in a final volume of 200 µl. After 24 hours of incubation with different 
stimuli at 37°C and 5% CO2, the plates were centrifuged at 1400 x g for 8 min, and the 
supernatants were collected and stored at −80°C until cytokine assays were performed.
Spleen cells were isolated by gently passing spleens through a sterile 200 µm filter chamber. 
After washing with sterile PBS and centrifugation at 4°C (1200 rpm for 5 min), cells were 
resuspended in 2 ml RPMI-1640 in the presence of 20% FCS, counted and concentrations 
were adjusted to 1×107 cells/ml. Cells were cultured in 24-wells plates (Greiner, Alphen 
a/d Rijn, The Netherlands) at 5×106 cells/well, and different stimuli were added in a final 
volume of 1000 µl. Supernatants were collected at two different time points (depending on 
the cytokine) as following: after 48 h of incubation at 37°C and 5% CO2, 500 µL supernatant 
per well were collected and stored at −80°C until cytokine assays were performed; thereafter, 
the plates were further incubated at 37°C and 5% CO2 for 3 more days. Ultimately, the plates 
were centrifuged at 1400 x g for 8 min, and the remaining supernatants were collected and 
stored at −80°C until cytokine assays were performed. Concentrations of mouse TNF-α, 
IL-1α and IL-1β were determined by specific radioimmunoassay (RIA). Mouse IL-6, KC, 
IL-17, IFN-γ, IL-22 and IL-10 concentrations were measured by commercial ELISA kits 
(BioSource, Camarillo, CA), according to the instructions of the manufacturer.
Leukocyte recruitment. Wild-type and Dectin-2-/- mice were injected with 100 µl of 1x105 
heat-killed Candida per mouse, intraperitoneally. After 4 hours cells were recruited from the 
peritoneum and 50 µl of cell suspension (1x106 cells per ml) was centrifuged in a cytospin at 
500 rpm for 10 minutes. The cells were stained with May-Grünwald Giemsa, observed and 
counted under the microscope.
Phagocytosis and killing of C. albicans. Peritoneal macrophages were recruited and 
phagocytosis and killing assays were performed as described elsewhere (8, 22). 
Ethics statement. All experiments in this study were carried out in strict accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals of the National 
Institutes of Health, the Dutch law on Animal experiments, and FELASA regulations. The 
protocol was approved by the Ethics Committee on Animal Experiments of the Radboud 
University Medical Centre. All efforts were made to minimize suffering of the animals. 
Statistical analysis. Differences in phagocytosis, intracellular killing, and cytokine production 
were analyzed using the Mann-Whitney U-test. Survival data were analyzed using the Kaplan-
Meyer log rank test. Differences were considered significant at P < 0.05. The experiments 
were performed at least twice. At least 4 mice per group per time point were used for the 
outgrowth, phagocytosis, killing, and cytokine synthesis. 10 mice/group entered the survival 
experiment, which was repeated two more times. Data are presented as means ±SEM.
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Results
Dectin-2-/- mice are more susceptible to systemic infection with C. albicans
A lethal dose of Candida was intravenously injected in wild-type and Dectin-2-/- mice, which 
were thereafter monitored for 28 days. Dectin-2-/- mice had significantly lower survival than 
wild-type mice (Fig. 1). On day 3, 7 and 14 post infection, organs of infected mice were 
isolated and CFU were counted. Interestingly, slightly fewer colonies were isolated from the 
livers of Dectin-2-/- mice than of the wild-type mice at the early time points; however, both 
groups of mice were able to reduce the fungal burden in the liver (Fig. 2A). On the other 
hand, an increase of 100-fold Candida colonies were found in the kidneys of Dectin-2-/- 
mice compared with the wild-type mice at late time points post-infection (Fig. 2B), which 
most likely is the cause of the increased mortality in the deficient mice. 
This observation was further underlined by histological examination of the kidneys of 
Dectin-2-/- mice, which developed inflammatory foci that were significantly larger than in 
wild-type mice (Fig. 2C-E, 2H). The foci consist mainly of lymphocytes with sporadic neutrophils 
(Fig. 2F and G), suggesting chronic inflammation, similar to systemic infection caused by C. 
glabrata (8). These results indicate that Dectin-2 is very important in the clearance of Candida 
predominantly from the kidneys, the target organ of disseminated candidiasis in mice. 
The impact of Dectin-2 deficiency on cytokine production capacity
To obtain a greater understanding of immunological responses during systemic candidiasis in 
Dectin-2-/- mice, we analyzed the cytokine production capacity during the course of infection 
with C. albicans. Interestingly, on day 3 and day 7 the production of proinflammatory 
cytokines (TNF-α, IL-6, IL-1α and IL-1β) by macrophages of Dectin-2-/- mice were 
significantly lower than in wild-type mice (Fig. 3A), which may represent an important cause 
of decreased resistance to the pathogen. On the contrary, on days 14 and 28 the production of 
Figure 1: Dectin-2-/- mice are more susceptible to C. albicans systemic infection. Survival curves of C57BL/6J 
wild-type (n = 20, continuous line) and Dectin-2-/- (n = 19, interrupted line) mice after intravenous injection 
with live C. albicans UC820 (2.5*105 cells/mouse). *p = 0.012 by logrank test.
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Figure 2: Candida outgrowth in the liver and kidneys of mice during systemic infection. Candida CFUs from 
liver (A) and kidneys (B) from wild-type and Dectin-2-/- mice at day 3, 7 and 14 post-infection. Wild-type 
and Dectin-2-/- mice received 1*105 CFU live C. albicans per animal intravenously. Results are presented as 
means ± SEM (n=9-12 mice per group from 3 independent experiments). Significance was determined 
with Mann-Whitney U-test. Statistically different groups are indicated as *, P < 0.05; **, P < 0.01; ***, P < 
0.001. Histopathological assessment of kidneys on day 14 in uninfected Dectin-2-/- (C), infected wild-type 
(D), infected Dectin-2-/- (E) (hematoxylin and eosin stained sections) and infected Dectin-2-/- (F and G) mice 
(periodic acid–Schiff stained sections). Representative localized lesions and C. albicans colonies are shown 
in the kidneys of Dectin-2-/- mice (D and E). The dimension of inflammatory foci is represented in Figure H. 
A minimum of 20 foci were measured in at least 7 different kidneys. Results are means ± SEM (n=4 mice per 
group) from 2 independent experiments. Significance was determined with Mann-Whitney U-test. Statistically 
different groups are indicated as  ***, P < 0.001.
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proinflammatory cytokines in the knockout mice recovered, but this is most likely due to the 
increase of fungal burdens at these late time points (Fig. 3A). 
We next analyzed the splenocyte-derived cytokines from mice with systemic candidiasis. 
Surprisingly, the production of TNF-α, IL-17, and IL-22 were moderately elevated from the 
splenocytes of knockout mice, particularly at day 3 post-infection (Fig. 3B), while mostly 
leveling up during the late course of infection (Fig. 3B). Interestingly, the production of the 
anti-inflammatory cytokine IL-10 was significantly decreased at day 28 after infection (Fig. 3B). 
The role of mannans for C. albicans recognition by Dectin-2
In order to assess whether mannans are the ligands for Dectin-2, as previously suggested in 
the literature (4, 5), we screened several α- and β-mannan mutants for their ability to stimulate 
cytokine production by peritoneal macrophages and splenocytes from Dectin-2-/- mice and 
wild-type controls. The macrophages from wild-type mice responded with normal production of 
TNF-α, IL-6, KC, IL-1α and IL-1β when stimulated with the majority of the C. albicans mutants 
(Fig. 4A). Interestingly, the triple mutant lacking β-mannan, bmt1∆/bmt2∆/bmt5∆, induced 
significantly higher amounts of IL-6 and KC than its parental strain C. albicans CAI4-CIP10, 
implying that α-mannan ligands are better accessible for recognition by cellular receptors on 
macrophages, as the triple mutant only lacks β-mannosides at the terminal end of α-mannosides, 
and phosphomannose on mannan and on phospholipomannan. Therefore, the lack of 
β-mannosides at the terminal end of α-mannosides suggests that α-mannans are still present on 
Candida triple mutant and, furthermore, are more exposed on Candida cells as they are no more 
hidden by β-mannosides. Candida hyphae and och1∆ mutant induced sizable amounts of IL-1α 
and IL-1β in macrophages (Fig. 4A). Likewise, all mutants induced TNF-α, IL-17 and IL-22 in 
splenocytes from wild-type mice, while IFN-γ and IL-10 production was low (Fig. 4B). 
Peritoneal macrophages from naïve Dectin-2-/- mice stimulated with C. albicans mutants 
produced lower amounts of cytokines than wild-type mice (Fig. 5A). Moreover, the triple mutant 
bmt1∆/bmt2∆/bmt5∆ did not induce more cytokines (in particular IL-6 and KC) than other 
mutants (Fig. 5A), suggesting that exposed α-mannan putative ligands interact with Dectin-2. 
Decreased neutrophil recruitment at the site of infection in Dectin-2-/- mice
Since neutrophils and monocytes are essential during fungal invasion, we investigated leukocyte 
recruitment after Candida injection into the peritoneal cavity of both Dectin-2-/- and wild-type 
mice. The recruitment of neutrophils was clearly inhibited in knockout mice (Fig. 6A), while no 
differences in the recruitment of other leukocyte populations were observed. This observation, in 
combination with our finding of an increased level of the neutrophil chemokine KC in Dectin-2 
knockout macrophages, suggests that Dectin-2 is important for the neutrophil response to KC.
Phagocytosis and killing of Candida by Dectin-2-/- macrophages
Since a number of C-type lectin receptors are involved in the engulfment and phagocytosis of 
fungi, we investigated the phagocytic capacity of peritoneal macrophages from Dectin-2 knockout 
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Figure 3: Cytokine profile during systemic infection with C. albicans. Wild-type or Dectin-2-/- mice received 
1*105 CFU heat-killed C. albicans per mouse, intravenously. After 3, 7, 14 and 28 days, peritoneal macrophages 
(A) were restimulated ex vivo with heat-killed C. albicans hyphae (Ca) for 24 h. TNF-α, IL-6 and KC 
accumulation in the supernatants and IL-1α and IL-1β accumulation inside the cells was measured by ELISA. 
Results are means ± SEM (n=8 mice per group) from 2 independent experiments. Significance was determined 
with Mann-Whitney U-test. Statistically different groups are indicated as *, P < 0.001; **, P < 0.01. Wild-type 
or Dectin-2-/- mice received 1*105 CFU live C. albicans per mouse, intravenously. After 3, 7, 14 and 28 days, 
splenocytes (B) were restimulated ex vivo with heat-killed C. albicans hyphae (Ca) for 48 h and 5 days. TNF-α, 
IL-10, IFNγ (48 h), IL-17 and IL-22 (5 days) accumulation in the supernatants was measured by ELISA. Results 
are means ± SEM (n=8 mice per group) from 2 independent experiments. Significance was determined with 
Mann-Whitney U-test. Statistically different groups are indicated as *, P < 0.05. 
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Figure 4: Stimulation of cells isolated from wild-type mice with C. albicans mutants. C. albicans mutants lacking 
O- and N-linked, α- and β-mannan were screened for their capacity to induce cytokines in wild-type peritoneal 
macrophages (A) and splenocytes (B) from naïve mice. Values represent means ± SEM (n=4 mice per group, 2 
independent experiments). Significance was determined with Mann-Whitney U-test. Statistically different groups 
are indicated as *, P < 0.05; **, P < 0.01; ***, P < 0.001. Ca y: C. albicans yeast heat-killed; Ca hy; C. albicans hyphae 
heat-killed.  The control strain NGY152, was derived from CAI-4, which is the parental Ura-auxotrophic strain of 
all mutants analysed, and was created by reintegration of a copy of URA3 gene at the RPS1 locus.
◀
mice. We consistently found a slightly reduced phagocytosis of Candida by the macrophages 
from Dectin-2-/- compared to the wild-type macrophages (Fig. 6B), suggesting a role of Dectin-2 
in engulfment of the pathogen. The killing capacity, corrected for the decrease in phagocytosis, 
was not significantly decreased in macrophages of the knockout animals (Fig. 6B).
Discussion
Our results demonstrate that mice lacking Dectin-2 are more susceptible to systemic C. 
albicans infection and we describe the altered host defense mechanisms that are responsible 
for this effect. The knockout mice exhibit diminished neutrophil recruitment into the 
peritoneal cavity, slightly decreased phagocytosis of Candida and larger inflammatory foci 
mostly devoid of neutrophils due to a higher fungal burden in the infected kidneys. We 
found that the macrophages production was lower for the majority of proinflammatory 
cytokines (with the exception of KC), which may represent the cause of these effects.
Our findings regarding an increased susceptibility of Dectin-2-/- mice to C. albicans 
corroborate with those of Saijo et al (5), who demonstrated similar survival curves of 
Dectin-2 knockout mice challenged with C. albicans. In addition, these findings are in line 
with the increased susceptibility of Dectin-2-/- mice to C. glabrata (8). Macrophage-derived 
proinflammatory cytokines such as TNF-α, IL-1, KC or IL-6 activate the recruitment, 
phagocytosis and killing of fungi, and mice deficient in these cytokines are more susceptible 
to systemic candidiasis (23, 24). Interestingly, with the exception of KC, significant defects in 
the production of these cytokines were observed in cells isolated from Candida-challenged 
Dectin-2-/- mice in our study. Saijo et al previously reported a much more dramatic decrease 
in cytokine production compared to the data reported here, i.e. non detectable IL-6, TNF-α, 
IL-1β and IL-10 after exposure of mononuclear phagocytes to Candida yeasts and very low 
production after exposure of Dectin-2-/- cells to hyphae. Our data show more moderate 
effects, which is in line with the well-known redundancy in the various pattern recognition 
receptors responsible for the recognition of Candida spp (25). Even a greater disparity with 
the findings of Saijo et al (5) was found with regard to cytokine production by splenocytes. 
At day 14 of infection, a significant amount of IL-17 was produced by splenocytes of Dectin-
2-/- mice, demonstrating that the Th17 differentiation in these mice is functional. The 
increased production of cytokines by splenocytes of Dectin-2-/- mice at certain time points 
after infection is most likely due to the higher antigen burden in the organs of the knockout 
mice. This is also discrepant with the findings of Saijo et al., and the cause of these differences 
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Figure 5: Stimulation of cells isolated from Dectin-2-/- mice with C. albicans mutants. C. albicans mutants 
lacking O- and N-linked, α- and β-mannan were screened for their capacity to induce cytokines in Dectin-
2-/- peritoneal macrophages (A) and splenocytes (B) from Dectin-2-/- mice. Values represent means ± SEM 
(n=4 mice per group, 2 independent experiments). Significance was determined with Mann-Whitney U-test. 
Statistically different groups are indicated as *, P < 0.05; **, P < 0.01; ***, P < 0.001. Ca y: Candida albicans yeast 
heat-killed; Ca hy; Candida albicans hyphae heat-killed.
◀
Figure 6: The role of Dectin-2 for leukocyte antifungal biological properties. Leukocyte recruitment in the 
peritoneum (A): wild-type and Dectin-2-/- mice were injected intraperitoneally with 100 µl of 1x105 heat-killed C. 
albicans per mouse. After 4 hours cells were recruited, stained with May-Grünwald Giemsa, and counted under 
the microscope. Phagocytosis and killing of C. albicans cells by murine peritoneal macrophages (B): the results 
are represented as percentage of phagocytosis (the percentage of fungal cells engulfed by macrophages present in 
the well) and percentage of killing (the percentage of killed fungal cells among the phagocytosed yeast). The C. 
albicans/macrophage ratio was 10:1. Values represent means ± SEM (n=5 mice per group) *, P < 0.05.
remains to be investigated. One likely explanation may be represented by differences between 
various C. albicans strains: such differences have been earlier reported to cause differential 
effects of various strains for the recognition of TLR4 (26, 27) and Dectin-1 (27).
The coordinated induction of proinflammatory cytokines is important for activating 
multiple host defense mechanisms against fungi, including leukocyte recruitment at the site 
of infection, phagocytosis and killing of the pathogen. The influx of neutrophils was decreased 
in the knockout mice, despite normal concentrations of the chemoattractant cytokine KC, 
pointing to a role of Dectin-2 in the chemotactic response of neutrophils. In addition, we 
observed that peritoneal macrophages lacking Dectin-2 were slightly less able to ingest the 
pathogen, while the killing of Candida was not affected. Phagocytosis is the main mechanism 
through which immune cells engulf and clear pathogens or cell debris. The latter observation 
of normal Candida killing by Dectin-2-/- cells is remarkable, since we have previously shown 
that Dectin-2-/- neutrophils produce less reactive oxygen species (ROS) upon stimulation (8), 
and ROS plays a significant role in Candida killing (28). Drewniak et al showed that human 
CARD9 deficiency resulted in selective defect in the host defense against invasive fungal 
infection caused by an impaired phagocyte killing (28); this suggest that CARD9-dependent 
C-type lectin receptors other than Dectin-2 are also important for Candida killing.
The increased susceptibility of Dectin-2-/- mice to C. albicans strain UC820 is suggested 
to be due to their incapacity to eliminate the fungus from the kidneys, the target organ of 
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disseminated candidiasis (29). The fact that the animals were able to eradicate Candida 
from the liver but not kidney confirms previous data related to organ-specific Candida 
infection and immune responses mediated primarily by neutrophils and monocytes (30-32). 
The ultimate pathways responsible for the increased susceptibility of Dectin-2-/- mice to 
systemic candidiasis is most likely due to the combination of defective cytokine production, 
reduced neutrophil recruitment and impaired phagocytosis of the fungus. 
α-mannans have been previously suggested to be the main fungal PAMP recognized 
by Dectin-2 (5). Furthermore, Dectin-2 binds to the terminal mannose of N-linked glycan 
(4), and recognizes mycobacterial mannose-capped lipoarabinomannan (33), and O-linked 
mannobiose-rich glycoproteins (α-1,2-linked mannose) from Malassezia (34). Considering 
these studies, we were surprised to observe that mutant C. albicans strains with defects in 
α-mannans induced largely intact cytokine amounts. Moreover, the mannan-defective strains 
induced less cytokines in macrophages from Dectin-2-/- mice compared with the wild-type 
animals. In accord with this, och1∆ and pmr1∆, induced lower Th-derived cytokines in 
splenocytes of wild-type and Dectin-2-/- mice previously infected with Candida, compared 
to the other strains of the fungus. Finally, the triple mutant lacking β-mannan and therefore 
exposing α-mannan, bmt1∆/bmt2∆/bmt5∆, induced significantly higher amounts of IL-6 
and KC than its parental strain C. albicans CAI4-CIP10, confirming that, indeed, C. albicans 
α-mannan ligands are better accessible for recognition by cellular receptors on macrophages. 
Moreover, bmt1∆/bmt2∆/bmt5∆ did not induce more cytokines than other mutants in the 
Dectin-2-/- cells, suggesting that these exposed α-mannan ligands interact with Dectin-2. 
In conclusion, we demonstrate that Dectin-2 is an important component of the anti-
Candida host immune responses. However, the extent of immune responses triggered by 
Dectin-2 during systemic candidiasis may vary depending not only on Candida species, 
but also on the strain of Candida. Deciphering the precise mechanisms responsible for host 
defense against the different C. albicans strains represents an important step in understanding 
of the pathophysiology of systemic candidiasis. Furthermore, revealing the exact Dectin-2 
ligand(s) important for induction of antifungal host defense mechanisms could lead to the 
development of novel immunotherapeutic strategies and possible vaccine development.
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Abstract
Although Candida glabrata is an important pathogenic Candida species, relatively little is 
known about its innate immune recognition. Here, we explore the potential role of Dectin-2 
for host defense against C. glabrata. Dectin-2-deficient (Dectin-2-/-) mice were found to be 
more susceptible to C. glabrata infections, showing a defective fungal clearance in kidneys 
but not in the liver. The increased susceptibility to infection was accompanied by lower 
production of T helper 1 (Th1) and Th17-derived cytokines by splenocytes of Dectin-2-/- mice, 
while macrophage-derived cytokines were less affected. These defects were associated with a 
moderate yet significant decrease in phagocytosis of the fungus by the Dectin-2-/- macrophages 
and neutrophils. Neutrophils of Dectin-2-/- mice also displayed lower production of reactive 
oxygen species (ROS) upon challenge with opsonized C. glabrata or C. albicans. This study 
suggests that Dectin-2 is important in host defense against C. glabrata and provides new 
insights into the host defense mechanisms against this important fungal pathogen. 
Keywords: Candida glabrata, Dectin-2, Th-derived cytokines, ROS 
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Introduction
The opportunistic fungal pathogen Candida glabrata is the second most frequent cause of 
candidiasis after Candida albicans, accounting for approximately 15 to 25% of Candida infections 
(1, 2). Similar to other Candida species, C. glabrata resides as a commensal within the normal 
microbial flora of humans, but it may also cause serious infections in immunocompromised 
patients. In the last 3 decades, the number of infections due to non-albicans Candida species has 
increased significantly (3, 4). The current rise in the incidence of invasive C. glabrata infections 
is largely the result of the combinational increase in immunosuppressive infections and modern 
prolonged invasive medical interventions (5). Moreover, C. glabrata is of added concern due to 
the fact that a fraction of clinical isolates have been proven to be resistant to antifungal agents, 
such as azoles (6). The mortality rate associated with bloodstream infection with C. glabrata is 
approximately 50% in cancer patients and is even higher in bone marrow transplant patients 
(7, 8). However, compared to the literature on C. albicans, few studies have investigated the 
pathophysiology of C. glabrata infections, despite its high morbidity and mortality burden. 
Pattern recognition of fungal components and activation of innate immunity are essential 
steps in the host defense against Candida species (9). The Candida cell wall is mainly 
composed of multiple layers of carbohydrates, such as mannan, β-glucan, and chitin, which 
are collectively recognized by C-type lectins, including macrophage mannose receptor (MR), 
SIGNR-1, Galectin-3, Mincle, Dectin-1, Dectin-2, and the Toll-like receptors. This recognition 
leads to activation of the host innate immune system. MR recognizes the N-linked mannans 
of fungal cell walls, SIGNR-1 recognizes branched α-mannans, and Galectin-3 recognizes 
β-(1,2)-mannans (9–11). It has recently been reported that Dectin-1 (Clec7a) and Dectin-2 
(Clec4n) are specific receptors for β-glucans (12) and C. albicans-derived α-mannans (13), 
respectively. Dectin-2 is a C-type lectin receptor primarily expressed by macrophages, 
dendritic cells and neutrophils, with specificity for structures rich in mannose (14, 15). 
Dectin-2 uses the FcRy chain to signal via Syk- and caspase recruitment domain family 
member 9 (Card9)-dependent pathways (16–18). It represents an important receptor for the 
generation of the Th17-like adaptive immune response, coordinating the Th1-like responses 
together with Dectin-1 (17). Human Dectin-2 has a mannose recognition EPN motif (15, 19), 
strengthening the likelihood that Dectin-2 plays an important role in antifungal immunity. 
Additionally, Saijo et al. have reported that Dectin-2 is the functional receptor for α-mannans 
and that Dectin-2-/- mice are more susceptible to C. albicans (13). However, little is known 
regarding the specific role of Dectin-2 for the host defense against C. glabrata. 
In this study, we have explored the contribution of Dectin-2 in the pathophysiology 
of murine C. glabrata systemic infection. We show that the burden of C. glabrata was 
significantly increased in kidneys of Dectin-2-/- mice, which was correlated with a decreased 
phagocytosis and killing of the fungus by the innate immune macrophages (as shown 
by live-cell video microscopy phagocytosis assays) and neutrophils (as shown by the ex 
vivo phagocytosis and killing assays). Moreover, the adaptive T helper-derived cytokine 
responses were also considerably affected in Dectin-2-/- mice. In conclusion, our data 
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demonstrate an important role of Dectin-2 for innate immune responses and its significant 
contribution to the adaptive immune responses against C. glabrata. 
Materials and Methods 
Generation of Dectin-2-/- mice. Dectin-2-/- mice were constructed by Ozgene Pty Ltd., Australia, 
as described previously (20). Briefly, a targeting vector was designed to introduce a conditional 
mutation into the mouse Clec4n gene (Ensembl version no. http://www.ensembl.org/Mus_
musculus/Gene/Summary?db=core;g=ENSMUSG00000023349;r=6:123229843-123247021). 
The strategy utilizes mutant loxP sites (lox66 and lox71) to enable an inversion of the flanked 
sequence in response to the expression of Cre recombinase. The recombination event 
inactivated the gene by switching the position and direction of the transcriptional termination 
(STOP) signal with Clec4n exon 2. The lox66 site was inserted upstream from Clec4n exon 2, 
and a neomycin selection cassette (PGK-Neo) was targeted into the intron between exon 2 
and exon 3. The selection cassette was flanked with FLP recombination target (FRT) sites to 
enable removal by FlpE-mediated recombination. An inverted STOP element and a lox71 site 
were placed downstream from the selection marker. The 5’ and 3’ homology arms of the vector 
were approximately 6.1 kb and 5.9 kb, respectively. The targeting vector was linearized with 
PmeI and electroporated into the C57BL/6 embryonal stem (ES) cell line Bruce4. Neomycin-
resistant clones were selected and screened by Southern blotting to identify homologous 
recombinants. Correctly targeted clones were microinjected into BALB/cJ blastocysts, which 
were transferred into pseudopregnant CBB6F1 foster females. Chimeric mice were obtained 
and outcrossed to C57BL/6J females to generate ES cell-derived targeted mutant progeny. 
Eight- to 12-week-old female Dectin-2-/- (Clec4n-/-) mice on a C57BL/6J background 
were obtained from a breeding colony at the Central Animal Laboratory, Radboud 
University Nijmegen Medical Centre. Age-matched C57BL/6J female mice were obtained 
from Charles River Wiga (Sulzfeld, Germany). All mice weighed between 20 and 25 g. The 
animals were fed standard laboratory chow (Hope Farms, Woerden, The Netherlands) and 
water ad libitum. Most of the experiments were repeated at least twice with a minimum of 
five animals per time point. All experimentation conformed to the terms and conditions 
of the Ethics Committee on Animal Experiments of Radboud University, Nijmegen. Key 
experiments, such as for fungal outgrowth and phagocytosis and killing of C. glabrata, were 
repeated using Dectin-2-/- mice generated independently, kindly provided by Y. Iwakura (13). 
These validation studies were performed at the animal facility of the University of Aberdeen. 
Live-cell video microscopy was conducted in Aberdeen; C57BL/6 and Dectin-2-/- (provided 
by Y. Iwakura) mice were obtained from breeding colonies. All mice were used at 8 to 16 
weeks of age. Animals were kept and handled in accordance with institutional guidelines. 
Candida strains, culture media, and growth conditions. C. glabrata CBS138 (ATCC 2001), a 
strain described elsewhere (21), was used in all experiments. C. glabrata was routinely grown 
and maintained on Sabouraud dextrose plates. For inoculum preparation, a single colony 
was grown in Sabouraud dextrose broth at 29°C for 24 h, with shaking. Cells were washed 
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twice in sterile phosphate-buffered saline (PBS) and counted using a hemocytometer. Cell 
density was adjusted with PBS to the desired inoculum level. C. glabrata was heat killed 
for 30 min at 95°C. Candida albicans ATCC MYA-3573 (UC 820) was grown overnight to 
generate yeast cells in Sabouraud dextrose broth at 29°C, with shaking. Cells were harvested 
by centrifugation, washed twice with PBS, and resuspended in culture medium (RPMI 1640 
Dutch modification). C. albicans yeast was heat killed for 30 min at 95°C. To generate hyphae, 
yeast cells were inoculated and grown overnight at 37°C in culture medium adjusted to pH 6.4 
with hydrochloric acid. Hyphae were killed by exposure to 95°C for 30 min and resuspended 
in culture medium to a hyphal inoculum size that originated from 1x108 CFU/ml. 
C. glabrata infection model and fungal burden. A nonlethal experimental model of 
disseminated candidiasis was used, in which wild-type and Dectin-2-/- mice were injected 
intravenously, via the lateral tail vein, with C. glabrata (1x107 CFU/mouse) in a 100 µl volume 
of sterile pyrogen-free PBS. Mice were monitored daily. For survival studies, groups of 10 mice 
were followed-up for a period of 28 days. For immunological and histological studies, subgroups 
of 5 animals were killed on day 3, 7, or 14 postinfection. Tissues were collected and processed 
for fungal burden and cytokine analysis. To assess the tissue outgrowth of C. glabrata on these 
days, the liver and kidneys were removed aseptically, weighed, and homogenized in sterile PBS 
in a tissue grinder. The number of viable Candida cells in the tissues was determined by plating 
serial dilutions on Sabouraud dextrose agar plates, as described elsewhere (22). The CFU were 
counted after 24 h of incubation at 29°C and expressed as log CFU per gram of tissue. 
Histopathology. Kidney samples from infected mice were kept in formalin until processed. 
Sections were dehydrated with xylene, rehydrated through a graded series of ethanol 
solutions, and stained with hematoxylin and eosin (H&E) or periodic acid-Schiff (PAS) 
using conventional staining methods. All individual segments were evaluated for the 
presence and intensity of inflammation, as well as for the presence of fungi. Tissue sections 
were analyzed with a VisionTek digital microscope (Sakura), using VisionTek Live software. 
In vitro cytokine production. Peritoneal macrophages were isolated from mice by injecting 
5 ml of ice-cold sterile PBS (pH 7.4) into the peritoneal cavity. After centrifugation and 
washing, cells were resuspended in RPMI 1640 culture medium containing 1 mM pyruvate, 
2 mM L-glutamine, and 50 mg/liter gentamicin. Cells were counted using a Z1 Coulter 
particle counter (Beckman Coulter; Woerden, The Netherlands), adjusted to 1x106 cells/ml, 
and cultured in 96-well round-bottom microtiter plates (Costar, Corning, The Netherlands) 
at 1x105 cells/well in a final volume of 200 µl. After 24 h of incubation with different stimuli 
at 37°C and 5% were centrifuged at 1,400 x g for 8 min, and the supernatants were collected 
and stored at -80°C until cytokine assays were performed. 
Spleen cells were isolated by gently passing spleens through a sterile 200 µm filter 
chamber. After washing with sterile PBS and centrifugation at 4°C (1,200 rpm for 5 min), cells 
were resuspended in 2 ml RPMI 1640 in the presence of 20% fetal calf serum and counted, 
and concentrations were adjusted to 1x107 cells/ml. Cells were cultured in 24-well plates 
(Greiner, Alphen a/d Rijn, The Netherlands) at 5x106 cells/well, and different stimuli were 
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added in a final volume of 1,000 µl. Supernatants were collected at two different time points 
(depending on the cytokine) as follows. After 48 h of incubation at 37°C and 5% CO2, 500 µl of 
supernatant per well was collected and stored at -80°C until cytokine assays were performed; 
thereafter, the plates were further incubated at 37°C and 5% CO2 for an additional 3 days. The 
plates were centrifuged at 1,400 x g for 8 min, and the remaining supernatants were collected 
and stored at -80°C until cytokine assays were performed. The concentrations of mouse tumor 
necrosis factor alpha (TNF-α), interleukin-1α (IL-1α), and IL-1β were determined by specific 
radioimmunoassay (RIA). Mouse IL-6, KC, IL-17, gamma interferon (IFN-γ), IL-22, and 
IL-10 concentrations were measured by commercial enzyme-linked immunosorbent assay 
(ELISA) kits (Biosource, Camarillo, CA) according to the instructions of the manufacturer. 
Phagocytosis and killing of C. glabrata. Peritoneal macrophages and neutrophils were 
recruited and phagocytosis and killing assays were performed according to a modification of a 
method described elsewhere (23). C. glabrata/macrophage or C. glabrata/neutrophil ratios of 
10:1 were used in the phagocytosis and killing studies. Peritoneal macrophages or neutrophils 
from groups of 5 C57BL/6J (control) and 5 Dectin-2-/- mice were elicited by an intraperitoneal 
(i.p.) injection of heat-killed C. glabrata. Cells were collected in separate sterile tubes either 3 
days (macrophages) or 4 h (neutrophils) after C. glabrata infection by washing the peritoneal 
cavity with 5 ml of ice-cold PBS. Phagocytes were centrifuged (for 10 min at 2,250 x g), counted 
in a Bürker counting chamber, and resuspended in RPMI 1640 Dutch modification (with 
20 mM HEPES and without L-glutamine; ICN Biomedicals) supplemented with 5% heat-
inactivated fetal calf serum, 1% gentamicin, 1% L-glutamine, and 1% pyruvate. The processes 
of phagocytosis and intracellular killing were studied in an adherent monolayer of phagocytes. 
To create a monolayer of phagocytes, 5x105 cells in 100 µl of RPMI 1640 were dispensed into the 
wells of a 96-well flat-bottom plate (Costar) and incubated at 37°C and 5% CO2. Macrophages 
were allowed to adhere for up to 2 h, but neutrophils for only 30 min before the monolayers were 
gently washed with culture medium to remove nonadherent cells. The percentage of adherence 
was calculated as follows: (1-[number of nonadherent cells/5x105])x100. Subsequently, the 
cells were incubated with 1x104 CFU C. glabrata, which were opsonized for 30 min at 24°C in 
modified Eagle’s medium (MEM; Gibco Life Technologies) that contained 2.5% fresh mouse 
serum (effector/target ratio, 40:1). After 15 min, supernatants were aspirated, and monolayers 
were gently washed with MEM to remove noningested C. glabrata. The supernatant and 
well washings that contained the non-ingested Candida were combined and plated in serial 
dilutions on Sabouraud agar plates. The percentage of phagocytosed microorganisms was 
defined as follows: [1-(number of uningested CFU/CFU at the start of incubation)]x100. 
The killing of C. glabrata by phagocytes was assessed in the same monolayers. After removal 
of the nonphagocytized Candida, 200 µl of culture medium, consisting of Sabouraud in MEM 
(50%, vol/vol), was added to the monolayers. After 3 h of incubation at 37°C and 5% CO2, the 
wells were gently detached with a cell scraper and washed with 200 µl distilled H2O to achieve 
lysis of phagocytes. This procedure was repeated 3 times, after which the pooled washes were 
adjusted to a final volume of 1 ml with distilled water. Microscopic examination of the culture 
plates showed that there was an almost complete removal of phagocytes. To quantify the viable 
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intracellular Candida, 10-fold dilutions of each sample were spread on Sabouraud agar plates 
and incubated at 37°C for 24 h. The percentage of yeast killed by the phagocytes was determined 
as follows: [1-(CFU after incubation/number of phagocytized CFU)]x100. Phagocyte-free 
incubations of blastoconidia were included as a control for yeast viability. 
Live-cell video microscopy phagocytosis assays. Standard phagocytosis assays were 
performed as previously described (24). Briefly, 6x105 live C. glabrata yeasts were added to 
2x105 macrophages in µ-Slide 8-well chambers (ibidi GmbH, Germany) immediately prior to 
imaging. Video microscopy experiments were performed using an Ultra View VoX live-cell 
imaging system (PerkinElmer) with the environmental control chamber set at 37°C. Images 
were captured at 1-min intervals for 3 h using an electron-multiplying charge-coupled device 
(EMCCD) camera. At least two independent experiments were conducted for each mouse 
strain, and two movies for each mouse were analyzed (n=7 wild-type mice, and n=8 Dectin-2 
mice). Volocity 6.2.1 imaging analysis software was used to track macrophage migration at 
1-min intervals for the first 60 min of the phagocytosis assay. The software enabled high-
throughput analysis of macrophage migration, providing detailed information on the distances 
traveled and the directionality and velocity of hundreds of individual macrophages. The data 
were subsequently displayed in tracking diagrams and used to calculate the mean track velocity 
and track length of macrophages cultured with C. glabrata. The movies generated for migration 
analyses were also analyzed to determine phagocytic uptake at the 30-min, 60-min, and 
180-min time points (25). For each mouse, 20 macrophages were analyzed for the percentage 
of uptake of live C. glabrata yeasts (calculated by determining the number of macrophages per 
100 that had ingested at least one yeast). The phagocytic index was calculated by counting the 
total number of yeasts engulfed per hundred macrophages at each time point. 
Reactive oxygen species (ROS) assay. The spontaneous and stimulus induced oxygen 
radical production levels of isolated neutrophils were evaluated using luminol-enhanced 
chemiluminescence and determined in an automated LB96V Microlumat plus luminometer 
(EG & G Berthold, Bald Wilberg, Germany) as previously described (26). In this study, 
neutrophils (2x105 per well) were seeded into 96-well plates and incubated in medium 
containing either RPMI, phorbol 12-myristate 13-acetate (PMA; 5 µg/ml), live opsonized 
C. albicans (105 CFU/ml) or live opsonized C. glabrata (107 CFU/ml). Luminol was added to 
each well in order to start the chemiluminescence reaction. Each measurement was carried 
out in at least duplicate repetitions. Chemiluminescence was determined every 145 s at 
37°C for 1 h. Luminescence was expressed as relative light units (RLU) per second. Data 
were analyzed with Winglow software (EG & Berthold). 
Ethics statement. All experiments in this study were carried out in strict accordance 
with the recommendations in the Guide for the Care and Use of Laboratory Animals of 
the National Institutes of Health, the Dutch law on Animal Experiments, and FELASA 
regulations. The protocol was approved by the Ethics Committee on Animal Experiments 
of the Radboud University Nijmegen Medical Centre. All efforts were made to minimize 
suffering of the animals. All experiments performed in Aberdeen conformed to the terms 
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and conditions of United Kingdom Home Office licenses for research on animals and the 
guidelines of the University of Aberdeen ethical review committee. 
Statistical analysis. Differences in phagocytosis, postphagocytic killing, and concentrations 
of cytokines were analyzed using the Mann-Whitney U test. Survival data were analyzed 
using the Kaplan-Meyer log rank test. Differences were considered significant at a P value 
of 0.05. The majority of the experiments was performed at least twice, and at least 5 mice/
group/time point were used for the outgrowth, phagocytosis, killing, ROS, and cytokine 
synthesis experiments. A total of 10 mice/group were used for survival experiments. Data 
are presented as means ± standard errors of the means (SEM). 
Results 
Increased susceptibility to C. glabrata systemic infection in Dectin-2-/- mice 
To determine the role of Dectin-2 in the host defense against C. glabrata, we first compared 
the susceptibility to infection of Dectin-2-/- and wild-type control mice. Following infection 
with C. glabrata, both groups of mice were able to effectively control and eradicate the fungus 
from the liver within 2 weeks (Fig. 1A). In contrast, while wild-type animals restrained the 
infection in their kidneys, significantly higher C. glabrata loads were observed in Dectin-2-/- 
mice (Fig. 1B). Similar increases in the fungal burdens were observed in the kidneys of the 
Dectin-2-/- mice provided by Y. Iwakura (Fig. 1C). Nonetheless, Dectin-2-/- mice were less 
susceptible to C. glabrata than has been reported for C. albicans, with no mortality recorded in 
any of the mouse strains during the 28 days following intravenous infection (data not shown). 
Fig. 1: Greater C. glabrata loads in the kidneys of mice during systemic infection. (A and B). Quantification 
of Candida colonies from liver (A) and kidneys (B) of wild-type and Dectin-2-/- mice at day 3, 7 and 14 
postinfection is shown. Wild-type and Dectin-2-/- received 107 CFU of C. glabrata per mouse intravenously. 
After 3, 7 and 14 days, organs were collected and serial dilutions were plated on Sabouraud solid media. Results 
are means ± SEM (n=10-14 mice per group from 3 independent experiments). Significance was determined 
with Mann-Whitney U-test. Statistically different groups are indicated as *, P < 0.05; ***, P < 0.001. (C) Fungal 
burdens in the kidneys of wild-type and Dectin-2-/- mice provided by Prof. Iwakura. Wild-type or Dectin-2-/- 
mice received 107 CFU of C. glabrata per mouse intravenously. After 7 days, kidneys were collected and serial 
dilutions were plated on Sabouraud agar media. Data are represented as means ± SEM (n=12 mice per group 
from two independent experiments). Significance was determined with Mann-Whitney U-test, ** P < 0.01.
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Compared with the results for noninfected mice (Fig. 2A), histopathological analysis 
identified zones with lymphocytic infiltration suggestive of chronic inflammation in 
both wild-type control (Fig. 2B) and Dectin-2-/- (Fig. 2C) mice. Sporadic neutrophilic 
granulocytes could be detected (Fig. 2D and E). At day 7 and day 14 postinfection, the 
kidneys of Dectin-2-/- mice displayed significantly increased numbers of inflammatory 
foci compared with the kidneys of wild-type mice. Interestingly, fungi were only partially 
associated with inflammation and were often present in the lumina of tubuli, not in the 
tissue itself (Fig. 2D and E). Therefore, the foci of chronic, lymphocytic inflammation were 
Fig. 2: Dectin-2 deficiency affects kidney histopathology during systemic infection with C. glabrata. 
Histopathological assessment of kidneys in uninfected Dectin-2-/- (A), infected wild-type (B), infected Dectin-2-/- 
(C) (hematoxylin and eosin stained sections) and infected Dectin-2-/- (D and E) mice (periodic acid–Schiff stained 
sections). Representative localized lesions and C. glabrata colonies in the kidneys of Dectin-2-/- mice are shown (C, 
D and E). All observations in infected kidneys were performed at day 14 after intravenous injection with C. glabrata. 
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not associated with the presence of fungi. In conclusion, Dectin-2 appears to be an essential 
pattern recognition receptor for the adequate control of C. glabrata renal infection.
Defective Th-associated cytokine production in Dectin-2-/- mice
To further characterize the role of Dectin-2 for the recognition of C. glabrata, the ex vivo 
cytokine profile was assessed in peritoneal macrophages of naive wild-type and knockout 
mice. Interestingly, the innate response levels from uninfected Dectin-2-/- macrophages 
were slightly higher than the response levels of the macrophages isolated from the wild-type 
animals (TNF-α, IL-6, IL-1α, and IL-1β) (Fig. 3A). Only the IL-6 and KC production levels 
from Dectin-2-/- macrophages upon stimulation with C. albicans heat-killed hyphae were 
lower than those from wild-type macrophages, although the difference reached statistical 
significance only for KC (Fig. 3A). Regarding the T cell-derived cytokines (IL-10, IFN-γ, 
and IL-17) produced by the splenocytes of uninfected mice, no differences could be detected 
between the two groups of mice (Fig. 3B). The IL-17 production levels in the splenocytes 
from Dectin-2-/- mice were highly variable.
In a subsequent set of experiments, we studied the ex vivo cytokine responses of peritoneal 
macrophages and splenocytes isolated from mice infected with C. glabrata. No differences 
were detectable between the two groups of mice in most of the macrophage-derived 
cytokines assayed (intracellular/extracellular IL-1α and IL-1β and extracellular production 
of IL-6 and KC; data not shown), with the exception of TNF-α at day 14 postinfection (Fig. 
4A). Similar to the results for peritoneal macrophages, ex vivo stimulation of splenocytes 
from C. glabrata-infected mice resulted in significantly lower levels of TNF-α production 
by Dectin-2-deficient cells upon stimulation with either C. glabrata (Fig. 4B) or C. albicans 
(Fig. 4C), although dissimilarities were detectable earlier in the course of the infection. No 
significant differences could be detected in the amounts of the anti-inflammatory cytokine 
IL-10 produced by either strain. In addition to the responses of the innate cytokines, Th1 
and Th17 responses at 7 days postinfection were also significantly reduced in Dectin-2-/- 
splenocytes, as mirrored by the low production of IFN-γ and IL-17 (Fig. 4B). The levels 
of IL-22 were moderately reduced at day 14 postinfection (Fig. 4B). A similar pattern 
with more pronounced differences was observed when splenocytes from infected mice 
were restimulated with C. albicans yeast (Fig. 4C). As such, Dectin-2 deficiency results in 
decreased production of protective T helper-derived cytokines. 
Dectin-2-/- peritoneal macrophages are less efficient in the uptake  
and killing of C. glabrata ex vivo
The phagocytic clearance of microorganisms, including yeasts, by professional phagocytes 
is mediated by receptor activation that drives the engulfment and internalization of the 
pathogen. We therefore assessed the ability of Dectin-2-/- peritoneal macrophages to recognize, 
phagocytose, and kill live opsonized C. glabrata. Using a classical ex vivo phagocytosis and 
killing assay (23), wild-type peritoneal macrophages were found to be slightly more efficient in 
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Fig. 3: Cytokine profile from naïve mice. Cells from naïve mice were stimulated for 24 h (peritoneal 
macrophages) (A) or for 48 h and 5 days (splenocytes|) (B) with heat-killed (HK) or live C. glabrata (Cg), 
heat-killed C. albicans yeast (Cay) or hyphae (Cah) and live C. albicans (Ca). Levels of TNF-α, IL-6, KC, IL-1α, 
IL-1β, IL-10, IFN-γ and IL-17 accumulation were measured by ELISA. Data are represented as  means ± SEM 
(n=8 mice per group). Significance was determined with Mann-Whitney U-test. Statistically different groups 
are indicated as *, P < 0.05 and **, P < 0.01.
the phagocytosis and subsequent killing of C. glabrata than Dectin-2-/- macrophages (Fig. 5A). 
We further investigated the migration of peritoneal macrophages toward C. glabrata by live-cell 
video microscopy using a phagocytosis assay described previously (25). Dynamic analysis of 
individual macrophages, achieved by tracking cells to determine their directionality, distance, 
and velocity for the first hour of the assay, demonstrated no major differences in migration 
dynamics between macrophages harvested from wild-type or Dectin-2-/- animals (Fig. 5B). 
However, in the same experiment, a complementary analysis revealed a significant difference 
between the two types of macrophages in terms of the uptake and phagocytosis of live C. glabrata. 
Following 30 min of coincubation with live C. glabrata, 51% of the wild-type macrophages had 
ingested at least one yeast, whereas Dectin-2-/- macrophages showed a significantly reduced 
uptake of 34% (Fig. 5C). This significantly reduced uptake capacity was noticeable early during 
the phagocytosis assay (30 min and 60 min) but not at a later time point (180 min) (Fig. 5C). 
Additionally, the total numbers of fungal cells phagocytosed by macrophages from Dectin-2-/- 
mice were also significantly lower than the numbers phagocytosed by wild-type macrophages 
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Fig. 4: Dectin-2 is required during systemic C. glabrata infection for subsequent splenocyte recall responses. 
Wild-type or Dectin-2-/- mice received 107 CFU of C. glabrata per mouse intravenously. After 3, 7 and 14 days, 
peritoneal macrophages (A) were restimulated ex vivo with either heat-killed C. glabrata (Cg), heat-killed C. 
albicans yeast (Cay) or hyphae (Cah) for 24 h. Levels of TNF-α accumulation in the supernatants was measured 
by ELISA. Results are means ± SEM (n=9-10 mice per group) from 2 independent experiments. Significance 
was determined with Mann-Whitney U-test. Statistically different groups are indicated as *, P < 0.05 (A). 
Wild-type or Dectin-2-/- mice received 107 CFU of C.  glabrata. Per mouse intravenously. After 3, 7 and 14 
days, splenocytes (B, C) were restimulated ex vivo with either heat-killed C. glabrata (Cg) (B) or heat-killed 
C. albicans yeast (Ca) (C) for 48 h and 5 days. Levels of TNF-α, IL-10, IFN-γ (48 h), IL-17 and IL-22 (5 days) 
accumulation in the supernatants were measured by ELISA. Data are represented as means ± SEM (n=14-15 
mice per group) from 3 independent experiments. Significance was determined with Mann-Whitney U-test. 
Statistically different groups are indicated as *, P < 0.05; **, P < 0.01 and ***, P < 0.001.
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Fig. 5: Impact of Dectin-2 deficiency on phagocytosis and killing of C. glabrata by peritoneal macrophages. (A) 
Phagocytosis and killing of C. glabrata cells by murine peritoneal macrophages. The results are represented as 
percentage of phagocytosis (the percentage of fungal cells engulfed by macrophages present in the well) and 
percentage of killing (the percentage of killed fungal cells among the phagocytosed yeast). The C. glabrata/
macrophage ratio was 10:1. Data are represented as means ± SEM (n=5 mice per group). (B) Migration of 
peritoneal macrophages using live-cell video microscopy. Tracking diagrams illustrating the distances travelled, 
directionality and velocity of macrophages exposed to C. glabrata at a ratio of 3:1 fungal particles:macrophage. 
Due to the large number of macrophages tracked per video, the data were filtered to show only macrophages 
whose tracks lasted up until 30 min to 60 min, as previous work has shown that migration activity is greater early 
on [25]. Tracks represent the movement of individual macrophages relative to their starting position, symbols 
indicate the location of macrophages at 1 min intervals and arrows represent directionality. (n=7 control mice, 
and n=8 Dectin-2-/- mice for 4 independent experiments). Percentage of uptake (C) and phagocytic index (D) 
using live-cell video microscopy. The percentage of macrophages that have ingested at least one C. glabrata yeast 
and the number of C. glabrata yeasts per 100 macrophages are depicted. *, P < 0.05.
at 30 min and 60 min of coincubation (Fig. 5D). Altogether, these results highlight a partial, 
yet significant role of Dectin-2 in mediating the uptake and engulfment of C. glabrata by 
macrophages. In addition, partial effects on fungal killing may also be envisioned, although 
more studies should be performed to establish that definitively. 
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Dectin-2-/- neutrophils are less efficient in phagocytosing and killing 
C. glabrata ex vivo
We next assessed the recognition and killing of C. glabrata by neutrophils, pivotal players in the 
clearance of invading fungal cells from tissues. Neutrophils were harvested from the peritoneal 
cavity of both wild-type and Dectin-2-/- mice and further subjected to an ex vivo phagocytosis and 
killing assay (23). The phagocytosis of C. glabrata by the Dectin-2-/- neutrophils was considerably 
less effective than the phagocytosis of C. glabrata by neutrophils of wild-type mice (Fig. 6A). 
The killing of C. glabrata by the Dectin-2-/- neutrophils was slightly diminished compared with 
the killing by control neutrophils (Fig. 6A). Importantly, neutrophils from Dectin-2-/- mice 
showed a defect in secretion of ROS upon interaction with either live opsonized C. glabrata or C. 
albicans compared with the ROS secretion of wild-type neutrophils (Fig. 6B). Interestingly, the 
defect was specific for fungi, as no differences in ROS production were observed when cells were 
stimulated with PMA (Fig. 6B). Thus, Dectin-2 is important in both the uptake of C. glabrata by 
neutrophils and the subsequent ROS production and killing of the yeast. 
Discussion 
Dectin-2 is one of the main pattern recognition receptors for fungal mannans, with recent 
studies demonstrating an important role for this receptor in host defense against C. albicans 
(13). In the present study, we show that Dectin-2 is also an important component of the host 
defense against C. glabrata. The increased susceptibility of Dectin-2-/- mice to a systemic 
Fig. 6: Impact of Dectin-2 deficiency on phagocytosis and killing of C. glabrata by neutrophils. (A) 
Phagocytosis and killing of C. glabrata cells by murine neutrophils. The results are represented as percentage 
of phagocytosis (the percentage of fungal cells engulfed by neutrophils present in the well) and percentage of 
killing (the percentage of killed fungal cells among the phagocytosed yeast). The C. glabrata/neutrophil ratio 
was 10:1. Values represent means ± SEM (n=10 mice per group) for 2 independent experiments. P values are 
relative to phagocytosis or killing induced by wild-type and Dectin-2-/- macrophages. *, P < 0.05. (B) Dectin-2 
neutrophils cannot induce the respiratory burst at the same extent as wild-type. Dectin-2-/- or wild-type 
neutrophils were stimulated with RPMI, PMA, live opsonized C. glabrata or live opsonized C. albicans, and 
overall oxygen radical production (area under the curve after 60 min) was measured with luminal-enhanced 
chemiluminescence in isolated neutrophils. Data are represented as means ± SEM (n=10 mice per group) for 
2 independent experiments. Significance was determined with Mann-Whitney U-test. Statistically different 
groups are indicated as *, P < 0.05 and ***, P < 0.001. PMA: phorbol 12-myristate 13-acetate. 
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infection with C. glabrata is associated with a combination of decreased production of 
protective T helper-derived cytokines and defective phagocytosis and killing of the yeast by 
both neutrophils and macrophages. 
Little is known of the role of the C-type lectin receptor, Dectin-2. A recent study 
reported that Dectin-2-/- mice are highly susceptible to a systemic infection with C. albicans 
(13). Moreover, it has been shown that Dectin-2 plays an important role in the induction of 
protective Th17 responses (17) and that, together with Dectin-3, it forms a heterodimeric 
pattern recognition receptor for host defense against C. albicans (27). The intracellular 
signaling induced by Dectin-2 involves activation of CARD9 (28), phospholipase C-γ (29), 
and protein kinase C-σ (30). Our study demonstrates that Dectin-2 has a nonredundant role 
for host defense against C. glabrata. This is an important observation not only for our improved 
understanding of C. glabrata infection but also for Dectin-2 biology: while Dectin-2 has 
been suggested to recognize mainly C. albicans hyphae (13), its importance for recognition 
of a Candida species that does not usually develop hyphae is a broadening of the biological 
importance of Dectin-2. The increased susceptibility to C. glabrata was demonstrated in two 
independently generated groups of Dectin-2-/- mice, reinforcing this conclusion. However, 
these mice were less susceptible to C. glabrata than to C. albicans, as reported earlier (13). The 
increased susceptibility of Dectin-2-/- mice to C. glabrata was apparent through their incapacity 
to eliminate the fungus from the kidneys, the target organ of disseminated candidiasis (31). 
Previously reported studies already showed that systemic candidiasis increased the fungal 
burden in kidneys of Dectin-1-/- mice compared with the fungal burden in kidneys of the 
wild-type mice (12). The fact that the animals were able to eradicate C. glabrata from the liver, 
in comparison with the results for the kidneys, confirms recent findings concerning organ-
specific Candida infection and immune responses mediated primarily by neutrophils and 
monocytes, as well as by various molecular factors (32–34). 
Fungal pathogens have developed a number of strategies to improve their chance of 
survival in the host environment; e.g., Candida albicans and Cryptococcus neoformans 
either destroy macrophages or escape via nonlytic exocytosis (35, 36). Interestingly, C. 
glabrata engulfed by macrophages does not undergo a morphological transition but 
survives and multiplies within mammalian macrophages (37, 38), which are ultimately 
damaged by ingested C. glabrata (38). In our study, we assessed the role of Dectin-2 for 
the phagocytosis and killing of C. glabrata and observed that neutrophils and macrophages 
lacking this receptor were less capable of ingesting and killing the yeast. Using live-cell 
video microscopy, we found that significantly fewer Dectin-2-/- macrophages took up C. 
glabrata, in accordance with a lower phagocytic index where phagocytosis had occurred. 
These defects in the uptake and phagocytosis of C. glabrata could not be attributed to a 
defect in mobility. Finally, signaling through C-type lectin receptors induces cytokines and 
ROS that both activate the spleen tyrosine kinase (Syk)-caspase recruitment domain family 
member 9 (CARD9)-nuclear factor-κB (NF-κB) pathway (39) and, most likely, induce 
the intraphagosomal damage of fungal cells. In line with a role of the CARD9 pathway, 
Drewniak et al. showed that human CARD9 deficiency resulted in a selective defect in 
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the host defense against invasive fungal infection, caused by impaired phagocyte killing 
in unopsonized samples compared with the phagocyte killing in opsonized samples (40). 
In the present study, Dectin-2-/-neutrophils produced less ROS than wild-type neutrophils 
after stimulation of cells with either opsonized C. glabrata or C. albicans, suggesting a role 
of Dectin-2 in the killing of Candida species despite the presence of opsonins. 
The induction of proinflammatory cytokines is an important component of anti-Candida 
host defense. Macrophage-derived proinflammatory cytokines like IL-1, KC, or IL-6 activate 
the recruitment of phagocytes and the phagocytosis and killing of fungi by phagocytes, and 
mice deficient in these cytokines have an increased susceptibility to systemic candidiasis (41, 
42). No major defects in the production of these cytokines were observed in cells isolated 
from Candida-challenged Dectin-2-/- mice. In contrast, the secretion of cytokines produced 
by Th1 and Th17 lymphocytes was significantly decreased in Dectin-2-/- mice. IFN-γ is the 
main product of Th1 lymphocytes, and it has been proven to have a crucial role in antifungal 
host defense in mice (43). The defective production of IFN-γ by the splenocytes of Dectin-
2-/- mice may represent one of the mechanisms determining the increased susceptibility 
to C. glabrata in these mice. Similarly, the Th17 cytokine, IL-17, represents an important 
component of antifungal host defense through its activation of neutrophils (44), while 
patients with defective Th17 responses develop chronic mucocutaneous candidiasis (45). 
The level of IL-17 produced by Dectin-2-/- splenocytes was significantly decreased at day 
7 postinfection, suggesting a role for Dectin-2 in regulating splenocyte recall responses to 
fungal infection. The defective Th17 responses in Dectin-2-/- mice could therefore contribute 
to their susceptibility to C. glabrata. These results underline the conclusions of Saijo et al. (13) 
concerning Dectin-2-mediated immunity to C. albicans. The IL-17 defect in response to C. 
glabrata observed in our study was, however, less pronounced than that previously reported 
for C. albicans (13). Moreover, we should observe that the cytokine differences were most 
pronounced earlier during infection. At later time points during the infection, the picture 
starts to be biased by the higher fungal burden in the KO mice, which may counterbalance 
the defective cytokine production capacity. 
The known fungal ligands recognized by Dectin-2 are α-mannans (13). Whereas 
significant research has been conducted on the structure of the C. albicans cell wall, much 
less is known regarding the cell wall components of C. glabrata. While recognition of 
mannans of C. glabrata by Dectin-2 is most likely, future studies should define the precise 
ligand-receptor interaction profile, especially as C. glabrata is less likely to form hyphae than 
C. albicans. Moreover, both endogenous (T cell) and exogenous (microbial carbohydrate) 
ligands for Dectin-2 may be important for the generation and maintenance of tolerance or 
the recognition of carbohydrate structures. Of particular interest is that previous reports 
have highlighted the ability of Dectin-2 to specifically signal after recognition of the hyphal 
form of C. albicans (28). The interaction between C. glabrata and Dectin-2 is different, as C. 
glabrata does not form traditional compartmentalized hyphae. Still, previous reports have 
described tubes and pseudohypha formation in several clinical isolates of C. glabrata (46), 
and these might be recognized by Dectin-2. 
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In conclusion, we demonstrate that the immune responses triggered by Dectin-2 
during infection with C. glabrata might link innate immune recognition, phagocytosis, and 
killing of the fungus with the adaptive T helper-dependent responses. A combination of 
these mechanisms controls C. glabrata during systemic infection. Deciphering the precise 
mechanisms responsible for host defense against C. glabrata represents an important step in 
understanding of the pathophysiology of the disease and for the possibility to design future 
novel immunotherapeutic strategies. 
Acknowledgements
We thank A. Whittington for the useful discussion and H. M. J. Roelofs and E. D. Olthof for 
the assistance with ROS production. We thank the University of Aberdeen Animal Facility 
and Microscopy Facility and also D. MacCallum and R. Drummond for technical assistance. 
This work was supported by European Union ALLFUN (FP7/2007 2013, HEALTH-2010-
260338) (Fungi in the setting of inflammation, allergy and autoimmune diseases: Translating 
basic science into clinical practices ALLFUN) to D.C.I., M.G.N., and N.A.R.G. M.G.N 
and J.Q. were also supported by a Vici grant of the Netherlands Organization of Scien- 
tific Research (to M.G.N.). N.A.R.G. was also supported by the Wellcome Trust (080088, 
086827, 075470, and 097377). L.P.E. is a CSO Senior Clinical Fellow and supported by WT 
project, programme, and equipment grants (089930 and 094847). G.D.B. was funded by the 
Wellcome Trust (086558 and 097377). 
 
73
Role of Dectin-2 for Host Defense against Systemic Infection with Candida glabrata 
4
References 
1 Pfaller MA, Messer SA, Moet GJ, Jones RN, 
Castanheira M. Candida bloodstream infections: 
comparison of species distribution and resistance 
to echinocandin and azole antifungal agents in 
Intensive Care Unit (ICU) and non-ICU settings in 
the SENTRY Antimicrobial Surveillance Program 
(2008-2009). Int J Antimicrob Agents. [Research 
Support, Non-U.S. Gov’t]. 2011 Jul;38(1):65-9.
2 Abi-Said D, Anaissie E, Uzun O, Raad I, 
Pinzcowski H, Vartivarian S. The epidemiology 
of hematogenous candidiasis caused by 
different Candida species. Clin Infect Dis. 1997 
Jun;24(6):1122-8.
3 Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, 
McKinsey DS, Karchmer AW, et al. Prospective 
multicenter surveillance study of funguria in 
hospitalized patients. The National Institute for 
Allergy and Infectious Diseases (NIAID) Mycoses 
Study Group. Clin Infect Dis. 2000 Jan;30(1):14-8.
4 Ruan SY, Chu CC, Hsueh PR. In vitro susceptibilities 
of invasive isolates of Candida species: rapid 
increase in rates of fluconazole susceptible-dose 
dependent Candida glabrata isolates. Antimicrob 
Agents Chemother. 2008 Aug;52(8):2919-22.
5 Hajjeh RA, Sofair AN, Harrison LH, Lyon 
GM, Arthington-Skaggs BA, Mirza SA, et al. 
Incidence of bloodstream infections due to 
Candida species and in vitro susceptibilities 
of isolates collected from 1998 to 2000 in a 
population-based active surveillance program. J 
Clin Microbiol. 2004 Apr;42(4):1519-27.
6 Fidel PL, Jr., Vazquez JA, Sobel JD. Candida 
glabrata: review of epidemiology, pathogenesis, 
and clinical disease with comparison to C. albicans. 
Clin Microbiol Rev. 1999 Jan;12(1):80-96.
7 Anaissie EJ, Vartivarian SE, Abi-Said D, Uzun O, 
Pinczowski H, Kontoyiannis DP, et al. Fluconazole 
versus amphotericin B in the treatment of 
hematogenous candidiasis: a matched cohort 
study. Am J Med. 1996 Aug;101(2):170-6.
8 Goodman JL, Winston DJ, Greenfield RA, 
Chandrasekar PH, Fox B, Kaizer H, et al. A 
controlled trial of fluconazole to prevent fungal 
infections in patients undergoing bone marrow 
transplantation. N Engl J Med. 1992 Mar 
26;326(13):845-51.
9 Netea MG, Brown GD, Kullberg BJ, Gow NA. An 
integrated model of the recognition of Candida 
albicans by the innate immune system. Nat Rev 
Microbiol. 2008 Jan;6(1):67-78.
10 Poulain D, Jouault T. Candida albicans cell wall 
glycans, host receptors and responses: elements 
for a decisive crosstalk. Curr Opin Microbiol. 
2004 Aug;7(4):342-9.
11 Cambi A, Netea MG, Mora-Montes HM, Gow 
NA, Hato SV, Lowman DW, et al. Dendritic cell 
interaction with Candida albicans critically 
depends on N-linked mannan. J Biol Chem. 
2008 Jul 18;283(29):20590-9.
12 Taylor PR, Tsoni SV, Willment JA, Dennehy KM, 
Rosas M, Findon H, et al. Dectin-1 is required for 
beta-glucan recognition and control of fungal 
infection. Nat Immunol. 2007 Jan;8(1):31-8.
13 Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame 
H, Akitsu A, et al. Dectin-2 recognition of alpha-
mannans and induction of Th17 cell differentiation 
is essential for host defense against Candida 
albicans. Immunity. 2010 May 28;32(5):681-91.
14 Ariizumi K, Shen GL, Shikano S, Ritter R, 
3rd, Zukas P, Edelbaum D, et al. Cloning of a 
second dendritic cell-associated C-type lectin 
(dectin-2) and its alternatively spliced isoforms. 
J Biol Chem. 2000 Apr 21;275(16):11957-63.
15 McGreal EP, Rosas M, Brown GD, Zamze S, 
Wong SY, Gordon S, et al. The carbohydrate-
recognition domain of Dectin-2 is a C-type 
lectin with specificity for high mannose. 
Glycobiology. 2006 May;16(5):422-30.
16 Barrett NA, Maekawa A, Rahman OM, Austen 
KF, Kanaoka Y. Dectin-2 recognition of 
house dust mite triggers cysteinyl leukotriene 
generation by dendritic cells. J Immunol. 2009 
Jan 15;182(2):1119-28.
17 Robinson MJ, Osorio F, Rosas M, Freitas RP, 
Schweighoffer E, Gross O, et al. Dectin-2 is 
a Syk-coupled pattern recognition receptor 
crucial for Th17 responses to fungal infection. J 
Exp Med. 2009 Aug 31;206(9):2037-51.
18 Sato K, Yang XL, Yudate T, Chung JS, Wu J, Luby-
Phelps K, et al. Dectin-2 is a pattern recognition 
receptor for fungi that couples with the Fc receptor 
gamma chain to induce innate immune responses. 
J Biol Chem. 2006 Dec 15;281(50):38854-66.
19 Gavino AC, Chung JS, Sato K, Ariizumi K, 
Cruz PD, Jr. Identification and expression 
profiling of a human C-type lectin, structurally 
homologous to mouse dectin-2. Exp Dermatol. 
2005 Apr;14(4):281-8.
20 Zhang Z, Lutz B. Cre recombinase-mediated 
inversion using lox66 and lox71: method to 
74
Role of Dectin-2 for Host Defense against Systemic Infection with Candida glabrata 
4
introduce conditional point mutations into the 
CREB-binding protein. Nucleic Acids Res. 2002 
Sep 1;30(17):e90.
21 Koszul R, Malpertuy A, Frangeul L, Bouchier 
C, Wincker P, Thierry A, et al. The complete 
mitochondrial genome sequence of the 
pathogenic yeast Candida (Torulopsis) glabrata. 
FEBS Lett. 2003 Jan 16;534(1-3):39-48.
22 Kullberg BJ, van ‘t Wout JW, van Furth R. Role of 
granulocytes in increased host resistance to Candida 
albicans induced by recombinant interleukin-1. 
Infect Immun. 1990 Oct;58(10):3319-24.
23 Kullberg BJ, van ‘t Wout JW, Hoogstraten C, 
van Furth R. Recombinant interferon-gamma 
enhances resistance to acute disseminated 
Candida albicans infection in mice. J Infect Dis. 
1993 Aug;168(2):436-43.
24 McKenzie CG, Koser U, Lewis LE, Bain 
JM, Mora-Montes HM, Barker RN, et al. 
Contribution of Candida albicans cell wall 
components to recognition by and escape from 
murine macrophages. Infect Immun. 2010 
Apr;78(4):1650-8.
25 Lewis LE, Bain JM, Okai B, Gow NA, Erwig LP. 
Live-cell video microscopy of fungal pathogen 
phagocytosis. J Vis Exp. 2013(71).
26 Versleijen MW, Oyen WJ, Roelofs HM, van Emst-
de Vries SE, Willems PH, Jansen JB, et al. Immune 
function and leukocyte sequestration under the 
influence of parenteral lipid emulsions in healthy 
humans: a placebo-controlled crossover study. 
Am J Clin Nutr. 2008 Mar;87(3):539-47.
27 Zhu LL, Zhao XQ, Jiang C, You Y, Chen XP, 
Jiang YY, et al. C-Type Lectin Receptors 
Dectin-3 and Dectin-2 Form a Heterodimeric 
Pattern-Recognition Receptor for Host Defense 
against Fungal Infection. Immunity. 2013 Aug 
22;39(2):324-34.
28 Bi L, Gojestani S, Wu W, Hsu YM, Zhu J, Ariizumi 
K, et al. CARD9 mediates dectin-2-induced 
IkappaBalpha kinase ubiquitination leading to 
activation of NF-kappaB in response to stimulation 
by the hyphal form of Candida albicans. J Biol 
Chem. 2010 Aug 20;285(34):25969-77.
29 Gorjestani S, Yu M, Tang B, Zhang D, Wang D, 
Lin X. Phospholipase Cgamma2 (PLCgamma2) 
is key component in Dectin-2 signaling pathway, 
mediating anti-fungal innate immune responses. 
J Biol Chem. 2011 Dec 23;286(51):43651-9.
30 Strasser D, Neumann K, Bergmann H, 
Marakalala MJ, Guler R, Rojowska A, et al. Syk 
kinase-coupled C-type lectin receptors engage 
protein kinase C-sigma to elicit Card9 adaptor-
mediated innate immunity. Immunity. 2012 Jan 
27;36(1):32-42.
31 Spellberg B, Ibrahim AS, Edwards JE, Jr., Filler 
SG. Mice with disseminated candidiasis die 
of progressive sepsis. J Infect Dis. 2005 Jul 
15;192(2):336-43.
32 Lionakis MS, Lim JK, Lee CC, Murphy PM. 
Organ-specific innate immune responses in a 
mouse model of invasive candidiasis. J Innate 
Immun. [Research Support, N.I.H., Intramural]. 
2011;3(2):180-99.
33 Lionakis MS, Fischer BG, Lim JK, Swamydas 
M, Wan W, Richard Lee CC, et al. Chemokine 
receptor Ccr1 drives neutrophil-mediated 
kidney immunopathology and mortality in 
invasive candidiasis. PLoS Pathog. [Research 
Support, N.I.H., Intramural
34 Research Support, Non-U.S. Gov’t]. 
2012;8(8):e1002865.
35 Ngo LY, Kasahara S, Kumasaka DK, Knoblaugh 
SE, Jhingran A, Hohl TM. Inflammatory 
Monocytes Mediate Early and Organ-Specific 
Innate Defense During Systemic Candidiasis. J 
Infect Dis. 2013 Aug 28.
36 Alvarez M, Casadevall A. Phagosome extrusion 
and host-cell survival after Cryptococcus 
neoformans phagocytosis by macrophages. 
Curr Biol. 2006 Nov 7;16(21):2161-5.
37 Bain JM, Lewis LE, Okai B, Quinn J, Gow NA, 
Erwig LP. Non-lytic expulsion/exocytosis of 
Candida albicans from macrophages. Fungal 
Genet Biol. 2012 Sep;49(9):677-8.
38 Kaur R, Ma B, Cormack BP. A family of 
glycosylphosphatidylinositol-linked aspartyl 
proteases is required for virulence of Candida 
glabrata. Proc Natl Acad Sci U S A. 2007 May 
1;104(18):7628-33.
39 Seider K, Brunke S, Schild L, Jablonowski 
N, Wilson D, Majer O, et al. The facultative 
intracellular pathogen Candida glabrata 
subverts macrophage cytokine production and 
phagolysosome maturation. J Immunol. 2011 
Sep 15;187(6):3072-86.
40 Drummond RA, Saijo S, Iwakura Y, Brown GD. 
The role of Syk/CARD9 coupled C-type lectins 
in antifungal immunity. Eur J Immunol. 2011 
Feb;41(2):276-81.
41 Drewniak A, Gazendam RP, Tool AT, van Houdt 
M, Jansen MH, van Hamme JL, et al. Invasive 
fungal infection and impaired neutrophil killing in 
human CARD9 deficiency. Blood. [Case Reports
75
Role of Dectin-2 for Host Defense against Systemic Infection with Candida glabrata 
4
42 Research Support, Non-U.S. Gov’t]. 2013 Mar 
28;121(13):2385-92.
43 Basu S, Quilici C, Zhang HH, Grail D, Dunn 
AR. Mice lacking both G-CSF and IL-6 are more 
susceptible to Candida albicans infection: critical 
role of neutrophils in defense against Candida 
albicans. Growth Factors. 2008 Feb;26(1):23-34.
44 Gorjestani S, Darnay BG, Lin X. Tumor necrosis 
factor receptor-associated factor 6 (TRAF6) and 
TGFbeta-activated kinase 1 (TAK1) play essential 
roles in the C-type lectin receptor signaling in 
response to Candida albicans infection. J Biol 
Chem. 2012 Dec 28;287(53):44143-50.
45 Zhou P, Sieve MC, Bennett J, Kwon-Chung KJ, 
Tewari RP, Gazzinelli RT, et al. IL-12 prevents 
mortality in mice infected with Histoplasma 
capsulatum through induction of IFN-gamma. 
J Immunol. 1995 Jul 15;155(2):785-95.
46 Dejima T, Shibata K, Yamada H, Hara H, 
Iwakura Y, Naito S, et al. Protective role of 
naturally occurring interleukin-17A-producing 
gammadelta T cells in the lung at the early stage 
of systemic candidiasis in mice. Infect Immun. 
2011 Nov;79(11):4503-10.
47 van de Veerdonk FL, Plantinga TS, Hoischen 
A, Smeekens SP, Joosten LA, Gilissen C, et 
al. STAT1 mutations in autosomal dominant 
chronic mucocutaneous candidiasis. N Engl J 
Med. 2011 Jul 7;365(1):54-61.
48 Lachke SA, Joly S, Daniels K, Soll DR. Phenotypic 
switching and filamentation in Candida glabrata. 
Microbiology. 2002 Sep;148(Pt 9):2661-74.
76

PART TWO 
Modulation of innate immune 
responses after Candida infection: 
induction of trained immunity 
5
Trained immunity or tolerance:  
opposing functional programs induced  
in human monocytes after engagement  
of various pattern recognition receptors
Daniela C. Ifrim, Jessica Quintin, Leo A.B. Joosten, Cor Jacobs, Trees Jansen,  
Liesbeth Jacobs, Neil A.R. Gow, David L. Williams, Jos W.M. van der Meer, 
 and Mihai G. Netea
Clinical Vaccine Immunology Volume 21, Issue 4, Pp 534-545.
Differential cytokine induction by PRR families
5
Abstract
Upon priming with Candida albicans or with the fungal cell wall component β-glucan, 
monocytes respond with an increased cytokine production upon restimulation, a 
phenomenon termed “trained immunity.” In contrast, the prestimulation of monocytes with 
lipopolysaccharide has long been known to induce tolerance. Because the vast majority of 
commensal microorganisms belong to bacterial or viral phyla, we sought to systematically 
investigate the functional reprogramming of monocytes induced by the stimulation of 
pattern recognition receptors (PRRs) with various bacterial or viral ligands. Monocytes were 
functionally programmed for either enhanced (training) or decreased (tolerance) cytokine 
production, depending on the type and concentration of ligand they encountered. The 
functional reprogramming of monocytes was also associated with cell shape, granulocity, 
and cell surface marker modifications. The training effect required p38- and Jun N-terminal 
protein kinase (JNK)-mediated mitogen-activated protein kinase (MAPK) signaling, with 
specific signaling patterns directing the functional fate of the cell. The long-term effects on the 
function of monocytes were mediated by epigenetic events, with both histone methylation and 
acetylation inhibitors blocking the training effects. In conclusion, our experiments identify 
the ability of monocytes to acquire adaptive characteristics after prior activation with a wide 
variety of ligands. Trained immunity and tolerance are two distinct and opposing functional 
programs induced by the specific microbial ligands engaging the monocytes. 
Keywords: trained immunity, microbial ligands, monocytes, memory.
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Introduction
More than 3 decades ago, a number of studies reported enhanced immune responses upon 
reinfection in diverse invertebrate taxa that do not possess adaptive immunity, such as 
cockroaches (1–3), shrimp (4, 5), and mealworm beetles (6). Interestingly, invertebrates 
also have proven to be able to mount enhanced secondary immune responses (7) and to 
transmit protection to their offspring (8). While this protection is nonspecific, several 
studies demonstrated that these effects enable discrimination between different classes of 
pathogens. Recently, Witteveldt et al. showed that such immune memory can be used in 
the vaccination of invertebrates (9). Whereas vertebrates use somatic rearrangement of 
immunological receptors to induce adaptive immune responses, one mechanism employed 
by the host defenses of invertebrates to confer adaptation to infection is alternative splicing 
of pattern recognition genes, such as Down syndrome cell adhesion molecule, which 
generates a highly diverse set of >31,000 potential alternative splice forms (10, 11). These 
two molecular processes have the same consequence: they create a receptor repertoire that 
is sufficiently diverse for discriminating between the broad varieties of different antigens. 
The function of prototypic mammalian innate immune cells, such as NK cells, can also be 
enforced, leading to protection against reinfection with viral pathogens (12–15). Similarly, 
monocytes and/or macrophages exhibit memory characteristics that mediate protective 
effects after a second encounter with a pathogen (16, 17). We have termed this phenomenon 
“trained immunity,” defined as enhanced nonspecific innate immune protection that is 
suggested to be mediated by epigenetic mechanisms (18). In contrast to trained immunity, 
engagement of the Toll-like receptor 4 (TLR4) by lipopolysaccharide (LPS) has been known 
for several decades to inhibit the cell function in a process called LPS-induced tolerance 
(19, 20). LPS tolerance is an active process involving epigenetic remodeling (21), and this 
process has been suggested to be the basic mechanism responsible for the immunoparalysis 
that occurs after Gram-negative sepsis (22). Despite the importance of both LPS tolerance 
(19, 20) and trained immunity (16, 17), very little is known about the modulatory 
characteristics of the various classes of pattern recognition receptors and microbial ligands. 
The aim of this study was to systematically investigate the potential to either train or 
induce tolerance of the well-known classes of PRRs expressed on monocytes/macrophages, 
as depicted in Table 1. We demonstrate that several bacterial, fungal, and viral ligands 
induce the functional reprogramming of monocytes, leading to either nonspecific enhanced 
(training) or diminished (tolerance) cytokine production upon secondary stimulation, 
a process that is often dependent on ligand concentration. Understanding the nature of 
the signaling pathways in determining the functional fate of innate host responses upon 
sequential stimulation of pattern recognition receptors may represent an important step 
toward understanding bacterial and fungal colonization and/or invasion of the mucosa on 
one hand, and for developing novel immunotherapeutic strategies on the other hand.
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Materials and Methods
Blood samples. Blood was collected from healthy volunteers at Sanquin Bloodbank in 
Nijmegen, Netherlands. Informed consent was obtained from the volunteers included. 
Human peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats. 
Reagents. Culture medium used was Roswell Park Memorial Institute (RPMI) 1640 Dutch 
modifications from Sigma-Aldrich, supplemented with 1% gentamicin, 1% L-glutamine 
and 1% pyruvate (Life Technologies, Nieuwekerk, Netherlands). Candida β-glucan was 
isolated and purified as previously described (23). Other reagents were obtained as follows: 
Pam3CSK4 (EMC microcollections, L2000), LPS (E. coli serotype 055:B5, Sigma-Aldrich) 
with an additional purification step (24), Flagellin from Salmonella typhimurium FLA-ST, 
CpG type C ODN M362, Tri-DAP and R848 (InvivoGen), Poly(I:C) (Brunswick, USA), 
Syk inhibitor (EMD, 574711), P38-inhibitor SB202190 (Sigma-RBI, S7067), ERK inhibitor 
(Promega, V1121) and JNK inhibitor SP600125 (AG Scientific, Inc., S-2022), PMA 
(phorbol 12-myristate 13-acetate; Sigma), CD45-PC7 (Beckman Coulter), CD68-APC 
(Biolegend), CD14-PE (Beckman Coulter), CD11b-FITC (Beckman Coulter) and 
Table 1: Pattern recognition receptors, microbial ligands and their adapter molecules. 
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DC-SIGN (Biolegend). Versene solution was purchased from InVitrogen and the Cytotox96 
nonradioactive assay was purchased from Promega. Syk- inhibitor was used previously, as 
described (16). The epigenetic inhibitors, used previously (16, 17), were as follows: histone 
methyltransferase inhibitor (MTA, Sigma-Aldrich, D5011), epigallocatechin-3-gallate 
histone acetyltransferase inhibitor (HAT-i) (EGCG, Sigma, E4143), histone demethylase 
inhibitor (Pargyline, Sigma-Aldrich, P8013) and histone deacetylase inhibitor (ITF2357/9, 
ITALFARMACO S.p.A as described in patent WO 97/43251, US 6034096 (25, 26)).
Stimulation experiments. Mononuclear cells were isolated by density centrifugation 
of PBS-diluted blood (dilution 1:1) over a Ficoll-Paque PLUS gradient (GE Healthcare). 
PBMCs were washed 3 times with PBS and suspended in RPMI 1640 culture medium 
supplemented with 1% gentamicin, 1% pyruvate, and 1% L-glutamine. Cells were counted 
in a Coulter counter (Coulter Electronics), and the concentration was adjusted to 5 × 106 
cells/ml. For stimulation experiments, a 100 μl suspension of 5 × 105 PBMCs in RPMI 
medium was added to flat-bottomed 96-well plates (Greiner Bio-One) and incubated for 1 h 
at 37°C, with 5% CO2. Adherent monocytes were selected by three times washing out non-
adherent cells with warm PBS. For training, cells were preincubated for 24 h with either 
RPMI (negative control), β-glucan (1 μg/ml) (positive control), or with serial dilutions of 
Pam3CSK4 (100 μg/ml to 0.01 pg/ml), LPS (100 ng/ml to 10-5 pg/ml), Flagellin (10 μg/ml 
to 0.01 pg/ml), Poly(I:C) (100 μg/ml to 0.01 pg/ml), R848 (100 μg/ml to 0.01 pg/ml), CpG 
(10 μg/ml to 0.001pg/ml), Tri-DAP (10 μg/ml to 0.001 pg/ml), and MDP (10 μg/ml to 0.01 
pg/ml) for 24 h. After the first incubation, monocytes were washed with warm PBS and 
maintained in RPMI supplemented with 10% pooled human serum for 5 days (media was 
refreshed at day 3). Thereafter, the cells were subjected to a second stimulation of cytokine 
production with LPS (10 ng/ml), Pam3CSK4 (10 μg/ml) or RPMI (negative control). After 
24 h, duplicate supernatants were collected, pooled and stored at -20°C until assayed.
To investigate whether various inhibitors would affect training, adherent monocytes were 
preincubated for 1 h, prior to the first stimulation, with p38 inhibitor (1 µM), Syk inhibitor (140 
µM), JNK inhibitor (20 μM), ERK inhibitor (10 μM), MTA (1 mM), EGCG (15 µM), pargyline 
(3 µM) or ITF2357/9 (100 nM). Subsequently, the microbial stimuli were added to the cells 
together with the inhibitors for an additional 24 h. Thereafter, the cells were washed with PBS 
and further incubated in culture media supplemented with 10% pooled human serum for 5 
days. On day 6, the trained macrophages were subjected to a second stimulation with either 
LPS or Pam3CSK4, for 24 h. The supernatants were collected and stored at -200C until assessed. 
Cytokine assay. The concentrations of TNF-α (R&D Systems, Abingdon, UK) and IL-6 
(Sanquin, Amsterdam, Netherlands) were measured 24 h after the second stimulation, in 
cell culture supernatants using ELISA, according to the manufacturer instructions. 
Lactate hydrogenase (LDH) were performed with the CytoTox  96® Non-Radioactive 
Cytotoxicity Assay (Promega), according to the manufacturer’s instructions. Briefly, the 
adherent monocytes were incubated for 24 h with different microbial ligands and the secreted 
LDH was measured in cell culture supernatants. To check for putative cytotoxic effects of 
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MAPK-, Syk- and epigenetics inhibitors, the adherent monocytes were incubated for 24 
h with RPMI, MAPK kinase-, Syk- or epigenetic inhibitors. Thereafter, the supernatants 
and cells were collected and stored until assessed. The values of inhibitors in RPMI were 
considered as background and subsequently subtracted from the final results. RPMI was 
considered negative control. The final values are depicted in %.
Extracellular Cytokine Staining and Flow Cytometry. 3 ml of PBMCs with a concentration 
of 5 x 106 cells/ml were cultured in a well of a 6-well plate. After 1 h of incubation at 37°C, 
with 5% CO2, non-adherent cells were washed 3 times with warm PBS. The remaining 
adherent monocytes were prestimulated with concentrations of different ligands which 
would induce either training or tolerance, such us β-glucan (1 µg/ml), MDP (1 µg/ml), 
Flagellin (1 µg/ml), R848 (1 µg/ml), Pam3CSK4 (1 µg/ml) and RPMI (negative control), 
for 24 h. The stimuli were washed away and the cells were further incubated for 5 days in 
the presence of RPMI supplemented with 10% pooled human serum. On day 7, the cells 
were incubated for 1 h with Versene solution, collected, harvested by centrifugation and 
suspended in PBS supplemented with 1% PBA. The cells were washed two times and stained 
extracellularly with the following antibodies: anti-CD45-PeCy7 (Beckman Coulter), anti-
CD68-APC (Biolegend), anti-CD14-PE (Beckman Coulter), anti-CD11b-FITC (Beckman 
Coulter) and anti-DC-SIGN-APC (Biolegend). Samples were measured on a FACS FC500, 
and data were analyzed using the CXP software (Beckman Coulter).
Statistical analysis. IBM SPSS Statistics software, Version 20, was used to perform 
statistical analysis. All experiments were performed at least three times with minimum 
six volunteers. The data represent cumulative results of all experiments performed, and 
the number of donors is given as “n” in ﬁgure legends. In order to assess the training effect 
of a specific ligand upon a secondary stimulation, non-trained cells stimulated with LPS 
(or Pam3CSK4) were compared with trained cells restimulated with LPS (or Pam3CSK4). 
The differences between groups were analyzed with Wilcoxon signed rank test and were 
considered statistically significant at P values of < 0.05. 
Results
The type of ligand-PRR interactions as well as pathogen associated 
molecular pattern (PAMP) concentration decides the inflammatory 
state of monocytes 
Some microbial ligands such as β-1,3-glucan (β-glucan) and the muramyl dipeptide (MDP) 
component of peptidoglycans induce trained immunity through the engagement of dectin-1 
and nucleotide-binding oligomerization domain 2 (NOD2), respectively (16, 17), while the 
TLR4 agonist, LPS, induces tolerance (19, 20). We performed a systematical assessment to 
determine whether exposure of adherent monocytes to the microbial ligands of the TLR and 
NOD-like receptor (NLR) classes of pattern recognition receptors such as Pam3CSK4, LPS, 
Flagellin, Poly(I:C), R848, CpG and Tri-DAP also influences the cell response to a secondary 
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stimulation. The adherent monocytes were therefore exposed to each different PRR ligand for 
24 h (first stimulus) at a concentration that would induce an inflammatory response, followed 
by a washout step. Following a resting time of 5 days, period during which monocytes in 
the absence of any primary event differentiate into macrophages, cells were exposed to a 
secondary stimulation with either LPS or Pam3CSK4 (second stimulus) (Fig. 1A). 
The C. albicans cell wall component β-glucan strongly trains monocytes, leading to 
an enhanced production of TNF-α and IL-6 upon nonspecific secondary stimulation with 
LPS or Pam3CSK4 (16); therefore, β-glucan preincubation of monocytes was used as an 
inherent control of effective training throughout this study (Fig. 1B). In contrast to the 
training obtained upon engagement of dectin-1, the stimulation of the membrane receptors 
TLR2, TLR4 and TLR5 by inflammatory doses of Pam3CSK4 (100 µg/ml), LPS (100 ng/ml) 
and Flagellin (10 µg/ml) induced a long-term tolerant state in which monocytes produced 
fewer proinflammatory cytokines (TNF-α and IL-6) upon restimulation than did the RPMI-
treated control cells  (Fig. 1C-1E). Although LPS tolerance has been described in vitro (21) 
and in vivo (27) in short-term experiments, no studies have assessed the long-term effects 
of LPS. Using our training model of human adherent monocytes, we described a long-term 
tolerance effect of LPS (100 ng/ml) on the cytokine production observed upon secondary 
stimulation. In contrast to the membrane associated-TLRs, engaging cytosolic PRRs during 
a primary exposure to pure ligands revealed more diverse outcomes in terms of innate 
immune memory features. Preactivation of the endosomal TLR3 with a strong inflammatory 
dose of Poly(I:C) (100 µg/ml) maintained the cells in a tolerant status, being refractory to 
the second stimulation (Fig. 2A). Similarly, engagement of the endosomal TLR7/8 with R848 
(100 µg/ml) also induced a refractory state of monocytes for TNF-α but not for IL-6 (Fig. 2B). 
However, the use of CpG (10 µg/ml) to preactivate TLR9 failed to induce any trained or 
tolerant effect (Fig. 2C). In contrast, engagement of NOD1 by Tri-DAP (10 µg/ml) and 
NOD2 by MDP (10 µg/ml) significantly trained the cells towards an increased production of 
TNF-α and IL-6 (Fig. 2D and E). Of note, while no correlation could be observed between 
the trained or refractory status obtained and the intracellular adapter molecules of TLRs 
(i.e., MyD88, Toll-interleukin 1 receptor [TIR] domain-containing adaptor protein [TIRAP], 
and TIR domain-containing adapter-inducing beta interferon [TRIF]) (Table 1), it seemed 
that engaging receptors that signal through caspase recruitment domain (CARD) molecules 
favorite an enhanced trained immunity status. Altogether, the activation of TLRs present 
at the cell surface seemed to maintain the cells in a refractory status. However, engaging 
endosomal TLRs had a striking and different effect on the functional fate of monocytes, 
regardless of the adaptor molecules used to signal. Finally, engaging cytosolic NLRs receptors 
seemed to result in an enhanced proinflammatory immune status.  
In order to assess whether the ligand concentration would influence the training of 
monocytes, titrations of all the ligands assessed in this study were performed. None of the 
first incubations with low doses of ligands induced measurable amounts of proinflammatory 
cytokines in supernatants collected after the first 24 hours (data not shown). We first 
deciphered the titration response of the cell membrane-associated TLRs. Systematically 
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Fig. 1: (A) In vitro training scheme. Adherent monocytes were incubated with pure ligands (training stimuli) 
for 24 h at 37°C. Following the first incubation, the cells were washed with warm PBS and further incubated 
with RPMI and pooled human serum for 5 days. In the absence of any training stimulus during the first 24 h, 
primary monocytes maintained in culture for several days eventually differentiated into macrophages. After this 
resting period, different pattern recognition receptor ligands were added (second stimulus) for an additional 24 
h. (B to E) Tolerance induced by the membrane receptors. The cells were preexposed for 24 h to culture medium, 
β-glucan (1 µg/ml) (B), Pam3CSK4 (100 µg/ml) (C), LPS (100 ng/ml) (D), or Flagellin (10 µg/ml) (E). Primary 
stimuli were washed out, and after 6 days, the macrophages were restimulated with RPMI (negative control), LPS 
(10 ng/ml), or Pam3CSK4 (10 µg/ml). While β-glucan induced training, Pam3CSK4, LPS, and flagellin induced 
tolerance. The data are presented as the means ± SEM (n > 8, 5 independent experiments), *p<0.05, **p<0.01, 
***p<0.001, #p<0.05 (tolerance). Wilcoxon signed rank test was used to detect significant differences. 
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Fig. 2: Differential effects of endosomal and cytosolic receptors on adherent monocytes. The cells were 
preexposed for 24 h to culture medium, Poly(I·C) (100 µg/ml) (A), R848 (100 µg/ml) (B), CpG (10 µg/ml) 
(C), Tri-DAP (10 µg/ml) (D), and MDP (10 µg/ml) (E). Primary stimuli were washed out, and after 6 days, 
the macrophages were restimulated with RPMI (negative control), LPS (10 ng/ml), or Pam3CSK4 (10 µg/ml). 
While Poly(I·C) induced tolerance for TNF-α and IL-6, R848 was able to induce tolerance for TNF-α only, and 
CpG did not exert any significant effect on the inflammatory status of monocytes. Both types of NLRs were able 
to enhance the status of monocytes upon a second exposure to either LPS or Pam3CSK4. The data are presented 
as the means ± SEM (n > 8, 5 independent experiments), *p<0.05, **p<0.01, ***p<0.001, #p<0.05 (tolerance). 
Wilcoxon signed rank test was used to detect significant differences.
lowering the amount of Pam3CSK4 which is used to activate the cell membrane associated 
TLR2, strongly modified the monocytes reprogramming characteristics. Pam3CSK4 in low 
concentration (1 µg/ml) resulted in a tolerance status for TNF-α and IL-6 upon LPS secondary 
stimulation. Interestingly, upon restimulation with Pam3CSK4, Pam3CSK4-preactivated 
monocytes were programmed to produce an increased amount of IL-6 compared to that 
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produced by nonactivated (RPMI) control cells (Fig. 3A). The anti-inflammatory-trained 
pattern was generally observable for TNF-α upon LPS secondary stimulation (Fig. 3A). 
Similarly, decreasing the amount of LPS and Flagellin during the pre-activation period of 
monocytes led to the opposite effect of tolerance, that is a pro-inflammatory status represented 
by significantly elevated levels of TNF-α and IL-6 upon restimulation (Fig. 3B and C). 
We next deciphered the effect of differential engagement of cytosolic receptors. 
Preincubation of cells with low doses of Poly(I·C) or R848 gradually reversed the long-term 
tolerance effect (Fig. 4A and B), leading to a training effect upon restimulation with LPS or 
Pam3CSK4. Interestingly, lowering the concentrations of CpG (Fig. 4C), Tri-DAP (Fig. 4D), 
or MDP (Fig. 4E) did not reverse the long-term effect obtained with high inflammatory doses. 
Particularly, lowering the doses of CpG did not alter the “inert” status of priming, and none 
of the doses used triggered an enhanced or refractory immune status upon restimulation of 
the monocytes (Fig. 4C). However, although the enhanced proinflammatory status of the 
monocytes was not reversed to tolerance, the training effect obtained with the preactivation 
of NLRs eventually vanished by lowering the amount of Tri-DAP and MDP, resulting in 
normal nontolerant and nontrained cells (Fig. 4D and E). Cell viability and ligand toxicity 
were assessed at 24 h and at 7 days after the first stimulation for all the ligands tested, and 
none of the ligands used during the 24 h of primary cell stimulation enhanced LDH release 
Fig. 3: Dose responses of membrane-bound receptors. The cells were preexposed for 24 h to culture medium 
or to different concentrations of Pam3CSK4 (100 µg/ml to 0.01 pg/ml) (A), LPS (100 ng/ml to 10-5 pg/ml) 
(B), and Flagellin (10 µg/ml to 0.01 pg/ml) (C). The first stimuli were washed away, and adherent monocytes 
were further incubated for 5 days in culture medium supplemented with 10% pooled human pool serum. At 
day 6, the cells were restimulated with RPMI (negative control), LPS (10 ng/ml), or Pam3CKS4 (10 µg/ml). 
Depending on the concentration used, after several days, cells entered either a trained or tolerized status. The 
data are presented as the means ± SEM (n > 8, 5 independent experiments), *p<0.05, **p<0.01, ***p<0.001, 
#p<0.05 (tolerance). Wilcoxon signed rank test was used to detect significant differences. TNF-α and IL-6 from 
cells stimulated with RPMI were below the detection limit.
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compared to RPMI-treated cells (Supplementary Fig. S1), demonstrating that the decreased 
cytokine production was not due to the toxicity of the ligands used in the experiments.
Trained or tolerized cells exhibit a broad range of cell size, granulocity, 
and different macrophage markers at the surface 
Macroscopically, cells trained with β-glucan (1 µg/ml), MDP (1 µg/ml) and Flagellin 
(1 µg/ml) are considerable larger than nontreated cells (Fig. 5A-D), while macrophages 
that entered a tolerized status were comparable in size to RPMI-treated cells (Fig. 5E and 
F). The phenotype of considerable larger trained cells is reminiscent of a previous study 
Fig. 4: Dose responses of endosomal and cytosolic receptors. The cells were preexposed for 24 h to culture medium 
or to different concentrations of Poly(I·C) (100 µg/ml to 0.01 pg/ml) (A), R848 (100 µg/ml to 0.01 pg/ml) (B), CpG 
(10 µg/ml to 0.001 pg/ml) (C), Tri-DAP (10 µg/ml to 0.001 pg/ml) (D), and MDP (10 µg/ml to 0.01 pg/ml) (E). 
The first stimuli were washed away, and adherent monocytes were further incubated for 5 days in culture medium 
supplemented with 10% pooled human pool serum. At day 6, the cells were restimulated with RPMI (negative 
control), LPS (10 ng/ml), or Pam3CKS4 (10 µg/ml). Depending on concentration used, after several days, cells 
entered either a trained or tolerized status. The data are presented as the means ± SEM (n > 8, 5 independent 
experiments), *p<0.05, **p<0.01, ***p<0.001, #p<0.05 (tolerance). Wilcoxon signed rank test was used to detect 
significant differences. TNF-α and IL-6 from cells stimulated with RPMI were below the detection limit.
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by Daigneault et al (28), in which human mononocyte-derived macrophages with serum 
and PMA-activated-THP1 cells via activation showed increased light scattering due to 
the accumulation of organelles (28). To establish the similarities and differences between 
long-term innate immune reprogramming by PRRs ligands from the process of PMA-
induced-cell activation, we assessed the effect of two different concentrations of PMA (10 
µg/ml and 10 ng/ml) in our in vitro experimental model. Preincubation of monocytes with 
a low dose of PMA during the first 24 h resulted in an enhanced proinflammatory status, 
while higher concentration (10 µg/ml) induced a refractory immune status compared to 
the non-activated control macrophages (Supplementary Fig. S2). Hence, these results 
suggest the ability of PMA to induce differential activation of monocytes at the level of pro-
inflammatory cytokines production, in a dose-dependent manner, similarly to TLRs ligands. 
To further investigate the phenotype of trained versus tolerant cells, we assessed several 
surface markers on the cells treated with different PAMPs, by means of flow cytometry (Fig. 
6). Adherent monocytes were trained as previously described (Fig. 1A) and after 6 days, cells 
were restimulated with medium alone. RPMI-trained cells are represented in Fig. 6A. All the 
counts were gated on CD45+ high (Fig. 6B and C). β-glucan was used as an inherent control; 
thus, based on β-glucan trained macrophages, several cell populations were identified for 
CD14, CD68 and DC-SIGN positive cells (Fig. 6D to F), while for CD11b+ only one cell 
population was identified (Fig. 6G). The levels of CD14+, CD68+, DC-SIGN+ and CD11b+ at 
the cell surface were assessed. Interestingly, based on the side and forward scatter analysis, 
all β-glucan-trained cells proved to be of a broad granulocity and size range, and most of 
the cells positive for CD14, CD68 and CD11b (Fig. 6H to J). Similar observations were 
obtained with MDP and Flagellin-treated cells at a concentration that induces training (1 
µg/ml) (Fig. 6H and J), while CD68+ and DC-SIGN+ were less present on the MDP and 
Flagellin-trained cells. Tolerant macrophages treated with Pam3CSK4 (1 µg/ml) or R848 
(1 µg/ml) were significantly smaller than β-glucan-trained cells, with a broad granulocity, 
and fewer were positive for CD68, CD11b or DC-SIGN, while CD14 was still present to a 
similar intensity as β-glucan-trained cells (Fig. 6H to K).
Trained immunity is dependent on MAP kinase-dependent pathways 
and histone methylation and acetylation 
(MAPK) play a key role in the induction of the initial inflammatory cytokine response of 
the activated monocytes (29). This prompted us to investigate whether MAPK (ERK, JNK, 
and p38) and Syk pathways are involved in the training effects of monocytes. While β-glucan 
signaling induces trained immunity via the noncanonical Raf1 pathway (16), we show here 
that p38 and JNK are involved in the training of primary monocytes by MDP and Flagellin 
(Fig. 7A and B). In contrast, ERK and Syk inhibitors did not affect training by these ligands 
(data not shown). β-glucan and Mycobacterium bovis BCG-induced trained immunity is 
mediated by epigenetic mechanisms (16, 17). We assessed whether histone modifications 
by methylation or acetylation influence the observed training effects of MDP and Flagellin. 
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Fig. 5: Morphology of trained versus tolerized cells. The cells were preexposed for 24 h to culture medium (A) 
or to several pure ligands, such as β-glucan (1 µg/ml) (B), MDP (1 µg/ml) (C), Flagellin (1 µg/ml) (D), R848 (1 
µg/ml) (E), and Pam3CSK4 (1 µg/ml) (F). The first stimuli were washed away, and adherent monocytes were 
further incubated for 5 days in culture medium supplemented with 10% pooled human pool serum. At day 6, 
the cells were microscopically examined and representative pictures were chosen (x200). After several days 
in culture, primary monocytes differentiated into the macrophages. While trained cells appeared to be bigger 
and more activated (B, to D), cells that entered a tolerizing status seemed to be considerably smaller (E and F).
Inhibition of histone methyltransferases with 5’-deoxy-5’-methylthio-adenosine (MTA) or 
inhibition of histone acetyltransferases with epigallocatechin-3-gallate (EGCG) drastically 
inhibited the training of monocytes (Fig. 7C and D). In contrast, the inhibitors of histone 
demethylase or deacetylase enzymes did not significantly influence the training effects of MDP 
or Flagellin. Notably, the putative cytotoxic effects of MAPK, Syk, and epigenetic inhibitors 
used in the study were assessed by LDH measurements. None of the inhibitors used during 
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Fig. 6: Flow cytometric analysis of CD14-, CD68-, DC-SIGN-, and CD11b-positive cells gated on CD45+ 
populations after prestimulation with β-glucan, MDP, Flagellin, R848, and Pam3CSK4. A total of 3 ml at 5 
× 106 PBMCs was incubated for 1 h, washed 3 times with PBS, and the remaining adherent monocytes were 
coincubated with with β-glucan (1 µg/ml), MDP (1 µg/ml), Flagellin (1 µg/ml), R848 (1 µg/ml) and Pam3CSK4 
(1 µg/ml) or with RPMI (untrained control) for 24 h. Thereafter, the cells were washed and further incubated 
with RPMI supplemented with 10% pooled human serum for 5 days. At day 6, the macrophages were incubated 
with Versene solution for 1 h at 37°C, detached from the plate, and stained extracellularly using anti-CD45 
PECy7, anti-CD14 PE, anti-CD68 APC, anti-DC-SIGN APC, and anti-CD11b FITC antibody. (A) The side 
scatter (SS) and forward scatter (FS) of the RPMI-treated cells are shown. (B and C) One representative picture of 
the staining and gating on CD45+ high β-glucan -trained cells is shown. Depending on the fluorescence intensity 
as well as cell size, we identified several cell populations, depicted as negative (-), positive (+), and high positive 
(++). Gating on different populations of CD14+ β-glucan-trained cells (D), CD68+ β-glucan-trained cells (E), 
DC-SIGN+ β-glucan-trained cells (F), and CD11b+ β-glucan-trained cells (G) are shown. (H to K) % of positive 
cells gated on CD45+ high. The data are presented as the means ± SEM (n > 2, 4 independent experiments).
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the 24 h of primary cell stimulation enhanced LDH release compared with RPMI-treated cells 
(Supplementary Fig. S3), demonstrating that the molecules were not toxic to the cells.
Discussion
In the present study, we show that primary exposure to microbial ligands alters the functional 
fate of monocytes, which is determined by the nature and concentrations of the PRRs engaged. 
Engagement of NLRs (NOD1 or NOD2 receptors) induces trained immunity, a long-term 
enhanced immune status upon priming with high doses of MDP or Tri-DAP, which can 
Fig. 7: (A and B) MAP kinase-dependent pathways mediate trained immunity. Adherent monocytes were 
preincubated for 1 h with culture medium, p38, ERK, JNK, or Syk inhibitor (inh). After this inhibition period, 
100 µl per well of either culture medium, Flagellin (1 µg/ml) or MPD (1 µg/ml) was added to the cell suspension, 
without removing the inhibitors, for 24 h. Thereafter, the cells were washed and incubated with RPMI and 10% 
pooled human serum. At day 6, the cells were subjected to a second stimulation with LPS (10 ng/ml) for an 
additional 24 h. The data are presented as means ± SEM (n ≥ 7, four independent experiments), *p<0.05. The 
Wilcoxon signed-rank test was used to detect significant differences. (C and D) Blocking histone methylation 
and acetylation inhibits trained immunity induced by MDP and Flagellin. Before training, adherent monocytes 
were preincubated for 1 h with culture medium or with different epigenetic inhibitors, such as histone 
methyltransferase inhibitor (MTA), histone acetyltransferase inhibitor (EGCG), histone demethylase inhibitor 
(pargyline), and the histone deacetylase inhibitor ITF2357/9. Thereafter, 100 µl of culture medium, β-glucan 
(10 µg/ml), Flagellin (1 µg/ml) or MPD (1 µg/ml) was added to the cell suspension, without removing the 
inhibitors, and further incubated for an additional 24 h. At day 6, the macrophages were subjected to a second 
stimulation with LPS (10 ng/ml) for another 24 h. The data are presented as the means ± SEM (n = 6, three 
independent experiments), *p<0.05. Wilcoxon signed rank test was used to detect significant differences. 
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vanish with smaller amounts of ligands. The engagement of TLRs with high inflammatory 
doses of PRR ligands predominantly induces tolerance, with the exception of CpG, for which 
tolerance seems to be inherent at any dose assessed. Interestingly, low concentrations of 
TLR ligands not only abolished the tolerance-induced effect but also reversed it, and in fact, 
trained the monocytes to be maintained in a heightened proinflammatory state. Furthermore, 
functional reprogramming of monocytes was also associated with cell shape and cell surface 
marker modifications. Finally, training of monocytes by MDP and flagellin is mediated by 
p38 and JNK MAPK dependent pathways and depends on epigenetic histone modifications. 
Earlier studies have shown that β-glucan recognition by monocytes through dectin-1 
and CR3 induces trained immunity (30), which mediates protection to reinfection in a T-/B-
cell-independent fashion (16). Similarly, BCG vaccination in human volunteers induces 
epigenetic reprogramming of monocytes and enhances secondary responses to microbial 
stimulation (17). In this study we report that differential engagement of PRRs and that PMA 
activation of monocytes might result in either an enhanced or refractory innate immune 
status. These findings raise an important conceptual question: what is the difference between 
a stimulated cell, a differentiated macrophage, and a trained immune cell? The difference 
can be defined at a molecular epigenetic level: the unstimulated monocyte or macrophage 
is characterized by the absence of cytokine production, with silent markers for both histone 
acetylation and methylation. During cell activation and active transcription, both histone 
methylation and histone acetylation are present at the promoter and enhancer levels, 
potentiating gene transcription. The trained cell has lost its acetylation markers and thus has 
lost active transcription (after an initial stimulation). However, in a trained cell (in contrast to 
a naïve cell), the promoters of inflammatory genes are tagged by histone methylation, which 
allows for an accelerated and stronger response upon restimulation. We recently described 
the H3K4 methylation as a property of trained monocytes (16), and this characteristic was 
confirmed in a landmark study by Ostuni et al. (31) showing the kinetic events during 
macrophage training. The authors proposed the name “latent enhancers” for the epigenetic 
units determining cell training (31). The opposing process of trained immunity is the innate 
immune tolerance, which has been known for more than half a century and which was 
recently demonstrated to be regulated by epigenetic events (21, 32, 33).
Despite the importance of innate immune training and tolerance, no systematic studies 
have attempted to define which microbial ligands and pattern recognition receptors induce 
trained immunity or tolerance. In the present study, we screened the major TLR and 
NLR microbial ligands for their capacity to induce either training or tolerance. Although 
dose dependent, we identified important bacterial ligands, such as Flagellin and MDP, 
which can induce trained immunity. In flagellated bacteria, Flagellin is one of the major 
proteins in the cell, and mammals tend to have a strong immune response to Flagellin. This 
molecule is recognized in mammals by Toll-like receptor 5 (34, 35). Immune responses to 
Flagellin have been proposed to play an important role in the pathogenesis of inflammatory 
bowel diseases (36, 37). From this perspective, the capacity of Flagellin to induce trained 
immunity and a more potent inflammatory response may have important consequences for 
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the pathogenesis of this disease. On the other hand, our data may lead to the conclusion 
that Flagellin represents an important new type of adjuvant for improving vaccination, 
a hypothesis that is supported by earlier studies showing that Flagellin is an effective 
adjuvant for immunization against lethal respiratory challenge with Yersinia pestis (38). 
Muramyl dipeptide is a component of bacterial cell wall peptidoglycan that is recognized 
by NOD2 (39), which is present in most bacterial species. The importance of NOD2 in 
protection against inflammatory bowel disease has been highlighted by the fact that 
particular mutations in NOD2 are associated with susceptibility to Crohn’s disease (40, 41). 
Recently, it has been proposed that MDP functions as a mucosal adjuvant that enhances the 
immunogenicity of virus-like particles (42). Consequently, its capacity to induce trained 
immunity may represent an important advantage in these settings. 
In contrast, other microbial ligands, such as the TLR9 agonist CpG, had little, if any, 
long-term effects on the function of monocytes. This argues that only certain ligands at 
certain concentrations are capable of inducing trained immunity. A particular interesting 
finding is that TLRs in high doses, with the exception of TLR9, consistently induced 
long-term tolerance to secondary stimulation with bacterial ligands. These findings 
are supported by earlier studies showing that the in vitro tolerance and crosstolerance 
phenomena might be induced via TLR2, TLR4, and TLR9 (43). Additionally, it has been 
reported that TLR7/8 engagement mediates short-term tolerance in mice both in vitro and 
in vivo (44, 45). Further investigation of the mechanisms mediating this effect is warranted, 
especially in light of the known immunosuppressive effects of viral infections (46, 47). 
The levels of several activation markers at the cell surface were assessed. Based on the side 
and forward scatter analyses, β-glucan-, MDP-, and Flagellin-trained cells are of a broad 
granulocity and cell size and mainly positive for CD14 and CD11b, while cells positive 
for CD68 and DC-SIGN were less present. Tolerant macrophages, treated with Pam3CSK4 
or R848, were significantly smaller than β-glucan-trained cells, and fewer were positive 
for CD68, CD11b, or DC-SIGN, while the activation marker CD14 was still present on 
these cells. No clear effect was seen on the expression of DC-SIGN on the macrophages. 
The increase or decrease in these activation markers might thus contribute to an increase 
or decrease, respectively, in the innate immune responses during the induction of trained 
immunity; nonetheless, future studies are warranted in order to prove this. In addition, one 
may also speculate that trained cells present different classes of activation markers than 
tolerized cells, depending on the subclasses of macrophages induced upon prestimulation. 
An important question regarding trained immunity refers to the signaling and molecular 
mechanisms responsible for its induction. MAP kinases, such as p38, JNK, or ERK, are known 
to be crucial signaling pathways mediating the stimulation of inflammatory mediators (48, 
49), with the p38MAPKα pathway being critical for normal inflammatory responses in vivo 
(50). Notably, the TRIF-dependent late-phase activation of the p38MAPK/MK2 pathway has 
been demonstrated to be essential for the translational control of TNF-α production (51). 
LPS regulates the transcript stability of TNF-α (52, 53) via activation of the p38MAPK/MK2 
pathway. Considering these crucial biological functions of MAPKs, we assessed their role 
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in the induction of trained immunity. Our data demonstrate that JNK and p38 MAPK are 
central for the induction of trained immunity by Flagellin and MDP, and they might represent 
potential therapeutic targets for clinical situations in which trained immunity mediates a 
long-term inflammatory response. In contrast, ERK and Syk do not seem to be needed to elicit 
trained immunity.  Dynamic chromatin changes across immunological pathways participate 
in the training mechanism induced by the preincubation of monocytes with β-glucan (16). 
Exposure of monocytes to β-glucans induces high levels of H3K4 trimethylation at the 
promoter level of inflammatory genes, which correlates with longterm increased production 
of proinflammatory cytokines in β-glucan-trained monocytes, a hallmark of trained 
immunity (16). The blockade of histone methylation or histone acetylation inhibits trained 
immunity; the first of these modifications has been associated with a state of transcriptional 
priming, while the latter is associated with actual mRNA transcription. Similar mechanisms 
of epigenetic memory have been demonstrated in plants during the phenomenon of systemic 
acquired resistance (54) and may be involved in the resistance to reinfection in invertebrates 
(55); both classes of organisms are devoid of adaptive immune responses. Thus, the present 
study demonstrates that even in the presence of adaptive immunity, the training of innate 
immunity is operational and serves to enhance resistance to certain types of infection. 
A key aspect for consideration is that of the duration of trained immunity effects in 
vivo and their potential impact on hematopoietic stem cells. We recently demonstrated 
trained immunity effects of BCG on monocytes for up to 3 months after vaccination (17). 
Considering the fact that circulating monocytes have a short half-life of only days, this 
implies training effects of vaccination on monocyte progenitor cells, and future studies 
are warranted to assess this important aspect. Moreover, future studies should also assess 
whether the direct contact of monocytes with microbial ligands is absolutely necessary for 
the induction of trained immunity, or whether soluble factors, such as cytokines, may also 
induce similar effects in certain circumstances. In addition, one should also keep in mind 
that classical monocyte differentiation into macrophages also implies epigenetic changes. 
However, there are fundamental differences between the epigenetic elements in differentiation 
versus training of monocytes: in the classical differentiation, both histone methylation and 
acetylation epigenetic markers lead to the expression of proteins that are characteristic of a 
macrophage; in the training state, histone acetylation markers are lost, and the promoters of 
certain genes retain only the histone methylation markers characteristic of latent enhancers 
(31). These latent enhancers will determine the increased transcription of those genes only 
after cell stimulation. It can be also envisaged that in certain situations, both training and 
differentiation markers can be induced, with their respective functional consequences. 
Our data have a number of broad implications. By inducing long-term changes in cell 
capacity to respond to different pathogens, the processes of trained immunity and tolerance 
might have important effects on the susceptibility of a host to infections. Subsequently, a 
logical possibility is that the microorganisms encountered by the host on a regular basis may 
serve to differentiate and continually renew a pool of memory-like macrophages that have 
enhanced responses to an infectious challenge. By identifying the receptors and signaling 
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pathways that determine the functional fates of monocytes and macrophages, our findings 
have the potential to lead to the development of new therapeutics that can harness both the 
potential of trained immunity to induce robust responses to enhance pathogen defenses 
and of immune tolerance to inhibit autoimmune phenomena.
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Supplementary Fig. 1: LDH cytotoxicity assay. Adherent monocytes were cocultured for 24 h with either culture 
medium or with different microbial ligands. Thereafter, supernatants were collected (A) and cells were further 
cultured in RPMI supplemented with serum for another 6 days. At day 7 supernatants were once again collected 
(B) and subjected to a cytotoxicity assay, conform to manufacturer’s instructions. All the ligands, independently 
on the concentration, were proven to be non-toxic to the cells. Data are presented as mean ± SEM (n = 2).
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Supplementary Fig. 3: LDH cytotoxicity assay. Adherent monocytes were cocultured for 24 h with either culture 
medium or with p38-, ERK-, JNK-, Syk- and epigenetic inhibitors (MTA, EGCG, pargyline and ITF2357/9). 
Thereafter supernatants, as well as cells lysates, were collected and subjected to a cytotoxicity assay, conform to 
manufacturer’s instructions. MAPK-, Syk- as well as epigenetic inhibitors were proven to be non-toxic to the 
cells. Data are presented as mean ± SEM (n = 2).
Supplementary Fig. 2: The influence of PMA on prestimulation of primary monocytes. Cells were pre-
exposed for 24 h to culture medium or to PMA at two different concentrations: 10 μg/ml and 10 ng/ml. The 
first stimuli were washed away and adherent monocytes were further incubated for 5 days in culture medium 
supplemented with 10% pooled human serum. During the 6 days of incubation period, monocytes differentiate 
into macrophages. Cells were further subjected to a second stimulation with LPS (10 ng/ml) or Pam3CSK4 (10 
μg/ml) for an additional 24 h. TNF-α (A) and IL-6 (B) were assessed in the cells culture supernatants. Data are 
presented as mean ± SEM (n = 3).
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Abstract
The immune system is essential to maintain the mutualistic homeostatic interaction between 
the host and its micro- and mycobiota. Living as a commensal on human skin and being 
a passenger in the digestive tract, Saccharomyces cerevisiae could potentially modulate the 
host immunity and significantly shape the immune response. We observed that diverse 
S. cerevisiae strains induce trained immunity in monocytes through a strain-dependent 
manner leading to enhanced cytokine production upon secondary stimulation with TLR 
ligands and bacterial commensals. These features are reflected by the differences in the pro-
inflammatory properties dependent on the origin of the strains, which may be potentially 
related to the different adaptation to the environment from which they were isolated. We 
also established that in addition to β-glucan, S. cerevisiae chitin drives induction of trained 
immunity at several levels: increased cytokine production, but also direct antibacterial 
activity. Differential chitin content accounts for the differences in training properties 
observed among strains, with the clinical strains being the most effective. This study reveals 
how commensal and passenger microorganisms could be important in promoting health 
and preventing mucosal diseases by modulating host defense and regulating the microbiota. 
Dietary supplementation of specific probiotic microorganisms may be a viable strategy to 
train a healthy immune system.
Keywords: trained immunity, S. cerevisiae, strain diversity, inflammation, TLR ligands
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Introduction
In several higher organisms, including plants, a central mechanism for efficient protection 
from infection is defense priming, the preconditioning of immunity induced by microbial 
colonization after germination or birth (1,2), supporting the relevance of innate immune 
memory (3). This property of host defense is also referred as ‘trained immunity’, defined 
as an increased responsiveness of the innate immune system to secondary stimuli after an 
initial encounter with training microorganisms (4,5). 
Similarly to root symbioses, human microbiota functionally contributes to the 
nutrition and protection of the host, significantly shaping mammalian immunity both at 
the mucosal surface of the host and systemically (6–9). Recent studies have shown that 
fungal microbiota, or mycobiota, is an important player in the host-microbes interaction, 
and that its effects are integrated with those of the dominant bacterial component (10–12). 
The complex interaction between microbiota, mycobiota and the immune system is critical 
for establishing a balance between immunity and tissue health. A recent publication (9) 
added another fundamental contribution to the role of skin microbiota in activating and 
educating host immunity, shedding new light on the interplay between immune systems and 
microbiota in shaping each other. It has been earlier demonstrated that C. albicans triggers 
differential immune signaling upon interaction with either inflammatory or tolerogenic 
dendritic cells (6) and, similarly to what occurred for Aspergillus fumigatus (8) and harmless 
fungi such as Saccharomyces cerevisiae (13), the type and intensity of immune reactivity is 
strain dependent (7). Moreover, fungi modulate responses towards other microorganisms 
such as intestinal and skin bacteria (14,15).
Candida spp. are not the only fungal colonizer of humans. Saccharomyces cerevisiae 
has been earlier demonstrated to be a constant colonizer of skin (16) and human intestinal 
tract (17), and a recent study has shown that it may even surpass Candida species in some 
human populations (18). Even if it is a harmless fungus, S. cerevisiae shares with Candida 
many of the same cell wall structures, often leading to similar effects on host defense. In this 
work, we assessed the capacity of various S. cerevisiae strains to train human myeloid cells 
to react stronger towards other microorganisms such as bacteria or Candida. S. cerevisiae 
can efficiently induce trained immunity in human monocytes in a strain and strain origin-
dependent manner, leading to enhanced cytokine production in vitro. This effect was only 
partially dependent on β-glucan and mannan, and was mainly driven by chitin, explaining 
the major training properties observed upon challenge with strains presenting a chitin-rich 
cell wall, i.e. Crohn’s disease (CD) isolates. The differences in the stimulatory capacities 
of Saccharomyces depending on the strain and the context from which they were isolated 
underlines the need to understand the interaction between mycobiota and the host, in 
order to identify the boundaries between friend and foe, and between health and disease.
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Methods
Blood samples. Human peripheral blood mononuclear cells (PBMCs) were isolated 
from buffy coats provided by the Sanquin Bloodbank in Nijmegen, The Netherlands or at 
Careggi Hospital in Florence, after obtaining informed consent (ethical approval document 
n. 87/10). The study was designed in conformity with the international recommendation 
(Dir. EU 2001/20/EC) and its Italian counterpart (DM 15 Luglio 1997; D.Lvo 211/2003; 
D.L.vo 200/2007) for clinical trial and following the Declaration of Helsinki, to assure 
protection and care of subjects involved. Dectin-1-deficient cells were isolated from patients 
homozygous for the stop mutation Y238X (39). 
Reagents. Ficoll-Paque (GE Healthcare) was used to isolate PBMCs by differential centrifugation. 
RPMI 1640 Dutch Modification (RPMI) (Sigma-Aldrich), supplemented with 1% gentamicin, 
1% L-glutamine, and 1% pyruvate (Life Technologies, Nieuwekerk, The Netherlands) was used 
as culture medium. Monocytes were isolated using magnetic CD14 positive selection (Miltenyi 
Biotec). In a challenge experiment, IL-4 and GM-CSF (both from Gentaur, Belgium) were 
added to induce monocyte differentiation into dendritic cells. C. albicans and S. cerevisiae 
β-glucan and mannan were isolated and purified as described previously (40,41). Pam3Cys4 and 
LPS (Escherichia coli serotype 055:B5) were purchased from Sigma-Aldrich, with an additional 
purification step for LPS (42). Only preparation with > 98% purity were used in the experiments.
Microorganisms. S. cerevisiae strains, previously isolated from different environmental 
sources, were cultured in complete medium (YPD, 2% yeast extract, 1% peptone, 2% glucose) 
for 18 h, then collected. C. albicans ATCC MYA-3573 (UC 820), was grown overnight to 
yeast cells in Sabouraud broth at 37°C. Staphyloccus aureus and Escherichia coli were grown 
overnight in Tryptic Soy Broth (TSB, Difco) at 37°C. Cells were harvested by centrifugation, 
washed twice with PBS, and resuspended in culture medium (RPMI; ICN Biomedicals, 
Aurora, OH). For trained immunity assays, S. cerevisiae yeasts and Candida were heat-killed 
for 30 min at 95°C and resuspended in culture medium to a cell inoculum size of 106 cells/ml. 
Cell wall characterization and chitin purification. Cell wall characterization has been 
performed as described by Ferreira et al. (2006) (43) with modifications. Cells were cultured 
in YPD liquid medium at 28°C and collected at late exponential phase. The cells were washed 
once with distilled water and three times with 0.1 M Tris-HCl buffer (pH 8.5) containing 
1mM phenyl sulphonyl fluoride and disrupted in the same buffer with 0,5 mm-diameter 
glass beads by serial cycles of vortexing (30s at maximum speed) and ice cooling (20s). 
Cell walls were harvested by centrifugation for 30 minute at 4200 g and dried in a speedvac 
concentrator. To extract chitin, cell wall dried biomass was subjected to alkaline extraction, 
followed by acid extraction according to the protocol described by Ferreira et al. (2006) 
(43). Chitin was finally obtained by dialysis of the extract and lyophilized to determine the 
dry weight. Only preparation with > 98% purity were used in the experiments.
Cell preparation. The PBMC fraction was obtained by density centrifugation of diluted blood 
(1:1 ratio between blood and pyrogen-free saline) over Ficoll-Paque. PBMCs were washed twice 
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in saline and resuspended in culture medium. Monocytes were isolated from low density PBMCs 
by magnetic enrichment with anti-CD14 beads (Miltenyi Biotec). In a challenge experiment, 
monocytes were cultured in the presence of GM-CSF (800 U/ml) and recombinant IL-4 (1000 
U/ml) for 6 days to allow DC differentiation (44). DC activation was induced by S. cerevisiae 
strains. A serial dilution of live yeast preparations was added to the moDCs at different stimuli-
to-DC ratios. For confirmation experiments, PBMCs from the same healthy subjects were used; 
stimulation was performed as in DC challenge experiments. Depending on the experiment, 
supernatants were collected after 24 h or 5 d, and stored at -20°C until the assays.
In-vitro induction of trained immunity. Monocytes (106 cells/ml) were added in a volume of 
100 µl/well in flat-bottom 96-well plates (Greiner, Nurnberg, Germany). Cells were incubated 
with one of the first stimuli for 24 h, rested for 5 days and re-incubated for another 24 h with 
one of the second stimuli. As priming stimuli we used 1 X 104 cells/ml of the different S. 
cerevisiae strains, S. cerevisiae- or Candida-derived β-glucan (10 µg/ml), S. cerevisiae-derived 
mannan (10 µg/ml) or chitin (10 µg/ml). After 24 h, cells were washed to remove all stimuli, 
and they were allowed to rest for 5 days before being exposed to a second stimulation with 
various stimuli. The second stimuli were one of the following: LPS (10 ng/ml), Pam3Cys4 (10 
µg/ml), Staphylococcus aureus (1 X 107/ml), or heat killed C. albicans (1 X 106/ml) in a final total 
volume of 200 µl. To investigate whether priming could be blocked, monocytes were incubated 
for 1 h with dectin-1/CLEC7A Ab (dectin-1 antagonist; 10 µg/ml) or with the isotype control 
(10 µg/ml), before priming. After this, cells were treated with either RPMI or S. cerevisiae 
derived β-glucan (10 µg/ml) and incubated for 24 h, followed by a second stimulation with 
LPS (10 ng/ml) for an additional 24 h. Cytokines were measured after the second stimulation.
Cytokine assay. TNF-α and IL-6 levels on monocytes were determined by enzyme-linked 
immunosorbent assays on 24 h monocyte cell culture supernatants according to manufacturer’s 
instructions (R&D Systems). For the other experiments, at the indicated times, supernatants from 
human cell cultures were collected and cytokine detection was performed using the Milliplex® 
MAP human cytokine/chemokine kit (Millipore), according to the manufacturer’s instructions. 
Microorganism survival following uptake by primed monocytes. Monocytes (106 cells/ml) 
were added in a volume of 100 µl/well in flat-bottom 96-well plates (Greiner, Nurnberg, 
Germany). Cells were incubated with one of the first stimuli for 24 h, rested for 5 days and 
re-incubated for another 24 h with one of the second stimuli. As a priming stimulus, we 
used 1 X 104 cells/ml of YP4 S. cerevisiae strain, S. cerevisiae derived β-glucan (10 µg/ml), S. 
cerevisiae derived mannan (10 µg/ml) or YP4 derived chitin (10 µg/ml). After 24 h, cells were 
washed to remove all stimuli, and they were allowed to rest for 5 days before being exposed 
to a second stimulation with various stimuli. The second stimuli were E. coli (1 X 107/ml), S. 
aureus (1 X 107/ml), or C. albicans (1 X 106/ml) in a final total volume of 200 µl. After 6 h of 
stimulation, monocytes were collected, washed three times with PBS, treated with zymolyase 
(2 mg/ml) or lysozyme (10 mg/ml), and washed twice; cells lysated with a hypotonic solution 
(0.05% KCl) to release intracellular microorganisms were plated on solid complete medium 
(YPD for yeast cells, TSB for bacterial cells). Survival of microorganisms after uptake are 
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reported as the percentage of CFUs after 1 day (bacteria) or 3 days (fungus) relative to the 
total number of cells growing in the absence of monocytes exposure. Control experiments 
were carried out to verify that the hypotonic solution was not toxic to bacteria and yeasts. 
In vitro phagocytosis assay. Primed monocytes (as above) will be seeded into poly-
L-lysine slides and incubated for 30 min at 37°C and 5% CO2 and then infected with E. 
coli or C. albicans. For C. albicans internalization evaluation, after PBS washing and 
medium replacement, cells were infected with Oregon green 488 (Molecular Probes, Life 
Technologies) prelabelled Candida cells (1X106 cells/mL in complete RPMI) and further 
incubated for 1.5 h. Thereafter, calcofluor white (Sigma-Aldrich) was added (20 µL per well) 
15 min before each end point. Cells were washed with PBS to remove nonadherent yeasts 
and fixed with cold ethanol for 30min at -20°C and labeled in red with PHK26 (Sigma-
Aldrich). Calcofluor white staining of fungi allows one to discriminate between adherent 
(Calcofluor white accessible) and phagocytized (i.e. internalized, Calcofluor white) yeast 
cells. When visualized by epifluorescence microscopy, all the yeast cells appeared as 
green (independently of the localization), while the not-internalized yeast cells were blue 
stained. Finally, merging of Oregon green 488 and Calcofluor white images allowed one 
to definitively exclude the extracellular yeast cells. By contrast, E. coli were labeled using 
Oregon green (Molecular Probes, Life Technologies) only without distinguishing between 
internalized or not internalized bacteria. Cells where stained NucBlue Live Cell Stain Ready 
Probes reagent (Molecular Probes). A minimum of 200 monocytes per group were scored 
and any cell containing one or more particles was counted as phagocytic.
Phagolysosome acidification assay. To visualize the acid yeast-containing vesicles, chamber 
slides were prepared as in Phagocytosis assay; then, primed monocytes were exposed to the 
acidotropic dye LysoTracker DND-99 (75 nM) and infected as described above. Afterwards 
the samples were fixed with cold ethanol and immediately examined by fluorescence 
microscopy. Acidification control groups consisted of uninfected cells. A minimum of 200 
yeast/bacteria-containing phagosomes was scored; the percent of acid phagolysosomes was 
evaluated as the ratio between the number of LysoTracker-labelled phagosomes and the 
total number of yeast-containing phagosomes.
Statistical analysis. The paired Wilcoxon test was used to compare differences between the effect 
of a particular stimulus and the RPMI medium control. The level of significance was set at p<0.05.
Results
S. cerevisiae isolates train differently the cytokine responses towards 
TLR ligands and fungi
As C. albicans enhanced the cytokines response towards TLR ligands and colonizing bacteria 
(14), we tested whether S. cerevisiae was also able to induce trained immunity in monocytes. 
To investigate this effect, monocytes from healthy donors were first exposed to low doses of S. 
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cerevisiae (Fig. 1A) and C. albicans for 24 hr (Fig. 1B). After that, the initial stimulus was removed 
and the cells were washed. After an additional 5-days resting period, cells were restimulated 
with pure components of the bacterial cell wall or with C. albicans (Figs. 1A and B). Exposure 
of monocytes to a laboratory strain of S. cerevisiae yeast potentiated the production of TNF-α 
induced by a second bacterial stimulus such as LPS, the lipopeptide analog Pam3Cys4, or by the 
fungal pathogen C. albicans (Fig. 1A) to the same extent as C. albicans (Fig. 1B). 
Considering the variability in stimulating pro- and anti-inflammatory cytokines of fungal 
strains (8,13), we probed the ability of a set of S. cerevisiae strains to induce trained immunity 
towards different microbial ligands such as E. coli LPS (Fig. 2A) and Pam3Cys4 (Fig. 2B). This set 
comprises: 2 laboratory strains (SK1 (19) and BY4741 (20) used as reference strains in previous 
studies (21)), 9 clinical isolates (13) - 8 from CD patients, one from healthy subject -, 4 wild 
strains from Barriada wine region of Portugal, and 4 grape isolates from Tuscan vineyards (22). 
The results showed that different S. cerevisiae strains differentially train TNF-α production in 
response to both TLR ligands, in a similar or even higher extent than C. albicans (14). In contrast 
to the clinical and Tuscan grape isolates, laboratory and Barriada wine (wild) strains showed little 
Figure 1. In vitro training of monocytes with S. cerevisiae. Monocytes were trained with S. cerevisiae  (A) 
or C. albicans (B) (priming stimulus) and after 24 h washed to remove the stimulus. TNF-α and IL-6 were 
measured in supernatants after bacterial cell wall pure components or C. albicans second stimulation (n = 8; 
four independent experiments). Bars indicate mean + SD (n = 10, four independent experiments). *p<0.05 
trained cells versus RPMI–stimulated, Wilcoxon nonparametric test for two related samples. P3C, Pam3Cys4.
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ability to train the monocytes response to Pam3Cys4 (Figs. 2A and B). All strains were able to 
modulate TNF-α and IL-6 production upon challenge with LPS, albeit to different extents. The 
clinical YP4 isolate showed the greatest potential to train cytokine production (Figs. 2A and B). 
Since one of human commensal microorganisms is C. albicans itself, we tested whether 
S. cerevisiae isolates from different environmental niches train cytokine production in 
response to C. albicans stimulation. As shown in Fig. 2C, while the healthy human isolate 
Y13EU was not able to modulate TNF-α and IL-6 production, clinical and wild isolates 
enhance monocyte response to C. albicans with different extents.
β-glucans from S. cerevisiae mediate training partially through Dectin-1 
As in the case of C. albicans, the outer layer of the cell wall of S. cerevisiae is enriched 
with mannoproteins, whereas the inner layer is composed of chitin and β-glucan. Both 
mannosylated proteins, phospholipomannan and β-glucan are known inducers of 
proinflammatory cytokines through C-type lectin receptors (23). Therefore, we assessed 
whether purified β-glucan from S. cerevisiae (Sc) was able to exert a training effect similar to 
that obtained with S. cerevisiae whole organism or C. albicans (Ca)-derived β-glucan (14). 
S. cerevisiae-derived β-glucan trained the monocytes and led to an increased amount of 
TNF-α induced by the secondary stimuli (Fig. 3A). When we blocked the β-glucan receptor 
dectin-1 with an anti–dectin-1 antibody, β-glucan training effect was considerably reduced 
(~50%), but not abolished, whereas the isotype control antibody had no effect (Fig. 3B). To 
note that, the incomplete suppression of the training activity could be due to the little traces 
of mannan and chitin in the β-glucan preparation. We completed the assessment of the role 
of dectin-1 by using primary monocytes isolated from four dectin-1 deficient volunteers. 
In dectin-1-deficient cells β-glucan training was partially abrogated, validating the role of 
the dectin-1 receptor in mediating the β-glucan–dependent trained immunity (Fig. 3C). 
However, although these results show that β-glucan exerts a strong training effect, this 
mechanism does not account alone for the effect induced by the whole microorganism as 
revealed by using dectin-1 deficient cells (Fig.4A). Thus, we assessed the priming potential of 
S. cerevisiae-derived mannan alone and in combination with β-glucan (Fig. 4B). As shown, 
mannan alone could induce an increase of TNF-α production in response to a secondary 
infection, but the effect is merely additive to that of β-glucan, revealing that mannan is able 
to potentiate the training effect shown by β-glucan. This seems to be in contrast to what 
is observed in C. albicans, but in line with the differential branching of S. cerevisiae and 
Candida fungal mannan, which determines different immune reactivity (21, 24).
Fungal chitin drives/potentiates the immune training and potentiate 
intracellular killing of fungi and bacteria
Differential mannan branching only partially clarifies the different training properties shown 
by the diverse S. cerevisiae isolates. The isolates from patients we tested showing the most 
significant ability to modulate cytokine production to a secondary bacterial stimulation (Figs. 
114
Fungal chitin induces trained immunity in human monocytes during cross-talk with Saccharomyces cerevisiae 
6
Figure 2. S. cerevisiae strains enhance differently the cytokine responses of cells restimulated with TLR ligands. 
A. In vitro training of monocytes with different strains of S. cerevisiae towards LPS (A), Pam3Cys4 (B) or C. 
albicans (C) stimulation. White bars: laboratory strains; dark grey: clinical strains; light grey: Tuscan wine 
isolates; dashed: Barriada wild isolates. Bars indicate mean + SD (N=6). *p<0.05 trained cells versus RPMI–
stimulated, Wilcoxon nonparametric test for two related samples. P3C, Pam3Cys4.
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Figure 3. β-glucans are essential, but not sufficient, in enhancing cytokine production mediated by S. cerevisiae. 
A. Monocytes were incubated with RPMI or S. cerevisiae β-glucan (10 µg/ml), period after which the cells 
were washed to remove the stimulus. After 5 days of resting, monocytes were reincubated with pure ligands 
or heat-killed bacteria. B. Monocytes were incubated with RPMI, CLEC7A Ab, and the isotype control (10 µg/
ml). After 1 hr of incubation, cells were treated either with RPMI or β-glucan (10 µg/ml) and, after 5 days of 
resting, restimulated with LPS or Pam3Cys4. C. Monocytes from 4 healthy and 4 dectin-1–deficient subjects 
were incubated with RPMI and β-glucan (10 µg/ml) for 24 h, followed by a second stimulation with TLR 
ligands for an additional 24 h after 5 days of resting. For all the experiments, TNF-α and IL-6 were measured 
in supernatants after the second stimulation. Data are presented as fold increase with respect to not-trained 
(RPMI-stimulated) cells. For (A), n = 10; for (B), (C), n = 4. Bars indicate mean ± SD. *p <0.05, **p<0.01 versus 
RPMI–stimulated cells, Wilcoxon nonparametric test for two related samples. P3C, Pam3Cys4.
2C and 3A) were isolated from pediatric CD patients (13). Next, we investigated whether the 
strains isolated from different environments induce different inflammatory properties, which 
might explain the differential training. Therefore, in parallel to the current investigation, we 
screened the immune reactivity of monocyte-derived dendritic cells to an enlarged set of 
S. cerevisiae strains. This investigation showed a wide diversity in the immune-modulatory 
profiles among the different strains isolated from diverse ecological niches, quantified directly 
by cytokine production capacity comparison (S1 Fig.). In general, the different isolates showed 
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Figure 4. Training with S. cerevisiae strains isolated from Crohn’s disease patients is partially dectin-1-dependent, 
and mannans are important to potentiate the cytokine modulation. A. Healthy and dectin-1–deficient monocytes 
4 were incubated with RPMI and clinical S. cerevisiae isolates for 24 h, after which the cells were washed to 
remove the stimulus. This was followed by a second stimulation with TLR ligands for an additional 24 h after 5 
days of resting. TNF-α and IL-6 were measured in supernatants. B. Monocytes were exposed to RPMI, β-glucan 
(10 µg/ml), S. cerevisiae derived mannan (10 µg/ml) or a combination of both for 24 h, after which the cells were 
washed to remove the stimulus. After 5 days of resting, monocytes were restimulated with pure ligands. TNF-α 
was measured in supernatants. (A, B), Bars indicate mean ± SD (n=4). *p <0.05, LPS trained dectin1-/- cells 
versus LPS trained control cells. $p <0.05, P3C trained dectin1-/- cells versus P3C trained control cells. Wilcoxon 
nonparametric test for two related samples. LPS, lypopolisaccharyde; P3C, Pam3Cys4.
an immune-based diversity that seemed to correlate with their origin, as shown by clustering 
of the 6 cytokine profiles (S2A Fig.) and principal component analysis (S2B Fig.).
The interesting cytokines profile observed was confirmed using PBMCs for stimulation 
with live high- and low-inflammatory strains (S3 Fig.). The different isolates showed 
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diverse ability to promote IL-17 and IFN-γ production, and their inflammatory role was 
counterbalanced by different extents by IL-10 induction. We speculate that differences in 
the cell wall composition of the isolates tested influenced their ability to induce and train 
cytokine production, and could be the result of the different environmental selective forces. 
Thus, we investigated the cell wall composition of 4 strains with different ecological niches: 
the laboratory SK1 strain, the environmental BB2240 strain, the CD’s YP4 isolate and the 
healthy isolated Y13EU. While β-glucan content did not differ among the isolates, chitin 
was almost 10-fold more prevalent in the CD isolate with respect to the laboratory and 
the environmental strains (Fig. 5A). We isolated chitin from those strains and assessed the 
immune training properties of this fungal cell wall component. Chitin was able to induce a 
potent immune response in terms of IL-6 and TNF-α induction (Fig. 5B). 
We thereafter compared the ability of whole S. cerevisiae cell and its cell wall component 
to induce trained immunity for killing both fungi and bacteria. In this set of experiments, 
monocytes trained as previously described were exposed for 6 h to live fungus C. albicans, 
to the Gram-positive bacteria S. aureus or to the Gram-negative bacteria E. coli. 
Trained monocytes showed enhanced killing ability with respect to non-trained monocytes 
(Fig. 5C). Particularly, chitin-trained monocytes showed the most potent antibacterial killing. 
This result demonstrates an enhancement of direct antibacterial killing capacity of monocytes 
after induction of trained immunity by S. cerevisiae, and this effect is driven by chitin. 
As the internalization ability of chitin-trained immune cells did not differ from one of 
not-trained cells (Figs. 6A-B), in order to investigate the events following internalization 
by monocytes, we evaluated the fate of the yeast-containing phagosomes in terms of 
acidification. As shown in Figs. 6C-D, the percent of E. coli as well as C. albicans containing-
acid phagolysosomes was increased in chitin-trained cells with respect to not-trained 
monocytes, thus accounting for the more efficient ability to kill the pathogens.
Discussion
Although an anti-inflammatory potential of microbial/yeast strains was occasionally 
suggested in vitro (25, 26) or in experimental models (25, 26), few reliable observations 
were reported in terms of strain variability and of specific mechanisms involved (27, 28). 
To our knowledge, no studies addressed S. cerevisiae immune reactivity at a strain level 
and its ability to modulate the cytokines response of human primary cells to bacteria and 
fungi. The different S. cerevisiae isolates tested induce trained immunity in monocytes, 
resulting in an enhanced pro-inflammatory cytokine production when they are exposed to 
a secondary bacterial or fungal stimulus. 
The induction of trained immunity is dependent on the carbohydrate components 
of the cell wall of S. cerevisiae. This is in agreement with previous studies showing that 
β-glucan is an immunostimulant and is responsible for the training properties of C. albicans 
(14, 29). One of the main receptors mediating the priming effects of S. cerevisiae β-glucan is 
dectin-1, as shown by inhibitory experiments as well as the use of cells genetically deficient 
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Fig. 5. Chitin drives training immune properties of S. cerevisiae and enhanced intracellular killing of primed 
monocytes. A. Cell wall composition characterization of the laboratory SK1 strain, the environmental BB1533 
strain, the CD isolate YP4 and the healthy isolated Y13EU strain. Sugars composition is expressed in percentage 
of the total cell wall. Numbers on the top refer to the percentage of chitin content. B. Monocytes were exposed 
to RPMI, S. cerevisiae whole cell, S. cerevisiae derived chitin (10 µg/ml), β-glucan (10 µg/ml), mannan (10 
µg/ml) or a combination of mannan and β-glucan for 24 h, after which the cells were washed to remove the 
stimulus. After 5 days of resting, monocytes were restimulated with pure ligands or C. albicans. TNF-α and 
IL-6 were measured in supernatants. Data are presented as fold increase with respect to not-trained (RPMI-
stimulated) cells.  C. Survival of C. albicans and Gram+ (S. aureus) and Gram- (E. coli) bacteria after killing by 
trained monocytes. Data are expressed as percentage of CFU of microorganisms growing after 6 h exposure. 
*p<0.05, **p<0.01 trained cells versus RPMI–stimulated cells, Wilcoxon nonparametric test for two related 
samples. For (A), n = 3; for (B), (C), n = 4. Bars indicate mean ± SD. LPS, lypopolisaccharyde; P3C, Pam3Cys4.
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for this receptor. However, the incomplete abolishment of training in monocytes genetically 
deficient for a functional dectin-1 receptor suggests that part of the trained immunity signal 
is mediated by other cell wall components. 
Cell wall characterization in terms of β-glucan and chitin content indicated how isolates 
from different ecological niches showed a remarkable different cell wall composition, 
with the clinical isolates being highly enriched in chitin content. Under normal growth 
condition, chitin is a minor component of C. albicans cell wall, comprising only the 2-3% 
of its dry weight (30): however, chitin content of a S. cerevisiae isolate from a patient with 
Crohn’s disease represented 20% of the dry weight of the yeast. Our results show that strains 
specifically isolated from CD patients (13) are able to strongly modulate cytokines response 
to bacterial antigens and fungi and this effect is largely dependent on chitin. Because training 
is induced towards purified TLR ligands, which are important components of bacteria, we 
tend to conclude that the priming induced by the diverse S. cerevisiae strains acts on TLR-
dependent–signaling pathways, as shown by the reliable effect on Pam3Cys4 stimulation. 
Even though chitin is an essential structural polysaccharide of fungal pathogens and 
parasites, some controversy persists on its role in human immune response (31–34). Earlier 
studies have shown that C. albicans-derived chitin reduces direct stimulation of in vivo LPS-
induced inflammation and contributes to dampening the immune response by NOD2 and 
TLR9-mediated secretion of IL-10 (34). In a previous finding we showed how S. cerevisiae 
spores, which wall is largely composed by chitin, elicit inflammatory IL-17 responses, while 
cells of the same strain induce tolerance (21). Thus, by increasing the chitin content in their 
cell wall, fungi may influence the immune system in two ways: 1. favoring their persistence 
by influencing immune homeostasis and 2. training the innate host response against bacteria. 
The results presented here give a novel perspective on the role of non-pathogenic 
microorganisms for immune homeostasis. The chitin-induced training suggests how chitin 
levels could importantly help breaking potential dysbiosis, priming organismal protection 
against bacterial pathogens. This training effect does not require colonization but can be elicited 
simply via exposure to chitin rich yeast cells or spores. Thus yeasts would play a fundamental 
role in shaping gut microbiota simply when passengers, rather than necessarily persisting as 
colonizers. We can speculate that the recent elimination of S. cerevisiae, as well as of other 
immune regulators, from fermented foods, and overall the reduction of early exposure to 
beneficial microbiomes (or mycobiomes?), is not only causing a reduction in anti-inflammatory 
signals, but is more importantly causing a decreased ability of “training” our immune system 
to handle pathogenic microorganisms, resulting in potentially uncontrolled immune reactions. 
The finding that the best “trainers” are strains isolated from Crohn’s patients leads us to 
hypothesize an evolutionary advantage of chitin production in surviving and colonizing the 
human gut. It remains unclear if, in addition to these potential beneficial effects, induction of 
trained immunity may also have unintended deleterious effects, since fungi have been reported 
to increase the severity of intestinal inflammation in murine models of colitis (35,36). 
Several directions of research are opened by this study: on the one hand future 
investigations should assess the molecular pathways that are involved in the induction 
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of trained immunity by S. cerevisiae and chitin, as recently shown to involve epigenetic 
(37) and metabolic (38) reprogramming for β-glucan, and on the other hand translational 
studies should assess the clinical potential of these effects. Further studies on the ability 
to induce trained immunity of yeasts in Crohn’s mouse model will reveal whether trained 
immunity responses to fungi are potentially associated with onset of remission of Crohn’s 
disease. Discovering the factors that drive microbial colonization will help us develop new 
antimicrobial therapeutics based on their potential to induce trained immunity. Selected 
strains of the ‘Generally Recognized as Safe’ S. cerevisiae described in this study could be 
specially suited for this task and for developing novel therapeutic approaches to IBD, or in 
general, to disease associated to inflammatory responses towards an unbalanced microbiota.
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Supplementary Fig. 2: Immune reactivity to different S. cerevisiae isolates correlates with their origin. (A) 
Clustering of cytokine production induced by moDCs in response to different S. cerevisiae strains. Pearson 
correlation calculated using TMeV software. B. Principal components analysis (PCA) over cytokine response 
to different S. cerevisiae strains.
Supplementary Fig. 1: Immune reactivity to different S. cerevisiae isolates. The ability of DCs to discriminate 
among different strains of the S. cerevisiae species was tested as differential cytokine production. DCs were 
stimulated with yeast cells for 24 h and cultures supernatants used for TNF-α, IL-10, IL-1β, IL-6, IL-12p70 
and IL-23 measurements. TNFα was fairly uniform for the different strains investigated, with the exception of 
two clinical isolates – one derived from a healthy subject (Y13EU), one from a patient (YA5) - which showed a 
markedly low induction of this cytokine. Clinical isolates from patients showed a lower induction of IL-12p70 
with respect to the healthy human isolates. Despite differences in IL-12p70, the Tuscan grape isolates induced 
uniform levels of IL-10. Immune responses induced by wild Portuguese strains were more variable. Interestingly, 
the wild BB1533 strain induced a response similar to some clinical isolates. This strain also showed clear growth 
advantages on Cycloheximide, Paramomycin, Benomyl, 4-nitroquinoline oxide and vanadate in a phenomic 
screen and was genetically distinct from the other S. cerevisiae isolates (Santos M., unpublished observations). 
These results highlight the ability of S. cerevisiae to promote both, pro- or anti-inflammatory responses upon 
immune cell recognition. Bars indicate mean ± SD (n=6).
◀
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Supplementary Fig. 3: Immune reactivity to different S. cerevisiae isolates. Healthy PBMCs were stimulated with 
various S. cerevisiae strains for 24 h or 5 days, and cytokine protein levels were measured in the supernatants. 
Bars indicate mean + SD (n = 8). 
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Abstract
Patients with STAT1-dependent chronic mucocutaneous candidiasis (CMC) and patients 
with STAT3-dependent hyper IgE syndrome (HIES) display defects in Th17 cytokine 
production capacity. Despite this similar immune defect in Th17 function, they show 
important differences in the type of infections to which they are susceptible. Recently, our 
group reported differential regulation of STAT1 and STAT3 transcription factors during 
epigenetic reprogramming of trained immunity, an important host defense mechanism based 
on innate immune memory. We therefore hypothesized that STAT1 and STAT3 defects have 
different effects on trained immunity and this may partly explain the differences between 
CMC and HIES regarding the susceptibility to infections. Indeed, while trained immunity 
was normally induced in cells isolated from patients with HIES, the induction of innate 
training was defective in CMC patients. This defect was specific for training with Candida 
albicans, the main pathogen encountered in CMC, and it involved a type II interferon-
dependent mechanism. These findings describe the role of STAT1 for the induction of trained 
immunity, and may contribute to the understanding of the differences in susceptibility to 
infection between CMC and HIES patients. This study could also provide directions for 
personalized immunotherapy in patients suffering from these immunodeficiencies.
Keywords: trained immunity, CMC, HIES
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Introduction
Chronic Mucocutaneous Candidiasis (CMC) and hyper immunoglobulinemia E syndrome 
(HIES) are rare primary immunodeficiencies, both characterized by defective Th17 cytokine 
production; this immunological defect is mainly caused by STAT1 and STAT3 mutations, 
respectively (1-5). More rarely, mutations in IL-17F or IL-17RA have also been described 
in CMC patients (6), and DOCK8 mutations in autosomal recessive HIES (7). Despite 
the similarities between CMC and HIES concerning genetic and immunological defects, 
important phenotypic differences distinguish these clinical entities regarding susceptibility 
to infections. While CMC patients suffer mainly from Candida and dermatophyte 
infections, and only later during life from respiratory tract infections (8), HIES patients 
have an increased susceptibility to skin and respiratory tract infections, especially with 
Staphylococcus aureus and Streptococcus pneumoniae, while their fungal complications are 
less prominent (4, 9-12). The immunological substrate for these differences in susceptibility 
is not known. Other striking differences are the skeletal abnormalities in HIES and the 
autoimmune endocrinopathy in CMC (13, 14).
Recently, a novel host defense mechanism has been proposed, consisting of long-term 
enhanced biological activity of innate immune cells, which was termed trained immunity 
(15, 16). Trained immunity relies on epigenetic reprogramming of monocytes or 
macrophages, and represents a de-facto memory of the innate immune response (17, 18). 
The epigenetic and metabolic substrate of trained immunity has been lately described (19, 
20). Interestingly, these studies uncovered differential regulation of STAT1 and STAT3 
during induction of trained immunity and innate immune tolerance (19). This finding led 
us to hypothesize that the induction of trained immunity may be differentially regulated or 
defective in patients suffering from CMC and/or HIES. 
In the present study we explored the trained immunity responses in peripheral blood 
mononuclear cells isolated from either CMC or HIES patients. We demonstrate that CMC 
patients display a defective induction of trained immunity by Candida albicans, while this 
was normal in HIES patients. This defect in CMC patients is specific for Candida and is 
mediated through an interferon-γ (IFN-γ)-dependent pathway. These findings might 
explain the incapacity of CMC patients to clear fungal infections, and may lead to further 
understanding the differences between these two complex immunodeficiency disorders.
Materials and Methods
Patients and healthy volunteers. Blood samples were collected from five autosomal 
dominant CMC patients harboring mutations in the STAT1 gene, three HIES patients with 
STAT3 mutations, and from age- and gender-matched healthy volunteers who did not suffer 
from infectious or inflammatory diseases. Blood was collected by venipuncture into 10 
mL EDTA tubes (367525; BD). The study was approved by the Arnhem-Nijmegen Ethical 
Committee, and the participants gave written informed consent. 
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Reagents and microorganisms. Culture medium used was RPMI 1640 Dutch modifications 
(Sigma-Aldrich) supplemented with 1% gentamicin, 1% L-glutamine and 1% pyruvate (Life 
Technologies, Nieuwekerk, Netherlands). Particulate C. albicans β-1,3-glucan was isolated 
and purified as previously described (21). C. albicans ATCC MYA-3573 (UC 820) (22) was 
grown overnight in Sabouraud broth at 290C; cells were harvested by centrifugation, washed 
twice, and resuspended in PBS. Candida conidia were heat killed for 30 min at 95 0C. Other 
reagents were obtained as follows: LPS (E. coli serotype 055:B5, Sigma-Aldrich) with an 
additional purification step (23), CD56 MicroBeads were purchased from Miltenyi Biotec. 
Ustekinumab (CNTO 1275) was purchased from Janssen Biotech, Inc. Nanogam (IgG, 
human normal immunoglobulin, IVIg) was purchased from Sanquin and IL-18BP was 
kindly provided by Prof. Charles Dinarello (University of Colorado).
Stimulation experiments. Peripheral blood mononuclear cells (PBMCs) were isolated as 
previously described (24). PBMCs were counted on a Beckman Coulter Z1 Particle Counter 
and adjusted to 5 x 106 cells/ml. The trained immunity protocol was performed as described 
(17): in brief, 100 μl of the PBMC suspension were added per well in 96-well round-bottom 
plates, and pre-incubated for 24 h with either RPMI, β-glucan (1 μg/ml) or heat-killed 
Candida conidia 104 CFU/ml, at 37 0C and 5% CO2. After preincubation, cells were washed 
with warm PBS and let to rest in RPMI supplemented with 10% human pool serum for 5 
days (period during which media was refreshed on day 3). Thereafter, on day 6, cells were 
subjected to a second stimulation of cytokine production with various stimuli (RPMI, LPS 
10 ng/ml, or Candida 105 CFU/ml) in a final volume of 200 μl. After another 24 hours, 
supernatants were collected and stored at -20 °C until assayed. To investigate whether 
IFN-γ inhibitors affect Candida training, PBMCs were preincubated for 1 h prior to the 
first stimulation with IgG control, Ustekinumab or IL-18BP in a final concentration of 10 
µg/ml. Subsequently, RPMI or Candida were added to the cells with the inhibitors for an 
additional 24 h. Thereafter, PBMCs were washed with PBS and further incubated for 5 days 
in culture medium supplemented with 10% pooled human serum. On day 6, the trained 
macrophages were subjected to a second stimulation, for 24 h, with either LPS or Candida. 
The supernatants were collected and stored at -20°C until assessed.
To assess the role of NK cells in this process, NK cells were isolated via positive selection 
with CD56 isolation beads from Miltenyi Biotec conform manufacturer’s instructions. 
Thereafter, the CD56 positive cells were stimulated for 48 hours with heat-killed Candida 
(106 CFU/ml) or heat-killed S. aureus (107 CFU/ml). PBMCs depleted of NK cells were 
further included in training experiments, being trained with Candida (104 CFU/ml) as 
described above and restimulated with either LPS (10 ng/ml) or Candida (105 CFU/ml). 
After 24 hours of cell stimulation, supernatants were collected and stored at -20 °C until the 
amounts of TNF-α and IL-6 were assayed.
Enzyme-linked immunosorbent assay (ELISA). The concentrations of TNF-α (R&D 
Systems, Abingdon, UK), and IL-6 (Sanquin, Amsterdam, Netherlands) were measured 
24 h after the second stimulation in cell culture supernatants with ELISA, according to 
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the manufacturer instructions. The concentration of IFN-γ  (Sanquin, Amsterdam, 
Netherlands) was measured in cell culture supernatants at 48h after the stimulation.
Statistical analysis. Results from at least two sets of experiments with a minimum of four 
volunteers were pooled and analyzed in GraphPad. The data are presented as the means ± 
SEM and Wilcoxon signed-rank test was used to compare differences between groups. The 
level of significance was set at *p<0.05.
Results
PBMCs isolated from patients with CMC, but not HIES, display 
defective Candida-mediated trained immunity
As previously shown, PBMCs of patients who suffer from CMC due to STAT1 mutations 
stimulated for 24 h with heat-killed Candida were able to produce normal amounts of 
TNF-α and IL-6 compared to the healthy controls (2). We therefore tested whether trained 
immunity could be triggered by Candida. PBMCs from five CMC patients and nine healthy 
donors that were exposed to β-glucan, Candida and RPMI (negative control) for 24 h. On 
day 6 after recovery, cells were subjected to a second exposure to LPS, Candida or RPMI 
(negative control) for an additional 24 h. Interestingly, while PBMCs from CMC patients 
could be trained by β-glucan (Suppl. Fig. 1), they could not be trained by C. albicans (Fig. 1). 
In contrast, PBMCs isolated from HIES patients showed a normal degree of training with 
both Candida (Fig. 2) and β-glucan (Suppl. Fig. 2), as shown by the enhanced production of 
TNF-α and IL-6 upon restimulation with either LPS or Candida.
Figure 1: Defective trained immunity in CMC patients. PBMCs from healthy volunteers and CMC patients 
were trained for 24 hours by incubation with culture medium or low concentrations of C. albicans (104 CFU/
ml). Thereafter the stimulus was removed and cells were let to rest in RPMI with 10% human serum. On day 6, 
a second stimulation with LPS (10 ng/ml) or C. albicans (105 CFU/ml) was performed for an additional 24 h. 
TNF-α and IL-6 levels were measured in cell culture supernatants after the second stimulation. n = 9  healthy 
controls, n = 5 CMC patients. The data are presented as the means ± SEM. HC: healthy control; CMC: Chronic 
Mucocutaneous Candidiasis; LPS: Lipopolysaccharide; C.alb.: Candida albicans.
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Figure 2: Normal trained immunity in HIES patients. PBMCs from healthy volunteers and HIES patients were 
trained for 24 hours with culture medium or to very low concentrations of C. albicans (104 CFU/ml). At day 6, 
a second stimulation with LPS (10 ng/ml) or C. albicans (105 CFU/ml) was performed for an additional 24 h. 
TNF-α and IL-6 levels were measured in cell culture supernatants after the second stimulation. n = 9  healthy 
controls and n = 3 HIES patients. The data are presented as the means ± SEM. HC: healthy control; HIES: 
Hyper-IgE syndrome; LPS: Lipopolysaccharide; C.alb.: Candida albicans.
Defective IFN-γ production by NK cells from CMC patients
The defective trained immunity in PBMCs from CMC patients suggests that STAT1, but not 
STAT3, is crucial for Candida-induced trained immunity. IFN-γ is a proinflammatory cytokine 
produced by NK- and T-cells that induces activation of both innate and adaptive immunity 
against candidiasis. Because IFN-γ acts through an IFNGR- and STAT1-dependent signaling 
pathway, and has been previously reported to epigenetically reverse immune tolerance 
(25), we hypothesized that it may be involved in the defective trained immunity in CMC. 
Interestingly, while purified NK cells from HIES patients produced similar amounts of IFN-γ 
as the healthy controls (Fig. 3A), IFN-γ production was significantly diminished in CMC 
patients (Fig. 3A), suggesting defective NK cell function in patients suffering of CMC only. 
Moreover, when PBMCs from both groups of patients were depleted of NKs and subsequently 
trained with Candida, not only the cells from patients with CMC showed a defect in training, 
but NK-depleted cells from HIES were also not able to respond to a similar extend as PBMCs 
from healthy controls (Fig. 3B), demonstrating an essential role for the NK-cell-derived 
IFN-γ production for the induction of training in HIES patients. Of importance, depletion of 
NK cells in PBMCs from healthy volunteers did not abolish their capacity to mount a trained 
immunity response (Fig. 3C), suggesting that in healthy volunteers T-cell-derived IFN-γ is 
able to complement for the loss of NK-cell function. The defective Th1-cell function in CMC 
and HIES patients leads however to a strong dependency on NK-cell-derived IFN-γ. 
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Figure 3: NK-dependent production of IFN-γ mediated trained immunity. (A) Defective NK cells in CMC 
patients. NK cells from two CMC and two HIES patients were isolated with CD56 positive beads and thereafter 
stimulated with either C. albicans or S. aureus. IFN-γ was measured in cell culture supernatants after 48 hours 
of incubation. (B) Defective training of PBMCs depleted of NK cells in CMC and HIES patients. PBMCs from 
one CMC and two HIES patients were first depleted of NK cells and then trained for 24 hours with culture 
medium or to very low concentrations of C. albicans (104 CFU/ml). At day 6, a second stimulation with C. 
albicans (105 CFU/ml) was performed for an additional 24 h. TNF-α and IL-6 levels were measured in cell 
culture supernatants after the second stimulation. The data are presented as the means ± SEM. HC: healthy 
control; CMC: Chronic Mucocutaneous Candidiasis; HIES: Hyper-IgE syndrome; C.alb.: Candida albicans. (C) 
Training of PBMCs from healthy controls depleted of NK cells. PBMCs from healthy controls were trained for 
24 hours with culture medium or with very low concentrations of C. albicans (104 CFU/ml), after which they 
were stimulated as described above. n = 6, 3 independent experiments. The data are presented as the means ± 
SEM. LPS: Lipopolysaccharide; C.alb.: Candida albicans.
Inhibiting IFN-γ production by blocking IL-12 and IL-23 with Ustekinumab, or by 
blocking IL-18 with IL-18BP, significantly decreased the training by Candida in PBMCs 
from healthly controls, both for TNF-α and IL-6 (Fig. 4). Of note, the training was not 
abolished by IgG control (Fig. 4). Moreover, the inhibition was significant only for Candidia 
training and Candidia restimulation, and not for LPS restimulation (data not shown).
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Discussion
In this study we demonstrated that PBMCs from CMC patients failed to mount Candida-
induced trained immunity. This process was caused by STAT1 defects and mediated through 
NK-cell-dependent production of IFN-γ.
The findings of the present study are relevant at several levels. Firstly, they point to 
an important immunological difference between patients with CMC and HIES. As both 
these immunodeficiencies are caused by genetic defects in STAT molecules, and have a 
similar immunological defect in proper activation of Th17 pathway (1, 3), it remained 
unexplained why their susceptibility to infection is different. The identification of specific 
defects in Candida-induced trained immunity in CMC, but not HIES patients, represents a 
first clue for the severe susceptibility to fungal infections in CMC, compared with the less 
prominent susceptibility to fungal infections in HIES. Secondly, the discovery of trained 
immunity defects in CMC patients, and not in HIES, provides important insights into 
understanding the communication between important players in host defense. Through 
in vitro experiments with NK cells and NK cell depletions, we concluded that T- and NK 
cell-derived IFN-γ plays a central role in potentiating trained immunity in a paracrine and 
possible endocrine manner. Although trained immunity has been initially described to 
be induced in monocytes, it should be expected that important interactions should take 
place with other cell types. The first of such interactions is described here, with NK-cell 
derived IFN-γ playing a central role in potentiating trained immunity in a paracrine and 
possible endocrine manner. We found that while the role of NK-cells is redundant in 
healthy individuals with normal T-cell function, the release of IFN-γ by NK cells rescues 
the training in HIES patients that have defective T cell IFN-γ production. In contrast, CMC 
patients that display both defective T- and NK-cell production of IFN-γ explain defective 
trained immunity. A role for NK-cells in the induction of trained immunity has been also 
recently described after BCG vaccination (26).
Figure 4: IFN-γ-dependent Candida-induced training. Before training, PBMCs were preincubated for 1 h with IgG 
(isotype control) (10 µg/ml), Ustekinumab (10 µg/ml) or IL-18BP (10 µg/ml). Thereafter, 100 µl of culture medium 
or C. albicans (104 CFU/ml) was added to the cell suspension, without removing the inhibitors, and further incubated 
for an additional 23 h. At day 6, macrophages were subjected to a second stimulation with LPS (10 ng/ml) or C. 
albicans (105 CFU/ml) for another 24 h. TNF-α and IL-6 levels were measured in cell culture supernatants after the 
second stimulation. Data are presented as mean ± SEM (n = 5, three independent experiments), *p<0.05. Wilcoxon 
signed rank test was used to detect significant differences. U: Ustekinumab; Ca.: Candida albicans.
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The role of IFN-γ and STAT1 for the induction of trained immunity is in line with previous 
observations. We have described differential regulation of STAT1 and STAT3 during induction 
of trained immunity and immune tolerance (19), data that provided the initial impulse to study 
these mechanisms in CMC and HIES. Furthermore, IFN-γ has been demonstrated to reverse 
the effects of LPS tolerance, the ‘opposite’ of trained immunity, specifically by activating Brg1, 
which in turn remodels chromatin facilitating the access of transcription factors (25). IFN-γ 
exerts its biological activity through activation of intracellular pathways containing Jak1, Jak2 
and STAT1 (27). The role of STAT1 signaling for trained immunity may thus be explained 
through its role in the type II IFNGR pathway. In line with this, a recent study demonstrated 
that activation of STAT-1 by IFN-γ correlates with multiple histone modifications such as 
H3K4me2, H3K4me3, H3K9me3 and H3K36me3 (28).
It remains unclear why β-glucan is still able to train cells from CMC patients, as it 
has been proposed that the mechanism through which Candida trains immune cells 
is through β-glucan/Dectin-1 (17). However, recent data suggesting that other cell wall 
Candida structures, such as chitin, are also important for trained immunity induced by 
the whole fungus (Rizzetto L, unpublished data) may represent one possible explanation. 
One limitation of the study that should be acknowledged is the limited number of patients. 
Unfortunately, this was unavoidable due to the rare nature of both CMC and HIES diseases.
Although the in vitro model of training PBMCs is a simplified system, it does provide 
a direct assessment of the propensity of PBMCs from diverse individuals to be trained. 
However, this is the first study reporting defective trained immunity in CMC and normal 
training effects in HIES patients. Thereby this study enhances our understanding of specific 
immunological disturbances in each of these complex immunodeficiencies. Moreover, it 
can provide new openings in the design of novel immunotherapeutical strategies towards a 
personalized treatment of CMC and HIES. 
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Supplementary Figure 1: β-glucan-induced rained immunity in CMC patients. PBMCs from healthy volunteers 
and CMC patients were trained for 24 hours with culture medium or to very low concentrations of β-glucan 
(1µg/ml). At day 6, a second stimulation with LPS (10 ng/ml) was performed for an additional 24 h. TNF-α 
and IL-6 levels were measured in cell culture supernatants after the second stimulation. n = 9  healthy controls, 
and n = 5 CMC patients. The data are presented as the means ± SEM. HC: healthy control; CMC: Chronic 
Mucocutaneous Candidiasis; LPS: Lipopolysaccharide.
Supplementary Figure 2: β-glucan-induced rained immunity in HIES patients. PBMCs from healthy volunteers 
and HIES patients were trained for 24 hours with culture medium or to very low concentrations of β-glucan 
(1µg/ml). At day 6, a second stimulation with LPS (10 ng/ml) was performed for an additional 24 h. TNF-α 
and IL-6 levels were measured in cell culture supernatants after the second stimulation. n = 9  healthy controls, 
and n = 3 HIES patients. The data are presented as the means ± SEM. HC: healthy control; HIES: Hyper-IgE 
syndrome; LPS: Lipopolysaccharide.
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Abstract
A large variety of fungi are present in the environment, among which a proportion 
colonizes the human body, usually without causing any harm. However, depending on the 
host immune status, commensals can become opportunistic pathogens that induce diseases 
ranging from superficial non-harmful infection to life-threatening systemic disease. The 
interplay between the host and the fungal commensal flora is being orchestrated by an 
efficient recognition of the microorganisms, which in turn ensures a proper balance between 
tolerance of the normal fungal flora and induction of immune defence mechanisms when 
invasion occurs. Pattern recognition receptors (PRRs) play a significant role in maintaining 
this balance due to their capacity to sense fungi and induce host responses such as the 
induction of proinflammatory cytokines involved in the activation of innate and adaptive 
immune responses. In the present review we will discuss the most recent findings regarding 
the recognition of Candida albicans and Aspergillus fumigatus and the different types of 
immune cells that play a role in antifungal host defence.
Keywords: Candida, Aspergillus, pattern recognition receptors, inflammatory networks
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Introduction
During the last few decades, the prevalence of fungal infection has considerably increased, 
especially due to the immunosuppressive treatments in cancer therapy, transplantation, and the 
HIV epidemics (1). Moreover, pathogenic fungi are able to rapidly adapt and become resistant to 
antifungal agents (2). The human commensal Candida albicans and the environmental fungus 
Aspergillus fumigatus are facultative pathogens, which in immunocompetent individuals do 
not cause infection. However, immunocompromised patients are prone to systemic fungal 
infections in which mortality rates can rises up to 60% (3). While the clinical presentation of 
candidiasis and aspergillosis differs, the mechanisms needed to control infection, including 
the pattern recognition and inflammatory networks, share many characteristics.
Pattern recognition receptors in fungal infection 
Both Candida and Aspergillus undergo a continuous morphology switch between yeasts 
and hyphae, resulting in differential exposure of fungal pattern associated molecular 
patterns (PAMPs). C. albicans cell wall contains carbohydrate polymers and glycoproteins, 
comprising mainly chitin, β-1,3- and β-1,6-glucan and O- and N-linked mannan. The 
Aspergillus cell wall is predominantly composed of chitin, α-glucans, β-(1,3)-(1,4)-glucans, 
and galacatomannans. One important feature of the Aspergillus conidial cell wall is the 
outer layer of hydrophobic rodlets. During swelling of the conidial cell wall and subsequent 
germination, the hydrophobic layer changes into a hydrophilic structure exposing 
polysaccharides. During the course of fungal infection and invasion, the first crucial step 
in mounting effective immune responses is the recognition of the invaders by the host. 
Various pattern recognition receptors (PRRs) on differential cell populations will recognize 
fungal invaders and trigger bona fide signalling pathways and cellular responses (Figure 1).
C-type lectin receptors 
Mannans present in the outer layer of Candida and Aspergillus cell wall comes in direct contact 
with the host and can be recognized by the C-type lectin receptors (CLRs). Mannose receptor 
(MR), primarily present on macrophages, recognizes Candida N-mannan (4), and further induces 
IL-17 (5). MR has also been shown to recognize Aspergillus conidia and induces proinflammatory 
cytokines (5). Dectin-2, which is mainly expressed on dendritic cells (DCs), macrophages and 
neutrophils, recognizes Candida α-mannan and also triggers IL-17 (6). In addition to its role in 
modulating T helper (Th) responses, Dectin-2 has also been associated with ROS production, 
as well as phagocytosis and killing of Candida glabrata (7). Dectin-2 forms heterodimers with 
Dectin-3, leading to proinflammatory responses upon C. albicans infection (8). Dectin-2 is also 
important for the Aspergillus-specific immune response, being up-regulated upon recognition of 
the fungus. Its expression is restricted to the population of monocyte-derived macrophages (9). 
Galectin-3 on macrophages recognizes β-mannans (10), and induces a protective 
antifungal response in murine macrophages through the secretion of TNF-α. Moreover, 
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mice deficient in Galectin-3 are more susceptible to disseminated candidiasis (11). 
Mincle is a CLR expressed on monocytes and neutrophils, yet with an unknown ligand. 
In murine models, Mincle was responsible for inducing protective responses against C. 
albicans, mainly by the initiation of TNF-α production; mice deficient in this receptor 
were drastically susceptible to systemic candidiasis (12). However, the role of Mincle in 
Aspergillus recognition is still unknown. DC-SIGN is present on dendritic cells as well as 
macrophages and recognizes Candida N-linked mannan (13), and can bind and internalize 
Aspergillus conidia (14). It induces a cascade of cytokines that activate Th cells in order 
to differentiate and initiate adaptive immune responses. Mannose-binding lectin (MBL) 
is a soluble CLR that also binds mannan modulating the recruitment of phagocytes and 
proinflammatory responses against Candida (15). 
β-1,3 and β-1,6-glucan is shielded by the mannoproteins in C. albicans yeast, but they are 
exposed on budding yeast, and Candida hyphae. Dectin-1, a well-described CLR present on 
macrophages and monocytes, binds to a long β-1,3-glucan chain (16) inducing cytokines as 
well as internalization of the fungus upon formation of a “phagocytic synapse” (17). Resting 
Aspergillus conidia do not present abundant β-glucans on their surface either, which might 
account for the redundant role of Dectin-1 in induction of different Th subsets in experimental 
in vitro models (18, 19). Inhibition of Dectin-1 on alveolar macrophages did not affect 
phagocytosis of resting A. fumigatus conidia (20). In contrast, alveolar macrophages stimulated 
with germinated conidia produce innate cytokines via the Dectin-1 pathway (21). Dectin-1 
was described to be involved in both clinical spectra of aspergillosis: in an invasive aspergillosis 
mouse model, IL-17 production is mediated by Dectin-1 and was dependent on IL-23 (22), and 
in an allergic mouse model, Dectin-1 was demonstrated to drive pulmonary pathology via IL-22 
production (23). Corticosteroids block Aspergillus-induced autophagy via the Dectin-1/Syk 
pathway (24), and corticosteroid-resistant asthma was associated with detrimental IL-17 and 
IL-22 production (25), suggesting a strong role for autophagy and Dectin-1 to drive pathology 
in severe forms of asthma. Dectin-1 polymorphisms were not associated with disseminated 
candidiasis in humans, but were associated with Candida colonization, while susceptibility 
to invasive aspergillosis was dependent on Dectin-1 polymorphisms (26, 27). In conclusion, 
CLRs play an important role in mediating immunity against Candida and Aspergillus through 
inducing Th-derived cytokines and mediating uptake of the fungus.
Toll like receptors
Toll like receptors (TLRs) have been extensively studied in the context of fungal recognition. 
TLRs play a significant role in a murine model of disseminated candidiasis and, together 
with IL-1 receptor, activate several potent antifungal-signalling mechanisms (28). TLR2-/- 
mice were reported to have an increased susceptibility to disseminated candidiasis that 
could be attributed to a decreased secretion of TNF-α and MIP-2 and impaired recruitment 
of neutrophils (29). In contrast, others have shown that TLR2-/- mice are more resistant to 
systemic candidiasis exhibiting an increased chemotaxis and IFN-γ secretion, while IL-10 
was significantly impaired. Interestingly, the recruitment of monocytes was enhanced in 
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TLR2-/- mice, suggesting an increase in the candidacidal activity in these mice (30). TLR4-/- 
mice are more susceptible to systemic candidiasis due to an impaired secretion of KC and 
decreased neutrophil recruitment resulting in a higher fungal burden in the kidneys (31). 
However, TLR1 polymorphisms, but not TLR2 and TLR4 polymorphisms, have been 
associated with human susceptibility to C. albicans infection (27). TLR4-/- mice were more 
susceptible to Aspergillus infections, and TLR4 polymorphisms were associated with invasive 
aspergillosis (28, 32). Immunosuppression of TLR2-/- mice resulted in higher susceptibility 
to Aspergillus infections (33); however polymorphisms in TLR2 were not associated with 
invasive aspergillosis (26). The intracellular receptor TLR3 recognizes fungal nucleic acids. 
TLR3 had a protective role against Candida, as a mutation in the L412F variant of TLR3 
leads to lower activation of nuclear factor-kappa B (NF-κB) and decreased levels of IFN-γ, 
resulting in increased susceptibility to cutaneous candidiasis (34). TLR3-/- and TRIF-/- mice 
were found to be susceptible to invasive pulmonary aspergillosis, and TLR3 polymorphisms 
have been associated with invasive aspergillosis (26, 35), suggesting an important role of 
TLR3 in mediating protection against Aspergillus infection as well. Conclusions on the role of 
TLR7 and TLR9 in fungal infection have not been consistent, and no polymorphisms in TLR7 
and TLR9 have been associated to date with invasive aspergillosis or candidiasis (26, 27).
NOD-Like receptors 
NOD1 and NOD2 are intracellular NOD-Like receptors (NLRs) that recognize bacterial 
peptidoglycans. Chitin-mediated responses, such as the induction of IL-10, were found to 
be dependent on NOD2 as well as TLR9 and MR (36). However, there is presently only 
in vitro data to support a role for NOD2 in fungal infection, no in vivo studies in NOD2 
mice have been performed, and no studies have been performed on the role of NOD1 
in fungal infection. The best-characterized NLR is NLRP3, which is a component of the 
inflammasome. Mice deficient in NLRP3 are more susceptible to Candida infections 
(37-39). One study showed involvement of NLRP3 in anti-Aspergillus host defence in vitro; 
however, disseminated aspergillosis has not been studied in NLRP3-deficient mice (40). 
Inflammatory networks 
Recognition of fungal-associated molecular patterns by PRRs will lead to the initiation of 
an efficient host defence that is mandatory to clear the invading fungus. Several populations 
of cells are involved that orchestrate this clearance (Figure 2).
Epithelial cells 
The epithelium constitutes a mechanical barrier against invading fungi. C. albicans is in 
permanent contact with epithelial cells and infection with tissue invasion is associated with 
morphological changes of yeast into hyphae. Candida hyphae can penetrate the epithelial 
cells through two distinct mechanisms: induced endocytosis and active penetration. 
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Fig. 1: Recognition of C. albicans and A. fumigatus by innate immune cells. The pattern recognition receptors 
Dectin-1, Dectin-2, Dectin-3, FC gamma receptor (FcRγ), Mannose Receptor (MR), Dendritic Cell-Specific 
Intercellular adhesion molecule-3-Grabbing Nonintegrin (DC-SIGN), Mincle, Mannan-binding lectin (MBL), 
Complement Receptor 3 (CR3), Galectin-3, Cluster of Differentiation 36 (CD36), Toll-like receptors (TLRs), 
NACHT, LRR, and PYD domain–containing protein 3 (NLRP3), and nucleotide-binding oligomerization domain–
containing protein 2 (NOD2) recognize the fungal cell wall components β-glucan, α-mannan, β-mannan, N/O-
mannan, phospholipo-mannan (PLM), glucuronoxylomannan (GXM), chitosan, chitin, or fungal DNA and RNA. 
These signals activate canonical or non-canonical nuclear pathways, with the subsequent induction of an immune 
response, such as secretion of cytokines, chemokines, initiation of phagocytosis or inflammasome activation.
◀
Epithelial cells respond to Candida with activation of NF-κB and cytokine production 
when two pathways are induced; the second pathway, namely MPK1 and c-Fos activation, 
was dependent on hyphal formation. In this way, conidia are tolerated and germination is 
seen as a danger signal in which the epithelium plays an important initial step to induce a 
protective inflammatory network (41). Aspergillus species are not typical commensals. Lung 
epithelium not only acts as an efficient barrier, it can also phagocytose Aspergillus conidia. 
Although primary epithelial cells from the respiratory tract phagocytose Aspergillus conidia, 
the killing capacity of these cells is low (42). However, they can control outgrowth, and in 
addition potent antifungal drugs such as posocanazol, can accumulate in the membranes 
of lung epithelial cells and, in this way, might contribute to efficient exposure of antifungal 
drugs during Aspergillus infection. Thus, epithelial cells can play an important role in fungal 
infection by restricting fungal outgrowth and initiate potent antifungal host responses.
Monocytes and macrophages
Residential macrophages are phagocytes that are essential in mediating the first steps of an 
effective antifungal host defence. Fungi have evolved strategies to escape these initial first 
steps. Candida can inhibit phagolysosome maturation and production of NO by macrophages, 
while Aspergillus can inhibit phagolysosome acidification (20). In addition, fungi can change 
the characteristics of macrophages; Candida infection can induce a more anti-inflammatory 
phenotype enhancing fungal survival by switching M1 macrophages to a M2 phenotype (43). 
Recently, the importance of residential macrophages to control disseminated fungal infection 
was elegantly demonstrated. A deficiency in accumulation of residential macrophages in 
the kidney due to a deficiency in the chemokine receptor CX3CR1 lead to renal failure and 
death. Moreover, patients with a polymorphism leading to a decreased function in CX3CR1 
were more susceptible to disseminated candidiasis. These data highlight the essential role of 
residential macrophages, in particular, in the kidney to control disseminated fungal infection 
(44). In addition to macrophages, monocytes can also phagocytose spores and inhibit 
germination. Monocytes have a potent conidial killing capacity and are essential in the first 
48h to control disseminated candidiasis (45). Moreover, monocytes can rapidly differentiate 
into DC that transport spores to draining lymph nodes, where they prime and expand A. 
fumigatus-specific Th cells (46). In addition, monocytes can augment neutrophil conidiacidal 
activity and play a crucial role in controlling disseminated fungal infection (47).
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Neutrophils
Neutrophils are essential to clear fungal invasion, which is underscored by the observation 
that immunosuppression with prolonged neutropenia is a major risk factor for invasive fungal 
infections. Various neutropenic mouse models have clearly demonstrated a significant role for 
neutrophils in disseminated fungal infection. Mice depleted of alveolar macrophages prior to 
pulmonary aspergillosis recruited neutrophils normally and are able to restrict hyphal tissue 
invasion, while neutrophil depletion prior to or within 3 h after infection resulted in high 
susceptibility (48). Neutrophils use oxidative and non-oxidative killing mechanisms, which 
are both essential in Candida and Aspergillus infections. The oxidative burst is produced by 
the enzymes NADPH oxidase and myeloperoxidase. NADPH oxidase deficiency results in 
the disease chronic granulomatous disease (CGD), which is associated with an extraordinary 
increased susceptibility to invasive mold infection, highlighting the importance of 
NADPH-oxidase in controlling fungal infection. Another specific feature of neutrophils is 
their capacity to rapidly release granules that mediate extracellular killing. Those granules 
contain, next to NADPH oxidase and myeloperoxidase, other proteins with antimicrobial 
properties, like lysozymes, lactoferrins, elastases, defensins, gelatinases or cathepsin G (49). 
In a cell-free supernatant of degranulated neutrophils of CGD patients, a normal amount 
of iron-free lactoferrin was found, which was capable to decrease fungal growth (50). 
Additionally, neutrophil elastase and cathepsin B were described to have antifungal activity 
and elastase was found to contribute to neutrophil extracellular traps (NETs) (51). NETs, 
which are composed of DNA that forms large fibrillar structures that can bind pathogens 
and antimicrobial peptides, provide a mechanism to combat hyphae that are too big to be 
phagocytosed. It was demonstrated that Candida can be captured by NETs, however it did 
not contribute to efficient killing (52). Similarly, NETs were able to limit fungal growth, but 
not to kill Aspergillus conidia and hyphae (51, 53). Bianchi et al. have demonstrated that NET 
formation is deficient in CGD patients and that NET formation can be restored by gene-
therapy resulting in successful neutrophil-dependent elimination of A. nidulans conidia and 
hyphae. The neutrophil-associated calprotectin was identified to inhibit growth of A. nidulans 
in the NETs of CGD mice after gene therapy (54). The antifungal activity of calprotectin is 
not restricted to Aspergillus; it was also identified as the main component in NETs controlling 
Candida growth in vivo and in vitro (55). CGD is not only characterised by a deficiency in 
neutrophil killing and NET formation. The NADPH oxidase is also present in monocytes and 
macrophages, and has been shown to be also important for controlling fungal infection (56). 
In addition, macrophages and monocytes deficient in NADPH-oxidase have a defect in 
autophagy, an intracellular mechanism that can control Aspergillus outgrowth (57). Whereas 
autophagy appears to be crucial for Aspergillus infection, it seems redundant in candidiasis, 
although initially it was reported that mice deficient in autophagy were more susceptible to 
Candida infection (58, 59). A selective killing defect by neutrophils for C. albicans, but not for 
A. fumigatus, was found in CARD9 deficient neutrophils resulted in abnormal ultrastructural 
phagolysosomes and massive hyphal outgrowth, which was independent of ROS production 
and release of azurophilic granules. Neutrophils were found to display two independent killing 
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mechanisms: ROS-dependent that is crucial for clearing opsonized Candida and CARD9 
dependent that is crucial for unopsonized Candida (60). This suggests that neutrophils have 
an unknown killing mechanism that is specific for Candida initiated by CARD9.
IL-17 is a potent mediator of neutrophil recruitment. Next to Th cells and innate lymphoid 
cells, neutrophils themselves have been reported as a source for IL-17, in a Dectin-1- and 
IL-23-dependent manner, and RORγT-positive neutrophils exposed to IL-23 and IL-6 
express the receptor IL-17RC (61). This suggests an autocrine feedback loop in recruiting 
neutrophils to the site of the fungal infection. Mice deficient in IL-17 signalling are more 
susceptible to systemic candidiasis. However, patients with an IL-17 deficiency suffer from 
mucosal candidiasis, but do not develop invasive candidiasis, and are not more susceptible 
to invasive mould infection. It is still an open question to what extend IL-17 determines 
neutrophil faith and function at the mucosa. In a mouse model of oropharyngeal candidiasis, 
IL-17RA-/- and IL-23-/- mice depleted for neutrophils show higher fungal burden compared 
to non-neutropenic animals, suggesting that IL-17 deficiency does not result in a complete 
neutrophil function at the site of infection (62). In addition, the recruitment of neutrophils by 
vaginal epithelial cells producing S100 alarmins was independent of IL-17 production (63). 
Dendritic cells
Dendritic cells (DCs) achieve a crucial patrolling function. They are located in the mucosa 
and migrate to the draining lymph nodes to activate T cells. DCs stimulated with the fungal 
pathogens Aspergillus and Candida show increased activation markers like CD80 and CD86, as 
well as IL-8 and IL-12p70 production (64). Moreover, DCs play a crucial for the host response 
against Candida via the production of type-I IFN-β in a Dectin/Syk/IRF5 dependent pathway 
(65-67). DCs are mainly involved in activation and shaping Th responses. During pulmonary 
Aspergillus infection conidial transport from the lung to the lung-draining lymph nodes, 
priming of CD4+ T cell responses and the prevention of the pulmonary fungal burden was 
mediated by monocytes-derived CD11b+ DC population in a murine model (46). Aspergillus 
conidia triggered protective Th1 and Treg responses, whereas Aspergillus hyphae triggered 
an anti-inflammatory Th2/Th17 profile (68). The protective DC responses are dependent on 
the PI3K/Akt/mTOR pathway, while the anti-inflammatory DCs depend on STAT3/IDO 
activation (68). The direction of the airway inflammation in mice into either Th2 or Th17 
was dependent on TNF-α produced by monocyte-derived DCs: BALB/c mice showed a high 
amount of TNF-α-producing DCs promoting Th17 responses with subsequent neutrophils 
recruitment, while C57BL/6 mice displayed a low amount of TNF-α-producing DCs, 
associated with high IL-5 levels and eosinophilia (69). Plasmacytoid DCs (pDCs) represent a 
specific subset of DCs, and, in the context of fungal infections, have not been studied in great 
extend. In a mouse model of invasive aspergillosis a specific influx of pDCs was observed, 
and depletion of pDCs resulted in an increased susceptibility to invasive aspergillosis. In vitro 
analysis showed that hyphal growth was inhibited by pDCs in a contact-independent manner. 
Interestingly, pDCs produced inflammatory cytokines, such as IFN-α and TNF-α, that were 
independent of TLR9 (70). In contrast, pDCs in a vaginal candidiasis model were suggested to 
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mediate tolerance, since pDCs that were present in the draining lymph nodes of the infection 
lacked the upregulation major histocompatibility complex class II, CD80, CD86, and CD40 
(71). This could point to a crucial difference in pDC responses induced by Aspergillus or 
Candida that might be dependent on the site of infection.
Innate lymphoid cells
Recently, a novel population of innate lymphocytes called innate lymphoid cells (ILCs) has been 
identified. ILCs are analogous to Th subsets, but differ because they lack the T cell receptor. 
They have been named according to their cytokine profile. ILC1 cells express T-bet and produce 
IFN-γ, ILC2 cells express GATA3 and produce IL-5 and IL-13, and ILC3 cells express RORγt 
and produce IL-17 and IL-22. Only a few studies so far have deciphered a role for innate 
lymphoid cells in the host defence against Aspergillus or Candida. The IL-17-producing ILC3 
cells have been described as being important in the defence against and the control of pathogens 
at the mucosal barrier. C. albicans is a potent inducer of IL-17 (72) and mice lacking IL-17 
are highly susceptible to Candida infections (73). As described earlier, patients with an IL-17 
deficient phenotype such as hyper IgE syndrome (74) and patients with chronic mucocutaneous 
candidiasis (75), suffer from mucosal candidiasis, but the lack of IL-17 in these patients has been 
predominantly attributed to Th17 cells. Innate lymphoid cells would supply a faster source of 
IL-17 than the adaptive Th17 cells, and they represent an additional important source of IL-17. 
The first clues that ILCs play an important role in controlling fungal infection and 
colonization come from experimental mouse models. Fungal control in a murine model of oral 
candidiasis was mediated by IL-17 secreting ILCs and both, ILC depleted RAG-/- and RORC+ 
ILC-/- mice completely failed to control fungal outgrowth (76). The relevance of ILCs in mediating 
pulmonary host responses in the lung was demonstrated in a study where Candida airway 
exposure was able to protect against Pseudomonas aeruginosa-induced lung injury, an effect 
that was dependent on pulmonary ILCs that expressed IL-22 (77). It has been demonstrated 
that ILCs play a role in the pathogenesis of asthma and allergic reactions, and the contribution 
of GATA3+ ILCs to allergic reactions mediated by Aspergillus has recently been studied in 
patients with chronic sinusitis. These patients showed a significant proliferation of GATA3+ 
ILCs and increased GATA3+ ILCs responsiveness to IL-33 induced by Aspergillus extract which 
resulted in an increased IL-13 production (78). Interestingly, also invariant NKT (iNKT) cells 
are found to contribute to airway hyperactivity in an IL-33 dependent manner, directly activated 
by the Aspergillus glycosphingolipid Asperamide B (79). This might explain one mechanism 
via which Aspergillus can directly induce allergic responses in an immunocompetent host, 
and suggests a critical role for ILCs in fungal-induced allergic reactions. The role of ILCs in an 
immunosuppressive status during invasive fungal infection still needs to be investigated. 
Natural Killer Cells 
Natural Killer (NK) cells contribute to the rapid innate immune response against invading 
pathogens in an antigen-independent manner, mainly by recognizing infected cells and 
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induce cell death of the infected cell. NK cells also contribute to the host defence against 
fungal infections. The additional depletion of NK cells in a T/B-cell-deficient SCID mice 
increases the susceptibility to systemic candidiasis, while it had no (or even an opposite) 
effect in immunocompetent mice (80). NK cells might substitute for specific functions of 
B and T cells when these cells are absent, which is in line with the observation that NK cell 
activation by Candida results in the production of high amounts of GM-CSF, IFN-γ and 
TNF-α, cytokines that are also produced by T cells. Although phagocytosis by NK cells did 
not inhibit hyphal growth of Candida, antifungal activity against Candida was observed that 
was mediated by extracellular perforin production by NK cells (81). Comparably, NK cells 
could kill Aspergillus hyphae via a perforin-mediated mechanism, while Aspergillus conidia 
were not affected (82). Bouzani et al. also showed that only germinated morphological forms 
of Aspergillus were able to stimulate NK cells to produce high amount of IFN-γ. However, 
in contrast to Voigt et al. and Schmidt et al., they propose a perforin-independent killing 
mechanism, since they observed that the killing was mediated via a soluble factor (83). 
NK cells are potent producers of IFN-γ, and IFN-γ is crucial for controlling Aspergillus 
infection, which is highlighted by the fact that IFN-γ knockout mice display an increased 
susceptibility to invasive aspergillosis. In a murine model of invasive aspergillosis in which 
neutrophils were depleted, NK cells were the major population of cells that were able to 
secrete IFN-γ and to control fungal growth in the lung during early infection. The depletion 
of NK cells in IFN-γ-deficient mice did not result in increased severity of the infection, 
while depletion of NK cells in wild type mice resulted in a similar increases susceptibility 
to infection that was observed in IFN-γ-deficient mice. These data strongly suggest that in 
neutropenic conditions the protective IFN-γ responses during early invasive aspergillosis 
are critically dependent on NK cells. (84). 
Platelets
Classically, platelets, mediate blood coagulation after interruption of the endothelium. 
In addition, platelets are capable to mediate innate immune functions, especially during 
bloodstream infections. Although in vitro studies failed to show the capacity of C. albicans 
to aggregate human platelets, in vivo platelets bound to C. albicans and were activated 
after bloodstream injection in a murine model (85). Platelets produced peptides like 
Rantes or platelet factor 4 with antimicrobial activity against Candida and platelet-rich 
plasma inhibited the growth of Candida (86). In Aspergillus infection, the production of 
the proinflammatory IL-8 from human monocytes is enhanced by platelets activated by 
Aspergillus hyphae, and all Aspergillus morphotypes had the capacity to activate platelets 
(87). This seems to be an interesting feedback-loop, since Aspergillus germination and 
hyphal formation was inhibited by activated platelets (88). Interestingly, not only the direct 
contact of the platelets to Aspergillus was necessary, also Aspergillus cell culture supernatant 
was able to activate platelets, suggesting a potentially harmful contribution to systemic 
infection by increasing thrombotic status during invasive aspergillosis (88). 
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◀ Fig. 2: Signalling networks of the innate immune response against Aspergillus. (1) Inhaled Aspergillus conidia 
reaching the alveoli are endocytosed by the lung epithelial cells, in which they survive or escape from via hyphal 
formation. Epithelial cells react upon fungal growth with expression of pro-inflammatory cytokines. (2) Once 
internalized in alveolar macrophages and monocytes, Aspergillus conidia are phagocytosed, which is prevented 
by hyphal formation. Acidification in the phagolysosomes is essential for the killing of A. fumigatus conidia. 
Reactive oxygen species (ROS) are produced to effectively kill and eradicate Aspergillus. A defect ROS system 
of macrophages and monocytes like in CGD is associated with defect autophagy resulting in pro-inflammatory 
cytokine production. (3) Upon invasion, neutrophils are recruited by proinflammatory cytokines produced by 
macrophages and monocytes or by IL-17 expressed in RORgt+ neutrophils and acting on the IL-17RC receptor 
via an autocrine feedback loop. Aspergillus conidia are intracellular killed by the ROS system, while Aspergillus 
conidia and hyphae bind to neutrophils extracellular traps (NETs), which mainly consist of neutrophil DNA and 
antimicrobial proteins like calprotectin, inhibiting the fungal growth without killing. (4) Natural killer cells are 
activated by the germinated and hyphal forms of Aspergillus and mediate the killing via perforin release or directly 
via IFN-γ. Next to that, IFN-γ enhances conidial killing by macrophages. (5) The role of innate lymphoid cells 
(ILCs) in the lung during invasive aspergillosis is largely unknown. Invariant (i) NKT cells are directly activated 
by asperamide B derived from Aspergillus and cause together with IL-13, derived from Th2 cells, allergic airway 
responses. (6) Monocyte-derived dendritic cells recognize Aspergillus conidia and hyphae resulting in upregulation 
of CD80+ and CD86+ and the production of IL-8 and IL-12p70. DCs shape adaptive Th responses after migration 
to the lymph node. Aspergillus conidia induce preferentially Th1/Treg responses and Aspergillus hyphae Th17/
Th2 responses. DCs, high positive for TNF, mediate differentiation into the Th17 direction with production of 
IL-17 and low positive for TNF into the Th2 direction with production of IL-13. (7) As the last step of invasion, 
Aspergillus can overcome the endothelium and reach the blood stream. All growth forms of Aspergillus activate 
platelets, which activate monocytes to produce IL-8. Activated platelets are capable of inhibiting hyphal formation. 
Conclusions and future perspectives
During the past years, fungal pathogens have been of rising interest especially due to the 
increasing number of immunocompromised patients. In order to combat fungal infections, 
the human immune system needs to be able to efficiently sense the fungal pathogen, and to 
activate a plethora of immune cells that are able to engulf and clear the pathogen. In this regard, 
PRRs are of significant importance. Numerous studies revealed beneficial as well as detrimental 
roles of different TLRs in fungal infections. Furthermore, several studies on murine models are 
contradictory, probably due to the differences in the experimental setup, mouse strains that are 
used, as well as differences in fungal strains. Although many PRRs that recognize fungal PAMPs 
have been identified, there is still a large amount of unexplored PRRs that could contribute 
to antifungal host defence. Moreover, the interactions that have been described between PRRs 
point to an even more complex dynamic cell wall recognition system on immune cells. The 
knowledge that there could be many fungal PRRs that are dynamically expressed and have the 
capacity to interact with each other indicates that understanding fungal recognition at the host 
cell membrane needs further studies and will be challenging and complex. 
Fungal recognition as well as the interplay between the innate immune cells forms 
the initial inflammatory network that is needed to control fungal infection. A better 
understanding of the role of epithelial cells in fungal infection has lead to an increased 
awareness that non-classical immune cells, such as epithelial cells, endothelial cells, and 
platelets, also play a crucial role in the orchestration of an efficient antifungal host response. 
In addition, new subsets of immune cells, such as ILCs have come to stage and NK cells have 
gained interest in their contribution to control fungal infection. These new players next to 
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the traditional and well-known professional phagocytes such as neutrophils and monocyte/
macrophages open up relevant new questions. To what extend does immunosuppression 
with corticosteroids affect these new players? And in turn, does this influence the function 
of the classical phagocytes? Does NADPH-oxidase deficiency influence effective epithelial 
and endothelial antifungal host responses? In addition, recent studies have suggested an 
innate immune memory in NK cells as well as in monocytes, which opens new horizons 
regarding the host-fungus interactions. Hence, not only CLRs, but also some TLRs were 
shown to mediate immune responses to a microbe, upon a second encounter, by either 
strengthening or diminishing host responses by the means of host chromatin remodelling 
that can shape the host immune response (89, 90), making these receptors interesting 
candidates for further investigation as potential targets for vaccines. 
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Despite the increased knowledge on the mechanisms of Candida recognition and the 
networks of innate and adaptive host defense activated during infection (1), much remains 
to be learned regarding the distinctive modulatory effects of Candida spp on host immune 
responses, while further studies are warranted in order to decipher the complex host-
pathogens interactions and the relationship and synergy among the different PRRs. 
In Chapter 2 of this thesis we analyzed the capacity of C. albicans to modulate the cytokine 
responses of PBMCs to bacteria that normally colonize the skin and mucosa. We showed that 
C. albicans primes the cells for enhanced proinflammatory cytokine production when they 
are exposed to a secondary bacterial stimulus. This priming effect is dependent on β-glucan 
and N-linked mannan present on the Candida cell wall. Therefore, the chronic exposure of 
primary human immune cells to C. albicans primes them for subsequent stimulation with 
different microorganisms, mechanism that could explain the potential stimulatory effects of 
the fungus in hyperinflammatory conditions (e.g. the suggested role of Candida in Crohn’s 
disease). Therefore, the Dectin-1/Raf-1 signaling pathway described to be responsible for 
this effect may represent a potential therapeutic target in autoinflammatory diseases. 
In the next two chapters we investigated the role of Dectin-2, one important C-type lectin 
receptor, for the innate host defense against two of the most important Candida species: C. 
albicans and C. glabrata. In Chapter 3 we confirmed that Dectin-2-/- mice were more susceptible 
to systemic candidiasis, which is most probably due to the elevated fungal load in the kidneys. 
Phagocytosis of C. albicans by the Dectin-2-/- macrophages was moderately decreased. 
Interestingly, the secretion of most of the macrophage-derived cytokines from Dectin-2-/- mice 
with systemic candidiasis was defective. No striking differences among several Candida mutants 
defective in mannans could be detected between naïve wild-type and Dectin-2-/- mice, apart 
from the β-mannan-deficient bmt1∆/bmt2/bmt5∆ triple mutant, suggesting that β-mannan may 
partially mask α-mannan detection, which is the major fungal structure recognized by Dectin-2.
In Chapter 4 we showed that Dectin-2 is an important component of the host defense against 
systemic infection with C. glabrata. Dectin-2-/- mice were more susceptible to C. glabrata, 
susceptibility that was associated with a combination of decreased production of protective 
T-helper-derived cytokines and defective phagocytosis and killing of the yeast by neutrophils 
and macrophages, respectively. These results not only broaden our knowledge regarding the 
interaction between C. glabrata and the immune system, but they also give us insights into 
the possibility of designing future immunotherapeutic strategies based on Dectin-2 receptor. 
Trained immunity is a novel described phenomenon through which cells associated with 
the innate immune system exhibit memory characteristics upon a second encounter with a 
microorganism or with a microbial ligand (2, 3). In Chapter 5 we showed that a primary exposure 
to microbial ligands alters the functional fate of monocytes towards tolerance or training, and 
this is dependent on the nature of PRRs engaged and on their concentration. Trained immunity 
and tolerance may have important effects on the host susceptibility to infections by inducing 
long-term changes in innate cells, such as monocytes, macrophages or NK cells, in the capacity 
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of non-specifically responding to a secondary infection. This could be of exceptional interest 
in developing new therapeutic strategies against excessive autoinflammatory responses or for 
improving ineffective immune responses against an infection, by harnessing innate immune 
cells and their related receptors and signaling pathways.
In Chapter 6 we investigated whether other commensal fungi, such as Saccharomyces cerevisiae, 
are also able to induce trained immunity. We show that different strains of Saccharomyces 
are able to train human primary cells, with this training effect being dependent not only 
on β-glucan and mannan but also on chitin. Strains specifically isolated from CD patients 
are able to modulate cytokines response to bacterial antigens and fungi and this effect is 
mostly dependent on chitin. We observed a strong strain-specific variation of the cytokine 
production after stimulation of monocytes with different human environmental isolates of S. 
cerevisiae, which also correlated with the origin of the strain, suggesting that that differential 
adaptation to the environment might be a determining factor of fungal pathogenicity. 
Both patients with chronic mucocutnaeous candidiasis (CMC) and patients with Hyper-IgE 
syndrome (HIES) have defects in generation of Th17 responses, however their phenotype 
in terms of types of infections differs significantly. Recently STAT1 was identified as one of 
the transcription factors modulated during induction of trained immunity (4), and we have 
thus hypothesized that defects in trained immunity might characterize patients with defects 
in STAT1. In Chapter 7 we report that patients with STAT1-defective CMC are less able to 
mount trained immunity against C. albicans, and no such defect is observed in patients with 
STAT3-defective (HIES). These results may highlight a clinical significant fact with regard 
to the phenotype of those two groups of patients and their susceptibility to infections, 
since CMC patients predominantly suffer of Candida infections (5), while HIES patients 
encounter mainly Staphylococcal infections (6, 7). These finding are biologically important 
due to the fact that they identify a new STAT1- and NK/IFN-γ-dependent pathway that is 
important for induction of trained immunity.
Future perspectives
The results reported in these studies both contribute to an improved understanding of the 
innate immune responses activated during systemic Candida infections, and, at the same 
time, open new avenues of investigation for the future.
Candida-induced priming of innate immunity and the signaling pathways involved in 
this process may represent an important aspect of novel immunotherapeutic strategies, and 
therefore its potential exploitation in different Candida infections could be of significant 
interest, especially for patients suffering of autoinflammatory diseases. Of specific interest is 
the role of Dectin-2 in interaction with different Candida species and its synergy with other 
C-type lectins or with TLRs. Whether the Dectin-2 is involved in either the stimulation of 
Th17 immune responses or in induction and/or inhibition of innate immune cytokines may 
represent a new research line in the near future.
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Vaccination represents the most effective manipulation of the immune system; therefore, 
harnessing not only the adaptive, but also the innate immune responses may lead to more 
efficient ways of protection against different infectious factors. Several interesting points 
regarding the trained immunity remain to be investigated in the coming years. What is the 
training effect of a broad range of different microorganisms (either commensals or pathogens) 
on innate immune cells and what precisely is the relationship between them? What are the 
distinctive mechanisms through which different ligands induce either training or tolerance? 
Another interesting aspect could be the effect of sequential training with the same or with 
different microorganisms and/or ligands? Do they still induce training/tolerance and at 
which level? Do the time period between the training and the restimulation influence the 
final outcome? Can trained immunity be reversed and if yes, what is its clinical importance?
Of specific interest remains what kind of innate immune cells, apart from monocytes/
macrophages and NK cells, are able to exhibit memory characteristics. Are dendritic cells also 
able to respond to a secondary stimulation? What about neutrophiles or mast cells? What is the 
synergy (if there is any) between the innate and adaptive cells in inducing trained immunity?
Up till now, several epigenetic profiles of trained monocytes and/or macrophages have 
been described as probably the most important molecular mechanism involved in training. 
In the coming years we will need to decipher the epigenetic profiles of other innate immune 
populations and the period during which these changes are to be found after the training. 
In conclusion, the immune responses induced by Candida represent a complex signaling 
network in which Candida species and possibly particular strains induce specific effects, and 
in which cell wall morphology and the collaboration between PRRs and different cytokines 
play a significant role. Moreover, trained immunity represents an important newly described 
phenomenon that changes our understanding concerning the relation between fungi and the 
immune system, opening novel perspectives for therapeutic and prophylactic applications.
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Samenvatting en perspectieven
Ondanks de toegenomen kennis over de mechanismen van Candida herkenning en de 
geactiveerde netwerken van het aangeboren en het adaptieve immuunsysteem tijdens de 
infectie (1), blijft er nog veel  te leren over de onderscheidende modulerende effecten van 
Candida spp immuunreacties van de gastheer. Verdere studies zijn gerechtvaardigd om de 
complexe gastheer-pathogenen interacties en de synergie tussen de verschillende pathogen 
herkenningsrecptoren (PRRs) te ontcijferen.
In hoofdstuk 2 van dit proefschrift, analyseerden wij de capaciteit van C. albicans om de 
cytokine productie van perifere bloed mononucleare cellen (PBMC) op bacteriën die normaal 
de huid en slijmvliezen koloniseren, te moduleren. Wij hebben ontdekt dat C. albicans de 
PBMCs activeert tot een verhoogde pro-inflammatoire cytokineproductie wanneer de cellen 
worden blootgesteld aan een secundaire bacteriële stimulie. Dit activerend effect is afhankelijk 
van β-glucan en N-gekoppelde mannan die aanwezig zijn in de Candida celwand. Na de 
chronische blootstelling van primaire humane PBMCs aan C. albicans, worden ze geprikkeld 
voor een daaropvolgende stimulatie met verschillende micro-organismen. Deze mechanismen 
zouden de mogelijke stimulerende effecten van de schimmel in hyperinflammatoire 
omstandigheden (bijvoorbeeld de voorgestelde rol van Candida bij de ziekte van Crohn) 
kunnen verklaren. Daarom is de beschreven Dectin-1/Raf-1 signaalroute verantwoordelijk 
voor dit effect een potentieel therapeutisch doel bij autoinflammatoire ziekten.
In de volgende twee hoofdstuken, onderzochten wij de rol van Dectin-2, een van de 
belangrijkste C-type lectine receptoren (CLRs), voor de aangeboren afweer tegen twee 
belangrijke Candida species: C. albicans en C. glabrata. In hoofstuk 3, bevestigden wij dat 
Dectin-2-/- muizen gevoeliger zijn voor systemische candidiasis, wat waarschijnlijk veroorzaakt 
wordt door verhoogde fungale belasting in de nieren. De fagocytose van C. albicans door 
Dectin-2-/- macrofagen is verminderd ten opzichte van wild type macrofagen. Interessant is 
de vinding dat cytokine productie door macrofagen van Dectin-2-/- muizen met systemische 
candidiasis defect was. Er konden geen opvallende verschillen tussen verschillende Candida 
mutanten in mannanen worden gedetecteerd tussen naïeve wildtype en Dectin-2-/- muizen, 
behalve de β-mannan-deficiënte bmt1Δ/bmt2Δ/bmt5Δ drievoudige Candida mutant. Deze 
observatie suggereert dat de β-mannan gedeeltelijk de α-mannan detectie kan maskeren en 
dat α-mannan de belangrijkste schimmel structuur is die door Dectin-2 herkend wordt.
In hoofdstuk 4 hebben wij laten zien dat Dectin-2 een belangrijk onderdeel is van de afweer 
tegen systemische infectie met C. glabrata. Dectin-2-/- muizen waren meer gevoelig voor 
C. glabrata; deze gevoeligheid was geassocieerd met een combinatie van de verminderde 
productie van beschermende T-helper-afgeleide cytokinen, een defecte fagocytose en 
het doden van de Candida door neutrofielen en  macrofagen. Deze resultaten vergroten 
niet alleen onze kennis over de interactie tussen C. glabrata en het immuunsysteem, 
maar ze geven ons ook inzicht in de mogelijkheden van het ontwerpen van toekomstige 
immunotherapeutische strategieën die op de Dectin-2 receptor zijn gebaseerd.
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Getrainde immuniteit is een nieuw beschreven mechanisme waardoor cellen die 
geassocieerd worden met het aangeboren immuunsysteem geheugenkenmerken vertonen 
bij een tweede ontmoeting met een micro-organisme of een microbiële bestandsdeel (2, 3). 
In hoofdstuk 5, hebben wij bewezen dat een primaire blootstelling aan microbiële liganden 
het functionele lot verandert van monocyten ten opzichte van tolerantie of training, en 
dit afhankelijk is van het betrokken type receptor en van de concentratie van de receptor 
(PRR). Getrainde immuniteit en toleratie kunnen belangrijke effecten hebben op de 
vatbaarheid van de gastheer voor infecties. Dit zou kunnen komen door het induceren 
van langdurige veranderingen bij cellen van het aangeboren immuun systeem (zoals 
monocyten, macrofagen en NK-cellen) waardoor er een niet-specifieke reactie op treedt bij 
een secundaire infectie. Dit zou van uitzonderlijk belang kunnen zijn bij de ontwikkeling 
van nieuwe therapieën tegen overmatige autoinflammatoire reacties, of voor het verbeteren 
van ineffectieve immuunrespons tegen een infectie, door gebruik te maken van aangeboren 
immuunsysteem cellen en hun verwante receptoren en signaalroutes.
In hoofdstuk 6 onderzochten wij of andere commensale schimmels, zoals Saccharomyces 
cerevisiae, ook getrainde immuniteit kunnen induceren. Wij zien dat verschillende 
stammen van Saccharomyces menselijke primaire cellen (PBMCs) kunnen trainen. Dit 
trainingseffect is niet alleen van β-glucan en mannan afhankelijk, maar ook van chitine. 
Specifieke geïsoleerde Saccharomyces stammen van CD (Crohn) patiënten zijn in staat 
om de productie van cytokinen door PBMCs door bacteriële antigenen en schimmels te 
moduleren en dit effect is meestal afhankelijk van chitine. Wij hebben een sterke soort-
specifieke variatie van de cytokine productie na stimulatie van monocyten met verschillende 
menselijke milieu isolaten van S. cerevisiae waargenomen, die ook met de oorsprong van 
de stam is gecorreleerd. Dit suggereert dat de differentiële aanpassing aan de omgeving een 
bepalende factor van schimmel pathogeniteit zou kunnen zijn.
Patiënten met chronische mucocutnaeous candidiasis (CMC) of met Hyper IgE syndroom 
(HIES), hebben defecten in de opwikkeling van Th17 reacties, ondanks dat hun fenotype in 
termen van soorten infecties aanzienlijk verschillen. Onlangs werd STAT1 geïdentificeerd 
als een van de transcriptiefactoren die gemoduleerd is bij de inductie van getrainde 
immuniteit (4). Onze hypothese is dat cellen van patiënten met STAT1 defecten geen 
getrainde immuniteit kunnen ontwikkelen. In hoofdstuk 7 beschreven wij dat CMC 
patiënten met een STAT1-defect, een defect in de opbouwvan getrainde immuniteit 
tegen C. albicans hebben, en dat een dergelijk defect is niet waargenomen bij patiënten 
met STAT3-defect (HIES). Deze resultaten kunnen een klinisch significante waarneming 
benadrukken, met betrekking tot het fenotype van deze twee groepen patiënten en hun 
vatbaarheid voor infecties, aangezien CMC patiënten voornamelijk lijden aan Candida 
infecties (5), terwijl HIES patiënten vooral aan Staphylococcus-infecties lijden (6, 7). Deze 
resultaten zijn belangrijk vanwege het feit dat  nieuwe STAT1- en NK/IFNy-afhankelijke 
routes identificeerd zijn die belangrijk zijn voor de inductie van getrainde immuniteit.
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Toekomstperspectieven
De gerapporteerde resultaten van deze studies dragen bij aan een beter begrip van de aangeboren 
immuunrespons veroorzaakt door voortdurende systemische Candida-blootstelling?, en 
tegelijkertijd, bieden zij nieuwe mogelijkheden voor het onderzoek in de nabije toekomst.
Candida-geïnduceerde activering van de aangeboren immuniteit en de signaalroutes 
die bij dit process betrokken zijn, zouden een belangrijk aspect van de nieuwe 
immunotherapeutische strategieën kunnen zijn. Van bijzonder belang is de rol van 
Dectin-2 in de interactie met verschillende Candida-soorten en haar synergie met andere 
C-type lectines of met TLR’s. Of de Dectin-2 wordt betrokken bij de stimulatie Th17 
immuunreacties of bij de inductie en/of remming van het aangeboren immuunsysteem van 
cytokines zou in de nabije toekomst kunnen worden onderzocht.
Vaccinatie is de meest efficiënte manipulatie van het immuunsysteem; daarom kan het 
gebruik van niet alleen adaptieve, maar ook van de aangeboren immuunrespons, leiden 
tot meer effectieve manieren van bescherming tegen diverse besmettelijke infectieziekten. 
Diverse interessante punten met betrekking tot de getrainde immuniteit blijven over om 
nader te worden onderzocht in de komende jaren. Wat is het trainingseffect van een breed 
scala van verschillende micro-organismen (het zij commensalen of pathogenen) op de cellen 
van het aangeboren immuunsysteem en wat is de preciese relatie tussen hen? Wat zijn de 
belangrijkste mechanismen die de verschillende microbiele liganden induceren bij training 
of tolerantie? Een ander interessant aspect zou kunnen zijn, is het effect van opeenvolgende 
training met dezelfde of met verschillende micro-organismen en/of liganden? Induceren 
ze nog steeds de training/tolerantie en op welk niveau? Is de tijd tussen de training en 
restimulatie van invloed op het uiteindelijke resultaat? Kan de getrainde immuniteit 
teruggedraaid worden en, zo ja, wat is het klinische belang hiervan?
Van specifiek belang blijft welke soort aangeboren immuuncellen, afgezien van 
monocyten/macrofagen en NK-cellen, in staat zijn om kenmerkende herinneringen te 
vertonen. Kunnen dendritische cellen ook reageren op een secundaire stimulatie? Hoe zit 
het met neutrofielen of mestcellen? Wat is de synergie (als die er is) tussen de aangeboren 
en adaptieve cellen tijdens het induceren van getrainde immuniteit?
Tot nu toe, zijn er verschillende epigenetische profielen van getrainde monocyten en/
of macrofagen beschreven als waarschijnlijk de belangrijkste moleculaire mechanismen 
die betrokken zijn bij de training. Wij zullen de komende jaren nodig hebben om de 
epigenetische profielen van andere aangeboren immuuncellen en de periode waarin deze 
wijzigingen zijn terug te vinden na de training, te ontcijferen.
Concluderend, de geïnduceerde immuunreacties door Candida vormen een complex 
signalerend netwerk waarin Candida soorten en misschien zelfs bepaalde stammen 
specifieke effecten induceren en waarbij celwand morfologie en de samenwerking tussen 
PRRs en verschillende cytokines een belangrijke rol spelen. Bovendien is getrainde 
immuniteit een belangrijk nieuw beschreven mechanisme dat onze kennis van de relatie 
tussen schimmels en het immuunsysteem verandert. Dit opent nieuwe perspectieven voor 
therapeutische en profylactische toepassingen van getrainde immuniteit.
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Deși cercetarea a avansat foarte mult în ultimii ani în ceea ce privește mecanismele de 
recunoaștere a Candidei și activarea sistemului imunitar înnăscut (nespecific) și adaptiv 
(specific) în timpul infecției (1), multe rămân însă neelucidate în ceea ce privește efectele 
modulatoare distinctive ale diferitelor specii de Candida și răspunsurile imunitare ale 
gazdei. Studii suplimentare sunt necesare în scopul de a descifra interacțiunile complexe 
dintre gazdă și agenții patogeni, dar și relația de sinergie dintre diferiți receptori prezenți la 
suprafața sau in interiorul celulelor umane.
În capitolul 2 am analizat capacitatea Candidei albicans de a modula răspunsurile citokinelor 
produse de celulele mononucleare din sângele uman periferic (PBMC), la bacterii care 
în mod normal colonizează pielea și mucoasele. Am demonstrat că ciuperca C. albicans 
stimulează celulele imune umane către o producție mărită de citokine proinflamatorii 
atunci când celulele sunt expuse la un stimul bacterian secundar. Acest efect este dependent 
de β-glucan și de N-manan prezent în peretele celular al Candidei. Prin urmare, expunerea 
cronică a celulelor imune primare la C. albicans induce un efect de activare mărită 
către stimularea ulterioară cu diferite microorganisme, mecanism care ar putea explica 
eventualele efecte stimulatoare ale ciupercilor în condiții de hiperinflamare (cum ar fi 
rolul sugerat de Candida în boala Crohn). În concluzie, calea de semnalare Dectin-1/Raf-1 
descrisă în acest studiu ar putea fi responsabilă pentru acest efect, reprezentând o potențială 
țintă terapeutică în bolile autoinflamatorii.
În următoarele două capitole am investigat rolul receptorului Dectin-2 în imunitatea 
înnăscută împotriva a doua dintre cele mai importante specii de Candida: C. albicans și 
C. glabrata. În capitolul 3 am confirmat faptul că șoarecii deficienți în Dectin-2 sunt mai 
sensibili la candidoza sistemică, aceasta datorându-se faptului că numărul coloniilor de 
Candida a fost mărit în rinichii animalelor modificate genetic (fara receptorul Dectin-2) 
comparativ cu animalele din grupul control (cu receptorul Dectin-2). Fagocitoza Candidei 
de către macrofagele deficiente în Dectin-2 a fost moderat scăzută. Interesant, si secreția 
majorității citokinelor produse de macrofagele de la șoarecii deficienți în Dectin-2 ce 
sufereau de candidoză sistemică a fost deficientă. Nu există însă diferențe semnificative 
între mutanți ai Candidei deficienți în mannan în stimularea de citokine de la ambele 
grupuri de șoareci: control și fără Dectin-2. Excepție este însă mutantul triplu deficient în 
β-manan, bmt1Δ/bmt2Δ/bmt5Δ, care nu mai este capabil să inducă IL-6 și KC in animalele 
deficiente în Dectin-2 comparativ cu controalele, sugerând că β-mannan poate masca 
parțial detectarea α-mananului, structura fungică majoră recunoscută de Dectin-2.
În capitolul 4 am arătat că receptorul Dectin-2 joacă un rol important în protejarea împotriva 
infecțiilor sistemice cu C. glabrata. Șoarecii deficienți în Dectin-2 au fost mai vulnerabili la 
C. glabrata, susceptibilitate care a fost asociată cu o secreție scăzuta de citokine protectoare 
derivate de la celulele Th, și o fagocitoză defectuoasă a Candidei de către neutrofile și 
macrofage. Aceste rezultate ajută nu numai la extinderea cunoștințelor noastre în ceea ce 
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privește interacțiunea dintre C. glabrata și sistemul imunitar uman, dar aduce și perspective 
noi în ceea ce privește îmbunătătirea strategiilor immunoterapeutice bazate pe acest receptor.
Imunitatea antrenată (instruită) este fenomenul prin care celulele asociate cu sistemul 
imunitar înnăscut (nespecific) au caracteristici de a memora prezența unui stimul la a 
doua interacțiune cu un microorganism sau cu un ligand de origine microbiană (2, 3). În 
capitolul 5 am arătat că o expunere primară a celulelor imune umane la liganzi microbieni 
modifică soarta funcțională a monocitelor către toleranță sau stimulare, depinzând atât de 
natura receptorilor implicați în acest process, cât și de concentrația lor. Imunitatea antrenată 
și toleranța pot avea efecte importante asupra susceptibilității gazdei la diferite infecții prin 
inducerea de modificări epigenetice pe termen lung în celulele imunitare înnăscute (monocite, 
macrofage sau celule ucigașe naturale (celulele NK)), în ceea ce privește răspunderea non-
specifică la o infecție secundară. Această descoperire poate fi de interes excepțional atât în 
dezvoltarea de noi strategii terapeutice împotriva răspunsurilor autoinflamatorii excesive, 
cât si pentru îmbunătățirea răspunsurilor imune împotriva unei infecții prin valorificarea 
celulelor imune înnăscute, a receptorilor și a căilor lor de semnalizare.
În capitolul 6 am investigat posibilitatea altor ciuperci comensale, cum ar fi Saccharomyces 
cerevisiae, de a avea capacitatea de inducere a imunitătii antrenate. Interesant, am arătat 
că diferite tulpini de Saccharomyces sunt capabile de a instrui celule primare umane, efect 
dependent nu numai de β-glucan și manan, dar și de chitină. Tulpinile izolate în special 
de la pacienții cu Crohn au capacitatea de a modula răspunsul de citokine la antigene 
bacteriene și ciuperci, efect ce este în mare parte dependent de chitină. Am observat o 
corelație puternică între citokine și originea tulpinilor de Saccharomyces sugerând că 
adaptarea diferențiată la mediu ar putea fi un factor determinant al patogenității fungice.
Atât pacienții cu candidoză cronică muco-cutanata (CMC, STAT1), cât și pacienții cu 
sindromul Hyper-IgE (SHIE, STAT3) au defecte în răspunsurile Th17, însă fenotipul lor 
în ceea ce privește tipurile de infecții microbiene diferă semnificativ. Recent, STAT1 a fost 
identificat ca unul dintre factorii de transcripție modulat în timpul inducerii imunității 
antrenate (4). Ipoteza noastră s-a bazat pe faptul că defecte în imunitatea antrenată poate 
caracteriza pacienții cu defecte în STAT1. Prin urmare, în capitolul 7 am raportat că 
pacienții cu defecte în STAT1 (CMC) sunt mai puțin capabili de a dezvolta o imunitate 
antrenată împotriva Candidei albicans, defect ce nu se observă la pacienții cu sindromul 
SHIE (STAT3). Aceste rezultate pot evidenția un fapt clinic semnificativ în ceea ce privește 
fenotipul acestor două grupuri de pacienți și sensibilitatea lor la infecții, deoarece pacienții 
CMC suferă predominant de infecții cu Candida (5), în timp ce la pacienții cu sindromul 
SHIE persistă infecțiile stafilococice (6, 7). Aceste concluzii au importanță biologică 
deosebită datorită faptului că am identificat calea de semnalare STAT1- și NK/IFN-γ ca 
fiind importantă pentru inducerea imunității antrenate.
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Perspective de viitor
Rezultatele raportate în aceste studii contribuie la o mai bună înțelegere a răspunsurilor 
imune înnăscute activate în timpul infecțiilor sistemice cu Candida și deschide perspective 
noi de investigare în ceea ce privește candidozele umane. 
Capacitatea Candidei de a antrena sistemul imun înnăscut și căile de semnalizare implicate 
în acest process reprezintă un aspect important în ceea ce privește dezvoltarea de noi strategii 
imunoterapeutice. Prin urmare, potențialul de exploatare a diferitelor infecții produse de 
Candida ar putea fi de un interes semnificativ în special pentru pacienții care suferă de boli 
autoinflamatorii. Interesant este și rolul receptorului Dectin-2 și interacțiunea sa cu diferite 
specii de Candida, dar și sinergia sa cu alți receptori. O nouă linie de cercetare în viitorul apropiat 
ar putea fi reprezentată de implicarea receptorului Dectin-2 în stimularea răspunsurilor Th17 și 
în stimularea și/sau inhibarea citokinelor produse de sistemul imunitar înăscut.
Vaccinarea reprezintă cea mai eficientă manieră eficientă de manipulare a sistemului 
imunitar; prin urmare, valorificarea nu numai la nivel adaptiv, dar și la nivel înnăscut poate 
duce la modalități mai eficiente de protecție împotriva diferiților factori infecțioși (ciuperci, 
bacterii, virusuri etc). Multe aspecte de mare interes rămân a fi investigate în anii următori 
în ceea ce privește imunitatea antrenată. Care este efectul de antrenare a celulor sistemului 
imunitar înnăscut de către o mare varietate de microorganisme (comensale sau patogene) 
și care este relația dintre ele? Care sunt mecanismele distinctive prin care diferiți liganzi 
induc antrenare sau toleranță? Un alt aspect interesant ar fi efectul de antrenare secvențială 
cu aceleași sau cu diferite tipuri de microorganisme și/sau liganzi? Ar mai putea induce 
antrenare/toleranță și, dacă da, la ce nivel? Va fi rezultatul final influențat de perioada 
de timp dintre antrenare și restimulare? Poate imunitatea antrenată fi reversibilă și, dacă 
da, care ar fi importanța sa clinică? Care dintre celule sistemului imunitar înnăscut, cu 
excepția monocitelor/macrofagelor și a celulelor ucigașe naturale, sunt capabile să prezinte 
caracteristici de memorare? Sunt celulele dendritice capabile să răspundă la o stimulare 
secundară? Dar neutrofile sau mastocite? Ce sinergie ar fi (dacă există) între celulele 
înnăscute și adaptive în inducerea imunității antrenate?
Până în prezent au fost descrise mai multe profiluri epigenetice de monocite și macrofage 
antrenate ca fiind probabil cel mai important mecanism molecular implicat in formarea 
imunității antrenate. În anii următori va trebui să descifrăm atât profilurile epigenetice ale 
diferitelor populații de celule imune nespecifice cât și perioada în care aceste modificări se 
regăsesc după formare.
În concluzie, răspunsurile imune induse de Candida reprezintă o rețea complexă de 
semnalizare în care diferite specii de Candida și, probabil diferite tulpini, induc efecte 
specifice, iar morfologia peretelui celular și colaborarea dintre receptori și citokine joacă 
un rol foarte important. Chiar mai mult, imunitatea antrenată reprezintă un fenomen 
important ce revoluționează cunoștințele noastre privind relația dintre ciuperci și sistemul 
imunitar innăscut, deschizând perspective noi pentru aplicații terapeutice și profilactice.
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